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Summary
During herpes simplex virus (HSV) infection expression of 
the different classes of viral genes is co-ordinately regulated and 
sequentially ordered. The three major classes of genes - 
immediate-early (IE), early and late can be separated on the basis 
of  the kinetics of  their expression and requirements for ongoing 
DNA synthesis. At the core of this regulation are three of the IE 
proteins IE110, IE175 and IE63. Both IE175 and IE63 are
essential for viral growth and IE 110 while non-essential does 
confer growth advantage in cell culture. While much is known 
about transcriptional control of gene expression and the interplay 
of  these three IE proteins, little is known of any post-
transcriptional regulatory mechanisms that may be employed by 
the virus. Recent interest has focused on this area and the aim of 
this study has been the investigation of a virus induced factor, 
termed LPF (late processing factor), which was previously shown 
to selectively increase the 3' processing efficiency of the herpes 
simplex virus type-2 (HSV-2) UL38 late poly(A) site. In this 
study an in vitro 3' processing assay was used to examine the 3' 
processing efficiencies of a selection of herpes simplex virus 
type-1 (HSV-1) poly(A) sites from the three temporal classes of 
genes. It was demonstrated that LPF selectively increased
processing at the poly(A) sites of two late HSV-1 genes while 
having no effect on the processing efficiencies of  another four 
poly(A) sites from the IE and early classes of  genes. In addition 
both LPF responsive poly(A) sites were shown to be inherently 
less efficient 3' processing sites that the non-responsive sites. No 
common factor, which could be responsible for the reduced
efficiency of  these two sites, was identified by sequence or two 
dimensional structural analysis. Examination of  the protein 
binding properties of each of the test poly(A) site RNAs revealed 
that three protein bands A, B and C were consistently bound to 
the poly(A) site RNAs. These proteins were of similar size to 
components of the 3' processing complex required for efficient 
cleavage and polyadenylation of precursor mRNAs. In addition 
the level of  protein binding was shown to be increased by HSV 
infection.
As stated previously the HSV-1 IE63 gene is essential for 
viral growth and it has been shown by a number of  studies to be 
required for late gene expression. There is evidence that it can 
exert this influence at both the transcriptional and post- 
transcriptional levels and also that it may or may not influence 
late gene expression via an effect on DNA synthesis. In this 
study IE63 has been shown to be required for LPF activity and the 
expression of  selected true-late genes (UL38, UL44 and US11). 
IE63 also appears to be required for the efficient expression of 
three additional genes, two early genes UL29 and UL42 
components of the viral DNA synthesis machinery and the IE gene 
IE 110.
The evidence presented here supports a central role for IE63 
in the regulation of gene expession. At least part of the 
mechanism of  this regulation is at the post-transcriptional level 
mediated by its ability to increase the processing efficiency of 
selected poly(A) sites, with specific deficiencies in individual 
poly(A) sites making them targets for regulation. It is clear this 
is not the whole story and that IE63 may exert an additional 
influence via regulation of viral DNA synthesis.
HSV-1 and HSV-2 can transform mammalian cells to a 
tumourigenic phenotype and it has been proposed that 
transformation occurs via a hit-and-run mechanism since the 
continued presence of viral DNA or proteins is not required for 
the maintenance of  the transformed state. One way in which such 
a hit-and-run mechanism might operate is by increasing the 
frequency of  mutations and there is evidence that HSV-1 can act 
as a mutagen. The aim of the second part of this study was to 
identify the properties of  HSV-1 which could induce such 
mutations using a mutagenesis assay based on the shuttle vector 
pZ189. This study was the continuation of work initiated in the 
Institute by P. Clarke and the first step was to increase the 
efficiency of  transformant recovery in the assay. To this end each 
aspect - plasmid preparation, transfection, infection and 
tranformation was optimized in turn and transformant recovery 
increased 3 to 5-fold. Using this assay HSV-1 infection was 
shown to increase the mutation frequency by 2.5-fold, however 
this was not considered to be significantly different from the 
spontaneous mutation frequency and further use o f  the assay to 
determine the mutagenic properties of HSV-1 was not pursued.
iv
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In troduct ion
Chapter 1
Introduction
l . i  H e r p e s  s im p le x  v ir u s  ty p e -1  and  ty p e -2
The large family of Herpesviridae consists of  more than 80 
distinct herpesviruses isolated from a wide variety of  animal 
species. Herpes simplex virus type-1 (HSV-1) and type-2 
(HSV-2) are part of a small group of human herpesviruses of 
which seven have been isolated to date. These include the well 
characterised Epstein-Barr virus (EBV), human cytomegalovirus 
(HCMV) and varicella-zoster virus (VZV) plus the more recently 
identified and less well characterised human herpes virus type-6 
and type-7 (HHV-6 and HHV-7). The main focus of  this study are 
the herpes simplex viruses and the aim of this Introduction is 
therefore to give a general understanding of the properties of 
HSV-1 and HSV-2.
Herpes simplex virus (HSV) infections constitute an 
extremely prevalent communicable disease in humans. There are a 
range of clinical manifestations of infection from localised 
ulcerative vesicular lesions of the lips, nasal membranes or 
genital skin, to more severe but thankfully rarer infections such as 
keratoconjunctivitis, encephalitis, eczema, respiratory tract and 
gastro-intestinal tract involvement. Transmission of HSV occurs 
via close contact with virus at the mucosal membranes or skin 
break, in either the oral or genital area. Primary infection is 
normally localised and self-limiting in the immunocompetent 
individual, however severe infections of longer duration, which
1
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can also be disseminated, occur in the immunocompromised or 
immunologic ally immature individual (Whitely, 1985). In general 
HSV-1 is the predominant cause of oral infections and HSV-2 is 
responsible for genital infection, however a variable proportion of 
genital infections are due to HSV-1.
Following initial infection with HSV, the virus rapidly 
enters the peripheral nerve endings and is transported to the 
neuronal cell bodies of the sensory ganglia where the virus 
assumes a life-long latent state (reviewed by Rock, 1993). The 
latent virus can be reactivated at widely varying intervals and is 
transported ante-retrograde along the sensory axon from the 
ganglion back to the epithelial cells. In general recurrent disease 
is of  shorter duration and milder than the primary infection.
1.1.1 M orphology
All members of the Herpesviridae, including HSV-1 and 
HSV-2, show the same morphology, which is the primary basis of 
identif ication. Each virion is between 120-200nm in diameter and 
is made up of the following four components (reviewed by Rixon, 
1993) (Figure 1.1).
The core was originally thought to be composed of a 
f ibri llar spool around which the viral DNA was wrapped. 
However recent studies suggest that there is little or no protein 
present in the core and that the volume is taken up entirely by 
DNA, the liquid state of which gives the featureless appearance 
seen by electron microscopy (Booy et al., 1991).
The capsid is an icosahedral structure (100-1 lOnm in 
diameter) which surrounds the core and is composed of 150 
hexameric and 12 pentameric capsomeres.
2
DNA
Tegument
/
Envelope Capsid
FIGURE 1.1:
Representation of the virion morphology of 
the Herpesviridae, showing the relative 
positioning of the outer envelope layer 
containing glycoprotein molecules, the 
tegument and the capsid surrounding the 
central core of double stranded DNA.
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The tegument is the most poorly understood part of the
virion and is the layer of proteinaceous material found between
the capsid and the envelope.
The envelope is the bilayered lipid membrane surrounding 
IS
the tegument which^studded with multiple copies of virus encoded 
glycoprotein molecules.
1.1.2 C lassif ication
Members of the Herpesviridae family have been classified 
into three sub-groups (a, P and y) on the basis of their biological 
properties. The other main system of classification is based on 
the arrangement of reiterated DNA sequences within the virus 
genome, with the Herpesviridae being divided in to six sub-groups 
on this basis (A to F) (Figure 1.2). The biological properties of  
each newly isolated herpesvirus are easy to establish and this 
method has therefore been adopted as the dominant criterion for 
classification (reviewed by Roizman, 1993).
(a) Alpha herpesv iruses
Alpha herpesviruses can have either a narrow or wide host 
range both in vivo and in vitro. The reproductive cycle is 
characteristically short (<24h) with rapid spread of infection in 
cell culture resulting in the mass destruction of susceptible cells. 
Latent infection can be established and is frequently but not 
exclusively in sensory ganglia. Included in this group are HSV-1, 
HSV-2, bovine herpes virus-2 and VZV.
3
Example
(No of isomers)
CCV (1)
HVS (1)
EBV (1) 
VZV (2) M
Group
A
B
C
D
2LHSV (4) 0  
MCMV (1)
I <— > E
F
FIGURE 1.2:
A schematic diagram of  the DNA sequence arrangements of the 
six classes (A-F) of genomes of the Herpesviridae. Lines 
represent unique sequences and arrowed lines show possible 
inversions. Repeats o f  > lkb  are represented by open boxes and 
small reiterated sequences are represented by lined boxes. 
Arrows above the boxes denote whether the repeats are direct or 
inverted. The relative positioning of the a sequences are 
indicated. The number of possible isomers are given in 
parenthesis. CCV I channel catfish virus, HVS : herpesvirus 
saimiri, EBV : Epstein-Barr virus, VZV : varicella-zoster virus, 
HSV : herpes simplex virus, MCMV : murine cytomegalovirus, 
(adapted from Roizman, 1993).
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(b) Beta herpesviruses
Beta herpesviruses have a narrow host range in vivo, their 
replicative cycle is relatively long and lytic progression slow. In 
culture the infected cells frequently become enlarged. Latent 
infection is possible in secretory glands, lymphoreticular cells 
and kidneys. Members of this group include HCMV.
(c) Gamma herpesv iruses
The gamma herpesviruses have a limited host range, 
infecting only T or B cells in vivo and lymphoblastoid cell lines 
in vitro. In lymphocytes viral replication is often arrested at 
either the pre-lytic or lytic stage, arrest at the pre-lytic stage 
results in persistence with minimal viral gene expression. The 
length of the reproductive cycle is variable and latent infection is 
frequently demonstrated in lymphoid tissue. A classic example of 
this grouping is EBV.
1.1.3 The virus life cycle
HSV infection of mammalian cells, the subsequent 
replication of the virus with production of numerous progeny and 
the ultimate lysis of the host cell takes a relatively short time (18- 
20h in fully permissive tissue culture). This time span does not 
reflect the complex and incompletely understood nature of  the 
series of steps required for this occurrence. The following 
section gives a brief outline of the viral replicative cycle as we 
understand it to date (reviewed by Roizman and Sears, 1993).
4
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(a) Entry
Entry of the virus into the host cell occurs in two phases, 
viral attachment with rapid transition to penetration of virus into 
the cell. The surface of the virus is covered by multiple copies of 
glycoprotein molecules, of which 10 have been identified : gB 
(UL27), gC (UL44), gD (US6), gH (UL22), gK (UL53), gL (UL1), 
gG (US4), gE (US8), gj (US5) and gl (US7) (reviewed by Spear, 
1993). Entry of the virus is thought to require the sequential or 
simultaneous interaction of the virion envelope glycoproteins with 
cell surface receptors (Fuller and Lee, 1992). The initial 
interaction is between the virion glycoprotein C molecules and 
heparan sulphate on the cell surface (McClain and Fuller, 1994; 
Herold et a t ., 1991). The subsequent interaction of glycoproteins 
B, H and D with the cell surface results in stable attachment of 
the virion and fusion with the plasma membrane and finally 
release of the nucleocapsid into the cell cytoplasm (Cai et a l ., 
1988; Fuller and Spear, 1987; Desai et a l ., 1988). Both
glycoproteins B and C are capable of binding to the cell surface 
heparan sulphate molecules (Fuller and Lee, 1992; Herold et a l ., 
1991; Kuhn et al., 1990), however other cell surface receptors 
involved in this process remain to be identified. The precise roles 
of  these glycoproteins are not known and it is probable that other 
surface glycoproteins are also involved in the process. Two likely 
candidates are glycoprotein K, which is thought to play a role in 
controlling virus-induced cell fusion and glycoprotein L which 
forms a heterodimer with glycoprotein H an association which 
appears to be required for the processing and intracellular 
transport of  both the glycoprotein H and glycoprotein L proteins 
(Hutchinson et al., 1992). Although virus entry of  the cell can
5
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occur by endocytosis this route is thought to be non-productive 
and results in the destruction of the virus in the intracellular 
lysosomes (Spear, 1993).
(b) R elease  of  v iral  DNA
The now de-enveloped virus capsid is transported to the 
nuclear pores via the cellular cytoskeleton where its DNA is 
released into the nucleus of  the cell. Release of the viral DNA 
requires a viral protein, thought to be the product of  the UL36 
gene (Batterson et al., 1983). In addition, there is a requirement 
for certain virion components to make their way into the nucleus. 
Host macromolecular synthesis is subsequently shut off by the 
virion host shut off  factor (VHS), a component of  the virion 
tegument, whilst  transcription of viral IE genes, by the cellular 
RNA polymerase II, is induced by the virion tegument protein 
Vmw65 (VP 16, ctTIF, UL48).
(c) Viral gene express ion
Transcription of  viral DNA by host cell RNA polymerase II 
takes place in the nucleus of the cell, the mature transcripts are 
transported to the cytoplasm where protein synthesis is carried 
out. A detailed description of the co-ordinate regulation of HSV 
gene expression (Honess and Roizman, 1974; Clements et al., 
1977; Watson et al., 1979) is given in Section 1.1.6.
(d) V iral DNA synthes is
Viral DNA synthesis occurs in the host cell nucleus, can be 
detected from 3h post infection (pi) and continues for at least 
another 9-12h pi. DNA is replicated by a rolling circle
6
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mechanism producing head-to-tail concatamers of unit-length viral 
DNA, which are cleaved and packaged into pre-formed capsids. 
The viral proteins involved in the process of DNA synthesis and 
their various functions are discussed in Section 1.1.8.
(e) Capsid  assembly
Three basic capsid forms are evident from electron 
microscope examination of HSV infected cells (reviewed by 
Rixon, 1993). 'A' capsids which have no internal structure
(Gibson and Roizman, 1972; Cohen et al., 1980), 'B' intermediate 
capsids which lack viral DNA but possess a core consisting of  a 
second proteinaceous layer inside the outer capsid shell (Sherman 
and Bachenhiemer, 1988; Rixon et al., 1988), and 'C' full capsids 
containing the viral genome. 'B' capsids are thought to be the 
progenitors of  the fully mature 'C' capsids, with the core proteins 
of the B capsids being lost prior to DNA packaging. The 
additional proteins found in ’B' capsids are thought to have 
protease and scaffolding functions (Rixon, 1993), and 'A' capsids 
are generally thought to be the end products of defective 
packaging (Schrag et al., 1989) The proteins encoded by the 
HSV-1 genes that have been identified as components of the virus 
capsid are as follows : UL19, UL38, UL26.5, UL26, UL18 and 
UL35, with the UL26 and UL26.5 proteins only present in the 'B' 
capsids. Recently Tatman et al., (1994) demonstrated, using a 
baculovirus expression system, that the polypeptide products of  
UL19, UL38 and UL18 genes (VP5, VP19C and VP23) are 
required for formation of the major structural components of the 
outer capsid shell, with UL26 and UL26.5 encoding proteins 
involved in scaffold formation. However the exact relationship of
7
In troduc t ion
the three capsid forms and their roles in assembly and DNA 
packaging remain to be clarified.
(f) Envelopm ent and viral egress
Different theories exist regarding the mechanisms by which 
the virus capsid becomes enveloped and leaves the cell (reviewed 
by Rixon, 1993). The first, and undisputed stage, is budding of 
the capsid through the inner nuclear membrane, the virus then 
follows one of two possible routes. (a) The newly acquired 
envelope fuses with the outer nuclear membrane, or with the 
contiguous endoplasmic reticular membrane and the capsid is 
released into the cytoplasm. Envelopment of the capsid ocurring 
by budding through a cytoplasmic membrane (Cheung et a l ., 1991; 
Whealy et a l ., 1991). (b) The envelope acquired in the first step
is retained and the virion enters the cytoplasm in a vacuole 
formed by the outer nuclear membrane. Both theories suggest that 
final maturation of the virion is achieved in the golgi with egress 
of the virion by exocytosis from golgi-derived vesicles. Much of 
the information available on capsid envelopment is based on 
electron microscopic examination of virus infected cells, which 
have been treated with Brefeldin A, which results in dissassembly 
of the golgi complex. The results of these experiments show that 
Brefeldin A inhibits the formation of viral particles without 
affecting nucleocapsid formation, with aberrant accumulation of 
enveloped virions within the perinuclear cisternae and rough 
endoplasmic reticulum, lending support to theory (a) (Eggers et 
a l ., 1992; Cheung et a l ., 1991; Whealy et a l ., 1991). There is as 
yet no clear evidence to indicate whether the final stage of
8
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tegumentation takes place in the nucleus or the cytoplasm of the 
cell.
(g) L ight-part ic les
Cells infected with HSV-1 and a number of other a  
herpesviruses release not only virions but in addition non- 
infectious virion related particles, termed light or L-particles 
(Szilagyi and Cunningham, 1991; McLauchlan and Rixon, 1992). 
In cell culture infected cells release mature virions and L- 
particles in approximately equal amounts. L-particles are 
composed of tegument surrounded by envelope components but 
lack capsid and viral DNA. The pathway of L-particle formation 
is unclear, however the ability of L-particles to attach to and fuse 
with cells and release tegument proteins has been shown to be 
similar to wild type (wt) virus (McLauchlan et al., 1992a; Rixon 
et al., 1992), this would suggest that virions and L-particles are 
produced by related pathways. Although L-particles have not 
been shown to occur in vivo , equivalent structures have been 
demonstrated in infections with other a  herpesviruses 
(McLauchlan and Rixon, 1992), the role of L-particles could 
therefore constitute a general feature of herpesvirus infections. 
L-particles have been demonstrated to deliver two tegument 
proteins,  Vmw65 and VHS, to the cell cytoplasm with an 
efficiency equal to the wt virion (McLauchlan et al., 1992a). A 
possible advantage of L-particles in vivo would be to increase the 
supply of tegument-derived helper functions thereby enhancing 
the infectious process.
9
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(h) Virion host shut o f f  (VHS)
During HSV-1 or HSV-2 infection of permissive cells, viral 
gene expression and polypeptide synthesis occurs against a 
background of declining host macromolecular synthesis and 
inhibition of host DNA synthesis (reviewed by Fenwick, 1984). 
The efficiency with which host shut off occurs varies between the 
two virus strains, HSV-2 in general is more efficient than HSV-1, 
with effects being seen from 2-4h pi. There are two distinct 
phases of  host protein synthesis suppression (Kwong et a t ., 1988), 
the initial phase, dissociation of mRNA from the polysomes, is 
mediated by a virion tegument component, the product of the 
UL41 gene (Kwong et a t ., 1988; McGeoch et a t ., 1988). This first 
phase does not require viral gene expression, having been shown 
to occur in cells infected in the presence of actinomycin D 
(preventing viral gene expression), and in cells infected with UV- 
irradiated virus (Kwong and Frenkel, 1987). The second mechanism, 
reduction of the remaining levels of  protein synthesis, similarly 
does not require viral gene expression and results in the 
degradation of mRNA to non-hybridizable fragments and a decline 
in DNA synthesis (Fenwick and Clark, 1982; Fenwick, 1984). 
Kwong et at., (1988), have mapped virus mutations which affect 
both phases of shutoff of  host protein synthesis to a single 265bp 
region of the virus genome and propose therefore that both these 
activities are mediated by a single viral gene (UL41). This 
function has been shown to shorten both cellular and viral mRNA 
ha l f  lives (Strom and Frenkel, 1987) and while VHS is not 
essential for virus growth in cell culture it appears to confer 
growth advantage to the wt virus.
10
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(i) Latency
A significant and as yet incompletely understood property of 
herpesviruses is their ability to establish latent infections in their 
natural hosts (reviewed by Rock, 1993, Fraser et al., 1992). The 
a  herpesviruses are neurotropic and can be maintained in the non­
dividing cells of the neurons and therefore are not required to 
replicate to maintain their latent state. The normal infective cycle 
consists of viral replication at the site of primary infection
followed by axonal transport of the virus to the neuronal cell
bodies. After acute ganglionic infection subsides virus persists in 
the neuron, during this time infectious virus is not recoverable 
from ganglionic homogenate. Reactivation of the virus can be 
induced by a variety of stimuli, stress, UV irradiation, nerve root 
section, trauma at the site of primary infection, hyperthermia or 
explant culture of ganglia. During reactivation the virus is
transported centrifugally via the nerve cell axon to the original 
site of infection.
In latency the virus genome is present in a non-integrated 
episomal state (Mellerick and Fraser, 1987). Restricted viral 
transcription has been demonstrated in the latently infected
neurons of rabbits, mice and humans. Three collinear latency 
associated transcripts (LATs) of 2.0 kb, 1.5 kb, and 1.45kb have 
been detected by Northern analysis of RNA isolated from latently 
infected ganglia (Spivack and Fraser, 1987, Stevens et al., 1987, 
Wagner et al., 1988), the 2.0 kb transcript can also be detected in 
productively infected non-neuronal cells (Spivack and Fraser, 
1987, Stevens et al., 1987), and recently an approximately 8kb 
RNA species homologous to the LAT region has been observed in 
productively infected cells (Zwaagstra et al., 1991; Devi-Rao et
1 1
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al., 1991). The LATs map to the long repeat region of the viral 
genome, are anti-parallel to and overlap the 3' terminus of the 
immediate early IE110 gene (Figure 1.3). The small 
predominantly nuclear poly(A)‘ RNAs are related by splicing 
(Spivack et al., 1991), and are thought by some to represent stable 
introns of the larger 8kb transcript (Farrell et al., 1991, Rader et 
al., 1993). To date expression of LAT related HSV-1 proteins has 
not been convincingly demonstrated and it is possible that the 
LATs are functional RNAs which do not encode proteins. A 
number of LAT deletion mutant viruses have been used to study 
the function of these transcripts however the exact role of the 
LATs in latency has not been established. The general consensus 
of opinion is that the LATs are not required for the establishment 
or maintenance of latent infection but may play a role in 
reactivation from latency (Block et al., 1990; Dobson et al., 1989; 
Lieb, 1989a; Javier, et al., 1988; Deshmane et al., 1993; Hill et 
al., 1990). There is some conflicting in vitro and in vivo evidence 
emerging to suggest that the LATs may be involved in both of 
these functions (Sawtell and Thompson, 1992). Differences in the 
reactivation phenotypes of the LAT mutant viruses appears to be 
related to the extent and positioning of the deletions involved. 
Deletion mutants missing a 168bp region upstream of the putative 
promoter (Batchelor and O'Hare, 1990) and the TATA element 
(Nicosia et al., 1993), in which no LAT transcripts were 
detectable, showed normal explant reactivation (Block et al., 
1990). Whereas deletion of the promoter and portions of the 5' 
region of the major 2kb LAT transcript, produced viruses which 
were unable to reactivate (Block et al., 1993) or reactivate poorly 
(Hill et al., 1990) from the latent state. It was init ially proposed
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FIGURE 1.3:
The LAT region of HSV-1, (taken from Fraser et al., 1992).
A : conventional prototype map of the HSV-1 genome, showing 
the posit ion and orientation of the latency associated transcripts 
(LATs) within the genome.
B : The LAT region, showing the positions (in bp) of the smaller 
LAT transcripts (LAT), the larger transcript (mLAT), the adjacent 
genes UL54, UL55 and UL56, the overlapping IE 110, the IE 175 
gene and neurovirulence factor y 34.5 (RL1), relative to the 152kb 
genome. The TATA box of the promoter is located at position
118773.
In troduct ion
that the LATs may function as antisense regulators of  IE110 
expression (Stevens, 1987) however there is as yet no data 
available from animal models to support this hypothesis and IE110 
deletion mutant viruses have been shown both to fail to reactivate 
(Lieb et al., 1989b) and to reactivate efficiently (Clements and 
Stow, 1989).
(j) Transform ation
The effect of HSV infection on cellular transformation and 
the association of HSV with cervical cancer will be discussed in 
Chapter 5.
(
1.1.4 Genome structure
The HSV genome is approximately 150kb in length and has a 
G+C content of 68% (HSV-1) or 69% (HSV-2) (Roizman and 
Sears, 1993). It consists of two covalently linked components 
designated L (long) and S (short). Each segment contains unique 
sequences ( U l  and Ug) flanked by a pair of repeat sequences, one 
of  which is terminal ( T R l  and TRg) and the other internal ( IR l  
and IRs)- The molecule contains regions of terminal redundancy, 
a sequences, which vary in size from strain to strain (400bp in 
HSV-1), one or more of  which are located internally at the L/S 
jo in t  a ' and lie in the opposite orientation to the terminal a 
sequences (Sheldrick and Berthelot, 1975) (Figure 1.4). In 
addition to the a sequences and inverted repeats HSV-1 DNA 
contains a number of small tandemly reiterated sequence elements 
varying in copy number (McGeoch et al., 1988). Preparations of 
HSV virion DNA contain equivalent amounts of four isomers 
(Figure 1.4) which differ in the orientation of the L and S
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FIGURE 1.4:
Shows the structure of the HSV-1 genome.
A : the unique sequences are il lustrated as solid lines (UL and 
U s), the repeats TRL, IRL, IRS and TRS are illustrated as boxes, 
showing the relative positions of the a sequences.
B : the isomers of HSV-1. P (prototype), Is (S inverted with 
respect to P), II  (L inverted with respect to P), Ils (L and S 
inverted with respect to P).
In troduct ion
segments around the joint (Delius and Clements, 1976; Wilkie, 
1976; Hayward et al., 1975). The a sequences present at the L/S 
jo in t  contain signals required for the cleavage and packaging of 
the concatameric DNA (Stow and McMonagle, 1983; Varmuza and 
Smiley, 1985; Mocarski and Roizman, 1982). The presence of 
internal copies of the a sequences therefore provides alternative 
sites for these events and could account for half  of the 
isomerizations.  The isomers appear to be functionally identical 
(Davison and Wilkie, 1983) however the significance of the 
ability of  the virus to produce such isomers is uncertain.
1.1.5 The nucleotide sequence
The HSV-1 genome has been fully sequenced (reviewed by 
McGeoch et al., 1988) and the entire HSV-2 genome is currently 
being sequenced (F. Jamieson personal communication). The 
HSV-1 genome is estimated to encode at least 74 unique genes, 
three of which are present in the inverted repeat regions and are 
therefore duplicated. The U l  region contains 58 genes and the 
U s region 12 genes with an additional 2 genes in the U l  inverted 
repeats and one gene in the Ug inverted repeats (McGeoch et al., 
1985; 1986; 1988). A diagram of the HSV-1 genome map taken 
from the study of McGeoch and Schaffer (1992), is shown in 
Figure 1.5. In general transcripts start close upstream of the 
ORFs and terminate adjacent to poly(A) sequences located either 
immediately downstream of the ORF to be expressed or further 
downstream after another similarly orientated ORF or ORFs.
The HSV-1 and HSV-2 genomes are generally similar (Kieff 
et al., 1971; Kudler et al., 1983), 50% of their sequences exhibit 
homology and the coding sequence of corresponding genes show
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FIGURE 1.5:
Diagrammatic representation of the genetic content of  HSV, 
(adapted from McGeoch and Schaffer, 1992), showing the scale of  
the DNA sequence in kbp. The location and direction of  proposed 
protein coding reading frames are indicated by broad arrows : 
Immediate-early (IE, a)  genes W* ; early (P) genes £§£&> ;
early-late (yj)  ^  ; and true late (7 2 ) genes ; genes of
unknown class are white. The gene designations are given below 
the relevant open reading frames (ORFs) and polyadenylation 
sites are indicated by small vertical arrows. RNA transcripts are 
shown as thin arrows, reasonably well characterised transcripts 
are shown as solid lines and poorly characterised transcripts or 
hypothetical transcripts  are shown as dashed lines. Positions of 
major families of  short tandem reiterations are shown as fi lled 
boxes beneath the gene layouts and are marked "R". ori ; origin 
of  replication.
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in general 70-80% identity and non-coding regions, in particular 
the major repeats, show greater differences (Davison and Wilkie, 
1981; Whitton and Clements, 1984).
1.1.6 HSV-1 gene expression
The HSV-1 genes and the functions or properties of the 
proteins they encode, which have been identified to date, are 
listed in Table 1.1 (McGeoch and Schaffer, 1992), with the 
addition of the recently identified US8.5 gene, which has as yet 
no known function (Georgopoulou et a l ., 1993). Two main
systems of nomenclature are used for the identification of HSV-1 
genes and their protein products, the Glasgow and Chicago 
systems. Use of these different systems leads sometimes to 
confusion regarding the gene being described. For simplification 
I have referred to the HSV-1 genes and proteins discussed in this 
study by their UL/US number (the Glasgow system), with the 
exception of the immediate early genes which will be referred to 
by their  IE number. Included in Table 1.1 are examples of the 
alternative nomenclatures used.
The genes of  HSV-1 form several groups whose expression 
is co-ordinately regulated and sequentially ordered in a cascade 
fashion (Honess and Roizman, 1974; Clements et a l ., 1977;
Watson et a l ., 1979). There are three major classes of  genes : 
immediate-early (IE, a) ,  early (P) and late (yj and 7 2 ), 
differentiated according to their kinetics of expression and 
requirements for ongoing DNA synthesis. Transcription of HSV 
DNA using the cellular RNA polymerase II takes place in the 
nucleus of  the cell, HSV mRNAs are similar to host cell mRNAs 
in capping, methylation and polyadenylation, however very few
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TABLE 1.1 :
A list of HSV-1 genes, indicating the function of the proteins 
they encode (where known) and whether the gene is essential  
(e) or non-essential  (ne) for viral growth in tissue culture, 
(taken from McGeoch and Schaffer, 1993).
TABLE 1.1
HSV-1 Prote in /Function  Status
gene (a lternative  nomenclature)
a 400bp terminal redundancy : sequence
contains signals for processing/packaging e
of nascent DNA
RL1 Neurovirulence factor (ICP34.5 y 34.5) ne
RL2 IE 110 (ICPO; VmwllO; a0, IE1) ne
LAT Latency associated transcripts ne
UL1 Glycoprotein L e?
UL2 Uracil-DNA glycosylase ne
UL3 Unknown ne
UL4 Unknown ne
UL5 Component of the DNA helicase- primase
complex e
UL6 Role in virion morphogensis (VP11-12?) e
UL7 Unknown
UL8 Component of  the DNA helicase- primase
complex e
UL9 Ori-binding protein e
UL10 Probable integral membrane protein ne
UL11 Myristylated tegument protein ; role in
envelopment and transport of nascent virions ne
UL12 Deoxyribonuclease ; role in maturation and
packaging of nascent DNA virions e
UL13 Tegument protein (VP18.8) ne
UL14 Unknown
UL15 Unknown; possible NTP-binding motifs e?
UL16 Unknown ne
UL17 Unknown ne
UL18 Capsid protein (VP23)
UL19 Major capsid protein (VP5) e
UL20 Integral membrane protein; role in egress
of nascent virions e/ne
TABLE 1.1 cont inued
UL21 Unknown -
UL22 Glycoprotein H e
UL23 Thymidine kinase ne
UL24 Unknown ne
UL25 Virion protein e
UL26 Capsid protein (VP24) ; proteinase e
UL26.5 Internal protein of immature capsids (VP22a) e?
UL27 Glycoprotein B e
UL28 Role in capsid maturation/DNA packaging e
UL29 ssDNA binding protein (ICP8) e
OriL Origin of replication ne
UL30 Catalytic subunit of DNA polymerase e
UL31 Unknown -
UL32 Unknown -
UL33 Role in capsid maturation/DNA packaging e
UL34 Membrane associated phosphoprotein ; 
substrate for US3 protein kinase _
UL35 Capsid protein (VP26) -
UL36 Very large tegument protein (VP1-2, Vmw273) e
UL37 Unknown : forms a complex with UL29 protein ; 
may have a DNA binding role -
UL38 Capsid protein (VP19c) e
UL39 Ribonucleotide reductase large subunit 
(ICP6, Vmwl36, R l) e/ne
UL40 Ribonucleotide reductase small subunit 
(Vmw38, R2) e/ne
UL41 Virion host shut off factor ne
UL42 Subunit of DNA polymerase; complexes 
with UL30 protein e
UL43 Unknown ; probable integral membrane protein ne
UL44 Glycoprotein C ne
UL45 Virion protein ne
UL46 Modulates IE gene transactivation by the 
UL48 protein (Vmw65) ne
TABLE 1.1 cont inued
UL47 Tegument protein (VP13-14?) ; modulates
IE gene transactivation by the UL48 protein ne
UL48 Major tegument protein ; transactivates IE
genes (Vmw65, VP16, a  TIF) e
UL49 Tegument protein (VP22)
UL49A Possible membrane glycoprotein e?
UL50 Deoxyuridine triphosphatase ne
UL51 Unknown ne
UL52 Component of the DNA helicase-primase
complex e
UL53 Glycoprotein K e?
UL54 IE63; post-transcriptional regulator of gene
expression (ICP27, Vmw63, IE2) e
UL55 Unknown ne
UL56 Unknown ne
RSI IE175; transcriptional regulator
(ICP4, Vmwl75, IE3) e
OriS Origin of  replication e?
US1 IE68; regulatory protein (ICP22, Vmw68, IE4) e/ne
US2 Unknown ne
US3 Protein kinase; phosphorylates UL34 ne
US4 Glycoprotein G ne
US5 Glycoprotein J? ne
US6 Glycoprotein D e
US7 Glycoprotein I ne
US8 Glycoprotein E ne
US9 Virion protein ne
US10 Virion protein ne
US 11 Virion protein; r ibosome-associated in the
infected cell ne
US12 IE12; function unknown (ICP47, Vmwl2, IE5) ne
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viral mRNAs are derived by splicing compared to host mRNAs, 
where the majority are spliced (Wagner, 1985). Only five HSV 
ORFs IE110, US12 (IE12), US1 (IE68) and UL15, contain introns 
(Watson, et a \ ., 1981, Rixon and Clements, 1982; Perry et al.,
1986).
A number of 5' and in particular 3' co-terminal "families" of 
mRNA transcripts have been described (McLauchlan and 
Clements, 1982; Wagner, 1985; Wagner and Roizman, 1969; 
Murchie and McGeoch, 1982; Frink et al., 1981; Watson and 
Vande Woude, 1982) (Figure 1.5) and a few RNAs are known to 
extend beyond the usual polyadenylation site (Holland et al., 
1984; Chou and Roizman, 1986; Anderson et al., 1981). In 
addition to these observations selective and possibly regulated use 
of polyadenylation signals has been described (McLauchlan et al., 
1989; 1992b).
(a) Im m ediate -ear ly  (a )  gene expression
The five IE genes IE110 (IE1), IE63 (IE2), IE175 (IE3), 
IE68 (IE4) and IE12 (IE5), are the first viral genes to be 
transcribed and do not require de-novo viral protein synthesis for 
their  expression (Honess and Roizman, 1974; Clements et al., 
1977; Wagner, 1985). IE110 and IE175 are encoded within the
terminal and internal repeat sequences of  the genome and are 
therefore diploid (Watson et al., 1979; Anderson et al., 1980; 
Mackem and Roizman, 1980; McGeoch et al., 1988). IE68 and 
IE 12, which contain identical promoter and 5' leader sequences 
are located in the short repeat region with their coding sequences 
in the US region (Watson et al., 1981). IE63, the only IE gene
not associated with the repeat sequences, is encoded entirely
16
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within the UL region of the genome (Figure 1.5). The regulatory 
regions of the IE gene promoters contain elements found in most 
eukaryote promoters, such as the TATA box and SP1 site (GC rich 
elements) (Figure 1.6). In addition all IE genes contain variable 
copy numbers of a unique DNA consensus motif, TAATGARAT, 
required for response of the promoter to the virus encoded 
transactivator Vmw65 (a TIF, VP16, UL48) (Roizman and Sears, 
1993, Gaffney et a l ., 1985, reviewed by O'Hare, 1993). Vmw65, 
a protein component of the virus tegument, by itself  binds DNA 
poorly, it has been shown however to interact with two cellular 
factors, Oct-1 and an additional factor variously termed HCF 
(host cell factor ; Greaves and O'Hare, 1990), Cl  factor (Kristie 
et al., 1989), VCAF (Vmw65 complex assembly factor ; Xiao and 
Capone, 1990) or CFF (complex forming factor ; Katan et al.,
1990), which direct the binding of  Vmw65 to the TAATGARAT 
consensus. Oct-1, which stimulates the transcription of a number 
of  cellular genes, binds to a sequence known as the octamer motif, 
ATGCAAAT, which overlaps with the 5' (TAAT) portion of the 
TAATGARAT element. Oct-1 and Vmw65 form a low affinity 
complex with TAATGARAT (Kristie et al., 1989; La Marco et al.,
1991), and the additional host factor has been shown to stimulate 
complex formation by several orders of magnitude (Kristie et al., 
1989). The transcriptional activities of  Vmw65 appear to be 
separate from its ability to complex with Oct-1 (Ace et al., 1988; 
Greaves and O'Hare, 1989; Triezenberg et al., 1988), with 
evidence that the acidic C-terminal domain of Vmw65 is essential 
for the in vivo transactivation of the IE genes (Greaves and 
O'Hare, 1989; Triezenberg et al., 1988; Werstuck and Capone, 
1989). It has been suggested that the C-terminal domain of
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FIGURE 1.6 :
Diagrammatic representation of the promoters of the three classes 
of HSV-1 genes (adapted from Johnson and Everett, 1986). All 
classes of  promoter contain a capsite and TATA box. IE 
promoters contain additional upstream promoter sequences and the 
TAATGARAT regulatory region required for activation of IE gene 
expression by the virion protein Vmw65. Early promoters require 
only the upstream sequences and late promoters consist of the 
TATA box and capsite linked to a functional origin of  replication.
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Vmw65 activates IE gene expression by promoting assembly of an 
initiation complex containing the TATA box binding protein 
topologically altered for productive initiation (reviewed by 
O’Hare, 1993).
(b) Early (P) gene expression
Expression of the early genes will only proceed after the IE 
genes have been expressed, requiring both the IE110 and IE175 
gene products for efficient activation of transcription, with peak 
expression occurring between 5-7h pi (Roizman and Sears, 1993). 
Information regarding the DNA sequence elements required for 
early promoter activation has been gained mainly from studies of 
the thymidine kinase promoter (UL23). Mutational analysis has 
shown that the promoter consists of  four regions located 
immediately upstream of the cap site : the TATA box, an inverted 
CAAT motif, and two GC rich elements which the bind the 
cellular transcription factor SP1 (McKnight et a l ., 1981; Jones et 
al., 1985) (Figure 1.6). These sequences are also important for 
activation of transcription in the absence of viral proteins, which 
suggests they interact with cellular factors (Everett, 1987).
(c) Late (y) gene expression
DNA replication is required for the maximal expression of 
this group of genes (Honess and Roizman, 1974; Swanstrom and 
Wagner, 1974; Powell and Courtney, 1975; Marsden et al., 1976), 
with peak expression occurring from 10-16h pi, approximately 2h 
after the peak of viral DNA synthesis (Roizman, 1969; Wilkie, 
1973). The late genes can be divided into two groups depending 
on the stringency of their requirement for DNA replication. The
18
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yj genes - sometimes described as leaky late or early late, have 
reduced but detectable levels of expression when DNA synthesis 
is inhibited. The 72  genes - the ’true' late genes, their expression 
is hard to detect in the absence of DNA synthesis (Wagner, 1985; 
Roizman and Sears, 1993). The promoter regions of this group of 
genes are minimal, with only a limited requirement for DNA 
sequences upstream of the TATA box and cap site (Johnson and 
Everett, 1986; Homa et a l ., 1986) (Figure 1.6). Recent studies, 
involving deletion and mutation of the UL38 (7 2 ) promoter region, 
have demonstrated that sequence elements downstream of the 
TATA box and spanning the transcriptional start site of this 
promoter are functionally different from the early and 71 
promoters. They show that this 7 2  promoter consists of a core of 
sequences from the TATA box to sequences up to and including 
the transcription start, linked to a downstream activating element 
within the nontranslated leader region (Guzowski and Wagner, 
1993). Transfection studies have shown that, like early gene 
promoters, late promoters are activated by IE proteins, with 
evidence for the involvement of IE63, IE68 and IE 175 in late gene 
expression (Sears et a l ., 1985; Sacks et a l ., 1985; Dennis and 
Smiley, 1984; De Luca and Schaffer, 1985; Everett, 1986). The 
role of IE63 in this process will be discussed in the following 
Section. There are two main theories explaining the dependence 
of late gene expression on DNA synthesis. The first suggests that 
late genes are self regulated during the early phase of viral 
infection, either by the binding of trans-acting negative factors or 
by physical constraints placed by the DNA secondary structure in 
the vicinity of  the late genes. In this case DNA replication would 
relieve the block allowing full expression of the late genes
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(Mavromara-Nazos and Roizman, 1987). The second theory 
suggests that a trans-activator is produced or modified during 
viral DNA replication thus allowing activation of late gene 
expression (reviewed by Roizman and Sears, 1993). To further 
complicate our understanding of late gene expression it has been 
shown that HSV-1 temperature sensitive (ts) mutants deficient in 
the major binding protein (UL29), which are blocked at the level 
of viral DNA synthesis, express low levels of a 7 2  protein 
glycoprotein C (UL44) (Godowski and Knipe, 1983), which would 
suggest that, in this case at least, late gene expression is not 
entirely dependent on the activation of DNA synthesis.
1.1.7 Protein expression
The majority of HSV proteins examined to date appear to be 
extensively post-translationally modified. Such modifications 
include cleavage (eg. UL26), phosphorylation (a number of HSV-1 
proteins are phosphorylated including the IE proteins IE 175, 
IE110, IE68 and IE63) (Purves et al., 1991; 1992; Purves and 
Roizman, 1992), sulphation (glycoproteins) (Erickson and Kaplan, 
1973; Hope and Marsden, 1983), glycosylation (glycoproteins) 
(Campadelli-Fiume and Serafini-Cessi, 1985), myristylation 
(UL11) (MacLean et al., 1992) and poly(ADP-ribosyl)ation 
(IE 175, UL18) (Preston and Notarianni, 1983; Blaho et al., 1992). 
However the relationship between these modifications and the 
functions of  the various proteins is unclear, although the 
glycoproteins must at least be partially glycosylated to function, 
and virions produced in the presence of tunicamycin (a drug 
which inhibits N-linked glyscoylation) are noninfectious 
(Kousoulas et al., 1983). Phosphorylation of proteins has been
2 0
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shown in other systems to modulate a variety of macromolecular 
events, such as transcription, translation and viral transformation 
(Hunter and Karin, 1992). Phosphorylation can also modulate 
protein function by inducing allosteric conformational changes 
(Hurley et a l ., 1990; Sprang et al., 1988). Eleven HSV induced 
phosphoproteins have been detected, which include four of the IE 
proteins, the UL41 (VHS) protein, the UL39 protein (the large 
sub-unit of  ribonucleotide reductase), and the UL42 protein (part 
of the viral DNA polymerase complex) (Marsden et al., 1987). 
Pulse chase studies have shown that the phosphates of several of 
these proteins (IE175, IE68 and IE63) cycle on and off during 
viral replication (Wilcox et al., 1980). However, the functional 
role of phosphorylation for most of these viral proteins remains 
unknown.
(a) The im m ediate -ear ly  proteins
Synthesis of the IE proteins reaches peak rates at 2-4 h pi, 
with mRNA and protein continuing to accumulate until late in 
infection. To date all IE proteins with the exception of IE 12, 
which has no known role as yet, have been shown to have 
regulatory functions (Roizman and Sears, 1993). All the IE 
polypeptides are phosphorylated and located predominantly in the 
nucleus of  infected cells (Hay and Hay, 1980; Periera et al., 
1977), with the exception of IE 12 which is not phosphorylated 
and is found in the cytoplasm of infected cells (Preston, 1979; 
Marsden et al., 1982).
IE110 (IE1) plays an important although non-essential role 
during productive infection in cell culture. Mutant viruses
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containing deletions of IE110 do not grow as efficiently as wt in 
cell culture and the replication efficiency of these mutants 
appears to be dependant on host range and multiplicity of 
infection (moi). Infection of Vero and HeLa cells at a low moi 
produced a lower virus yield from Vero cells than from HeLa 
cells, while at high moi virus yield was the same in both cell 
types (Chen and Silverstein, 1992). Transfection studies have 
demonstrated that IE110 is able to activate IE, early and late gene 
expression (Gelman and Silverstein, 1985; Cai and Schaffer, 1992; 
O'Hare and Hayward, 1985), with co-ordinate expression of IE175 
and IE 110 being required for the efficient activation of early 
genes (Gelman and Silverstein, 1986; Everett, 1984). In addition 
co-transfection studies have shown that IE 110 is capable of 
enhancing IE 175 expression from transfected viral DNA, and can 
thus activate IE gene expression in the absence of other viral 
proteins. It has been proposed therefore that IE110 could, by this 
ability to induce IE 175 expression, be involved in the reactivation 
of the virus from the latent state (Cai and Schaffer, 1992; Russell 
et a l ., 1987; Lieb et al., 1989a).
IE63 (IE2) is one of only two IE genes whose expression is 
essential for virus replication (Sacks et al., 1985), the other is 
IE 175. A number of studies have indicated that the IE63 protein 
is involved in the regulation of viral gene expression (Sacks et 
al., 1985; Smith et al., 1992; Sekulovich et al., 1988; Hardwicke 
et al., 1989, McMahon and Schaffer, 1990) and is specifically 
required for late gene expression. The plethora of conflicting 
information available and the apparently mult ifunctional nature of 
the IE63 protein makes identification of the specific mechanism of
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this regulation difficult. Initial studies of a range of virus 
mutants deficient or lacking in IE63 expression, showed generally 
similar phenotypes, overexpression of IE proteins, significant 
levels of  early proteins and reduced levels of late proteins. Thus 
demonstrating a role for IE63 in the regulation of HSV gene 
expression (Sacks et a l ., 1985). Transient transfection assays 
have demonstrated that IE63 acts synergistically with IE 175 
and/or IE 110 to trans-repress or trans-activate transcription from 
the promoters of  selected HSV-1 genes, while having little or no 
effect alone (Sekulovich et al., 1988, McMahon and Schaffer, 
1990, Hardwicke et al., 1989). However Rice and Knipe (1988), 
have shown that IE63 alone can stimulate at least one HSV 
promoter, that of  glycoprotein B (UL27). In general IE and early 
promoters were repressed and late promoters stimulated by IE63.
There is also evidence for IE63 mediated post- 
transcriptional regulation of viral gene expression (Sandri-Goldin 
and Mendoza, 1992; Smith et al., 1992; McLauchlan et al., 
1992b). Sandri-Goldin and Mendoza demonstrated that (a) 
poly(A)+ RNA levels were increased by IE63 where the target 
gene had only the minimal poly(A) signal and no further 
downstream regulatory sequences and that (b) spliced mRNAs 
containing 5' or 3' introns were reduced 5 - to 10- fold in the 
presence of IE63. A comparsion of the levels of transcription of 
wt HSV-1 with an IE63 ts mutant (Smith et al., 1992) showed that 
while synthesis of IE transcripts was reduced and synthesis of late 
transcripts continued in the mutant at NPT, this did not correlate 
with levels of  mRNA and protein present. IE mRNA and protein 
accumulated and late mRNAs and proteins were reduced. 
McLauchlan et al., (1992b) demonstrated that IE63 expression
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was required for the activity of a virus induced factor, termed 
LPF, which increased the 3' processing efficiency of the HSV-2 
UL38 late poly(A) site mRNA. Taken together these results 
provide strong evidence for IE63 mediated post-transcriptional 
regulation of these mRNAs.
It has been suggested (Sandri-Goldin and Mendoza, 1992) 
that IE63 down regulates host cell gene expression po’st- 
transcriptionally via an effect on splicing, this would be a 
convenient regulatory mechanism since very few virus transcripts 
are spliced in comparison to the host cell. During virus infection 
distribution of components of  the splicing machinery, small 
nuclear ribonulceoproteins (snRNPs), are found to condense into 
distinct foci in the nucleus of  the infected cell (Martin et a l .,
1987), and recent studies have demonstrated that IE63 is required 
for this localisation and in fact co-localises with the redistributed 
snRNPs (Phelan et a l ., 1993). In addition during HSV infection 
it has been shown that there is a decrease in splicing of the cellular genes 
GAPDH, actin and (3-tubulin which requires the expression of IE63 (Sandri- 
Goldin and Mendoza, 1992). In addition, IE63 deficient virus 
mutants show greatly impaired host shut off, although this is most 
likely due to the absence of a late gene product required for this 
function (Sacks et a l ., 1985).
The expression of late viral genes requires ongoing viral 
DNA synthesis and it has been proposed that IE63 affects late 
gene expression via an effect on DNA synthesis. Direct 
involvement of  IE63 in DNA synthesis has been difficult to 
demonstrate conclusively, the series of  ts and deletion virus 
mutants studied, show a range of DNA synthesis abilities, from 
little or no DNA synthesis in the deletion mutants (18% of wt
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HSV) (McCarthy et al., 1989), to moderate (46% of wt HSV), or 
unaltered synthesis (100% of wt HSV) in the ts mutants (Sacks et 
al., 1985). These differences are likely to be dependent on the 
nature of  the mutations, the deletion mutants producing little or 
no IE63 protein and the ts mutants producing aberrant forms of 
the IE63 protein. Curtin and Knipe (1993) have noted that in 
IE63 mutant virus infected cells, assembly of pre-replicative 
complexes in the nucleus is defective, and may be due to an 
observed conformational change in the UL29 protein, which is 
required for formation of these structures. It has also been 
reported that the electrophoretic mobility of IE 175 is altered in 
cells infected with IE63 mutant viruses (Su and Knipe, 1989). It 
is possible that IE63 could therefore be influencing gene 
expression indirectly by affecting the activities of components 
required for gene trans-activation and DNA synthesis.
The range of defects in protein expression seen in cells 
infected with IE63 mutant viruses demonstrate the multifunctional 
nature of  this protein. It would seem likely therefore that it 
contains several domains which affect gene expression both 
posit ively and negatively. Deletion analysis has identified several 
functional domains within the 512 amino acid polypeptide product 
of the IE63 gene (Figure 1.7). The trans-activating property of 
the protein has been mapped to its C-terminal half, and the trans­
repressing function localised to the C-terminal third of the protein 
(Hardwicke et al., 1989, Rice and Lam, 1994). In addition 
sequences which resemble zinc-finger metal binding domains, 
which are capable of binding zinc and single-stranded DNA in 
vitro , have been identified in the C-terminal 105 amino acids 
(Vaughan et al., 1992). Analysis of the acidic N-terminus has
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shown that whilst not required for the trans-activating and trans­
repressing functions, amino acids 12-63 are required for an 
essential lytic function of the virus (Rice et al., 1993). Mutants 
lacking this region are deficient in DNA replication but do not 
show severe defects in gene expression. The N-terminal half  also 
contains a nuclear localization signal within amino acids 109-138. 
Finally amino acids 138-152 encompass a region composed 
entirely of arginine and glycine residues, this RGG-box region has 
been found in several cellular proteins which have been 
implicated in nuclear RNA processing (core snRNP proteins, 
nucleolin and fibrillarin) (Lam et al, 1992).
Taken together these results provide a picture of a complex 
protein capable of activating and repressing gene expression, with 
these activities localized to the C-terminus and quite separate 
from the signals which may confer its nuclear localization.
IE175 (IE3) is essential for HSV replication and is the 
major transactivator of  HSV genes. Studies using HSV-1 ts 
mutants in IE 175 (eg. tsk) have demonstrated that at NPT there is 
overexpression of IE RNAs and polypeptides and early and late 
proteins are not synthesised (Courtney et al., 1976; Marsden et 
al., 1976). Temperature shift experiments showed the IE175 is 
continuously required for early gene transcription, since a shift to 
the non-permissive temperature ends early gene expression and IE 
mRNAs accumulate. It was concluded from this data that IE 175 is 
required for transcription of later classes of  genes (Watson and 
Clements, 1980) and is involved in autoregulation of IE gene 
transcription (Preston, 1979; Dixon and Schaffer, 1980). Alone 
IE 175 is capable of activating transcription, however the effect is
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increased substantially when IE 110 is present (Everett, 1984). 
Additional evidence suggests that IE63, IE110 and IE175 act co­
operatively to regulate viral gene expression (Everett, 1986;
Gelman and Silverstein, 1985, McMahon and Schaffer, 1990;
O'Hare and Hayward, 1985). IE175 has been implicated in the
regulation of IE gene expression, plasmids expressing IE 175 can 
repress both basal and activated levels of transcription from the 
IE175 promoter (Michael and Roizman, 1993; O'Hare and 
Hayward, 1985) In addition increased levels of IE175 have been 
shown to reduce transcription from IE175, IE68 and IE12 
promoters (DeLuca and Schaffer, 1985). Although IE175 is
clearly required for the expression of early and late genes the 
exact mechanism of this action has not been determined. Tedder 
et a l ., (1989) have shown that in vitro the presence of IE 175 
binding sites enhance the transcription of the early gene,
glycoprotein D (US6). However another study has shown that
mutation of the IE 175 binding sites within the glycoprotein D 
promoter region had no effect on transcription (Smiley et al.,
1992). Current theories suggest that IE175 has a role in the 
stabilisation of  TATAA box dependent factors (Roizman and 
Sears, 1993).
IE68 (IE4) As yet no clear function has been assigned to 
IE68. There is however some evidence to suggest it may play a 
role in late gene expression of the virus. A deletion mutant 
missing the carboxy terminal of the protein, has varied growth 
characteristics depending on the cell type infected, appearing to 
grow normally in some and poorly in others, with the activity of
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at least one true late promoter reduced (Post and Roizman, 1981; 
Sears et al., 1985).
IE12 (IE5) There appears to be no obvious or essential role 
for this protein during tissue culture infections, mutants lacking 
the entire gene remaining viable (Longnecker and Roizman, 1986; 
Umene, 1986; Brown and Harland, 1987).
(b) The early  proteins
The majority of early genes encode proteins which are 
involved in DNA metabolism and replication, their expression 
signaling the onset of viral DNA synthesis. DNA replication and 
the involvement of the following p gene products UL30 (DNA 
polymerase), UL29 (the major DNA binding protein), UL9 (ori 
binding protein), UL8 (component of  the helicase primase 
complex), and UL42 (subunit of the DNA polymerase) are 
described in detail in the following Section. In this Section 
therefore only a brief  description is given of those P gene 
products involved in the optimal utilization of the 
deoxyribonucleoside pools required for efficient DNA synthesis. 
The majority of these enzymes, with the exception of 
ribonucleotide reductase, are non-essential for virus growth in 
cell culture, however many of the enzymes involved in nucleotide 
metabolism appear to confer an advantage to the virus during 
infection of the natural host (Morrison, 1991).
Alkaline DNase, encoded by the UL12 gene, is thought to 
supply preformed nucleotides to the replicative machinery of the 
virus by hydrolysis of  cellular DNA (Weller et al., 1990). It has 
been proposed that this enzyme has an additional role in the
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cleavage of viral DNA concatamers prior to packaging of the viral 
DNA (Morrison, 1991).
Thymidine kinase, the enzyme encoded by the UL23 gene 
phosphorylates nucleoside analogues. The substrate specificity of 
the viral enzyme is much lower than its cellular counterpart and 
as such many of the anti-viral drugs used in the treatment of 
herpes infection are nucleoside analogues.
Ribonucleotide reductase is formed as a tetramer of  two 
subunits encoded by the UL39 gene (large subunit) and the UL40 
gene (small subunit) (Ingemarson and Lanikien, 1987). The 
enzyme catalyses the reduction of rNDPs to dNDPs a crucial step 
in the synthesis of deoxyribonucleotides.
dUTPase encoded by the UL50 gene hydrolyses dUTP to 
dUMP, the role of this enzyme appears to be suppression of the 
size of the dUTP pool relative to that of dTTP ensuring that the 
ratio of  U:T incorporated into newly synthesised DNA is kept low 
(Williams and Parris, 1987).
Three of the (3 proteins which have known functions encode 
virus structural proteins, UL49 is a constituent of the tegument, 
US6 encodes glycoprotein D and UL27 encodes glycoprotein B, 
the US6 and UL27 proteins have also been assigned to the yi class 
of proteins (Roizman and Sears, 1993).
(C) The late proteins
The majority of the structural components of the virus 
tegument, capsid and envelope are late proteins. For example : 
the tegument proteins encoded by UL48 (Vmw65) and UL41 
(VHS) are classified as yl proteins : the capsid proteins encoded 
by UL19 (the major capsid protein, VP5) and UL38 are members
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of the yi and 72  groups respectively. The surface glycoprotein 
components are divided between the yi and 7 2  groups, US8, US4, 
US5 and US7, are yi genes which encode glycoproteins E, G, J 
and I respectively. The UL22 and UL44 72  genes encode 
glycoproteins H and C respectively, and finally the UL45 7 2  gene 
encodes a structural protein which is non-essential for growth and 
most likely an envelope protein (Visalli and Brandt, 1991; 1993).
1.1.8 DNA replication
The HSV genome contains three origins of replication (ori), 
two ori elements map to the repeat sequences flanking the US 
region and one maps to the UL region, situated between the 
transcription start sites of UL29 and UL30 (McGeoch et al., 
1988). The three ori elements are functionally equivalent, with 
early studies showing that none of the ori elements are uniquely 
required for viral replication (reviewed by Roizman and Sears, 
1993). Transient complementation assays, in which cloned 
segments of  HSV DNA were tested for their ability to support 
replication of co-transfected plasmids containing the oriS and 
orih  have identified seven proteins which are required for ori 
dependent DNA synthesis (Wu et al., 1988; Challberg, 1986). 
These studies have recently been substantiated by Stow (1992), 
using a recombinant baculovirus system expressing the seven 
proteins. These proteins which are encoded by the HSV genes 
UL5, UL8, UL9, UL29, UL30, UL42 and UL52 are thought to 
form multiprotein complexes, held together by protein-protein 
and/or DNA-protein interactions such as those involved in other 
eukaryotic DNA replication systems (Bramhill and Kornberg,
1988). Figure 1.8 shows a schematic summary of the biochemical
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FIGURE 1.8:
Schematic summary of the activites of the HSV-1 
encoded proteins required for viral DNA 
replication and their functions in formation of the 
replication fork, proposed by Challberg (1991).
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activities of the HSV encoded proteins involved in DNA 
replication proposed by Challberg, (1991). However, it is likely 
that other viral and/or cellular proteins are required, for example 
no virus encoded ligase or topoisomerase has been identified as 
yet (Roizman and Sears, 1993).
UL9 The protein encoded by the UL9 gene has been shown 
to be capable of binding to the ori, and three UL9 binding sites 
have been identified within the ori (Challberg, 1991; Elias et a\., 
1990; Olivio et a t ., 1988). The DNA binding domain of the 
protein has been localised to the C-terminal third of  the 
polypeptide chain (Weir et a l ., 1989), however the exact
interaction of UL9 with the ori has not been fully determined. 
The events following binding of UL9 to the ori, that lead to 
init iation of DNA synthesis, are even less well understood : 
before intiation of synthesis of the DNA daughter strand can 
occur the two parental strands must be unwound and it has been 
proposed that the binding of UL9 triggers this in some way. 
Consistent with this idea is the finding that UL9 has an intrinsic 
helicase activity (Bruckner et a l ., 1991). Boehmer et a l ., (1993) 
have demonstrated that UL9 can catalyse the ATP-dependent 
unwinding of  a DNA duplex, alone UL9 has only limited DNA 
unwinding ability, their studies showed that the addition of the 
UL29 protein (the major DNA binding protein) had a stimulatory 
effect. Furthermore the UL9 protein has been shown, by the use 
of protein affinity-chromatography, to form a tight complex with 
UL29 (Boehmer and Lehman, 1993a). It has been proposed 
therefore that the UL29/UL9 protein complex plays an important 
role in the recognition of the ori and unwinding of the DNA
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duplex. To date however there is no experimental evidence that 
the UL9 helicase activity plays an essential role in the initiation 
of DNA unwinding at the origin of replication.
UL5/UL8/UL52 The proteins encoded by these genes form 
a complex in which each protein is present in equimolar amounts. 
This complex has been shown to function as both a primase and a 
helicase, and its biochemical properties suggest that it primes 
lagging strand synthesis as it unwinds DNA at the replication fork 
(Crute et al., 1988; 1989). Both the primase and helicase
activities of this complex require the presence of the UL29 
protein, which may serve to stabilize the ssDNA or localize the 
complex to the replication fork (Crute and Lehman, 1991). 
Studies using recombinant baculovirus expressed proteins have 
demonstrated that a subcomplex of the UL5/UL52 proteins 
contains both helicase and primase activity with no apparent 
requirement for UL8 (Calder and Stow, 1990; Dodson and 
Lehman, 1991). It has been proposed that UL8 may therefore 
function by stabilizing the association of the RNA primers with 
template DNA (reviewed by Challberg, 1991).
UL30/UL42 The DNA polymerase exists as a heterodimer 
of the UL30 and UL42 polypeptides (Hernandez and Lehman, 
1990; Gottlieb et a l ., 1990; Crute and Lehman, 1989; Monahan et 
al., 1993). UL30 contains the catalytic activity and in addition to 
its polymerase activity has an intrinsic 3' to 5' exonuclease 
activity, which may serve as a proof-reading function (O'Donnell 
et a l ., 1987) and a 5' to 3’ exonuclease/RNase H activity (Crute 
and Lehman, 1989). During the semi-discontinuous synthesis of
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the lagging strand, this activity may serve to remove the RNA 
primers from the 5' end of Okazaki fragments. UL42 has been 
shown to increase the processivity of the polymerase enzyme 
(Gallo et al., 1989; Hernandez and Lehman, 1990). For this 
increase to occur it has been demonstrated that the DNA binding 
protein of UL29 must be complexed to the single stranded DNA 
(Hernandez and Lehman, 1990).
UL29 The DNA binding protein (ICP8 ) encoded by the 
UL29 gene is a central component of the replication machinery. 
Three of the HSV-1 replication enzymes are stimulated by the 
UL29 protein, the DNA polymerase (Hernandez and Lehman, 
1990; Ruychan and Weir, 1984), the helicase-primase (Crute and 
Lehman, 1991), and the origin-binding protein (Boehmer et al.,
1993). In addition UL29 appears to be involved in the correct 
localisation of the replication proteins within the infected cell 
(Quinlan et al., 1984; De Bruyn Kops and Knipe, 1988; Curtin 
and Knipe, 1993). The UL29 protein has also been shown to 
lower the melting temperature of synthetic polynucleotides (Wang 
and Hall, 1990; Powell et al., 1981), de-stabilise partial DNA 
duplexes (Boehmer and Lehman, 1993b). It has also been shown 
to bind more tightly to single stranded DNA than double stranded 
DNA (Ruyechan, 1983; Ruyechan and Weir, 1984: Lee and Knipe, 
1985) where binding is co-operative and independent of 
sequence. It has been proposed therefore that UL29 functions by 
unwinding the parental duplex DNA thus facilitating the use of 
these strands as templates for the DNA polymerase (reviewed by 
Challberg, 1991), as yet however no direct evidence for this 
exists. Ellis-Dutch and Lehman (1993), have demonstrated that
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the UL29 protein can promote renaturation of complementary 
single stranded DNA and suggest a role for this protein in the 
high level of recombination that occurs during HSV-1 infection. 
Trans-dominant UL29 HSV mutants have been identified which 
can inhibit viral replication and significantly inhibit the 
production of wt HSV-1. Expression of the mutant UL29 protein 
inhibits wt UL29 function and results in a reduction of viral DNA 
replication and late gene expression (Gao and Knipe, 1991). In 
addition, the UL29 protein appears to have a negative regulatory 
effect on IE175 expression (Godowski and Knipe, 1986). UL29 
therefore appears to play an important role in maintenance of  the 
cascade of viral gene expression.
34
In troduc t ion
1.2 m R N A  3 f end f o r m a t io n
Eukaryotic gene expression requires the activities of  
complex biochemical machinery to transcribe, process and 
transport mature mRNA from the nucleus to the cytoplasm of the 
cell for translation into a functional protein product. The areas 
within the nucleus to which the transcriptional and post- 
transcriptional events are localised and the mechanism by which 
mRNA is transported into the cytoplasm for translation have not 
yet been fully identified. There is evidence however, which 
suggests that splicing and polyadenylation of nascent RNA 
transcripts occurs close to the site of transcription and fully 
processed transcripts, in particular spliced transcripts, are 
transported along tracks to the nuclear pores, where they exit into 
the cytoplasm, (reviewed by Rosbash and Singer, 1993). 
Regulation of gene expression could occur at a number of  levels, 
with the majority of past investigations focusing on 
transcriptional control. Over the past decade an increasing 
understanding of post-transcriptional events has stimulated 
interest in these processes as a means of regulating gene 
expression.
During synthesis of  the primary transcripts transcription 
continues across the polyadenylation site and termination of 
transcription can occur at a considerable distance downstream of 
the DNA sequences coding for the 3' mRNA termini (Citron et a l ., 
1984; Le Meur et al., 1984; Birnstiel et al., 1985).
Formation of the mRNA 3' end (Manley, 1988; Wahle and 
Keller, 1992; Leff and Rosenfeld, 1986) is carried out by an RNA 
processing reaction which involves the endonucleolytic cleavage 
of the RNA followed by addition of a poly(A) tract by the poly(A)
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polymerase. These poly(A) 'tails'  play an important role in the 
life of the mRNAs, with evidence emerging that they are involved 
in the control of mRNA stability, export of the RNA from the 
nucleus and mRNA translation (Jackson and Standart, 1990; 
Atwater et al., 1990; Wickens, 1990b; Bacharova, 1992).
Regulation of these events could therefore occur at any or 
all of the following stages; transcription termination, 3' end 
formation, splicing, stability and translation. In this study we 
have examined the effect of 3' processing efficiency on the 
regulation of gene expression. In this introduction the 
mechanisms of cleavage and polyadenylation of mRNA are 
considered in detail and a brief outline is given of the other post- 
transcriptional events which influence gene expression.
1.2.1 Cleavage and polyadenylation
Nearly all mammalian mRNAs, with the exception of the 
major histone mRNAs, are polyadenylated at their 3' ends. 
Polyadenylation of precursor mRNA occurs in a two-step reaction, 
endonucleolytic cleavage followed by the addition of a 200-300nt 
stretch of  A residues. The development of  in vitro systems, that 
faithfully reproduce these events (Manley, 1983; Moore and 
Sharpe, 1984; 1985), has been an important step forward in their 
investigation. The ability to study the cleavage and 
polyadenylation steps separately has in addition allowed the 
individual requirements of  these two events to be investigated.
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1.2.2 Sequence requirements
(a) Poly(A) signal
The hexanucleotide sequence AAUAAA, a pre-requisite for 
cleavage and polyadenylation, is found in virtually every 
eukaryotic mRNA that has been isolated or sequenced. Its 
distance from the mRNA 3' end, while not precise, is found in the 
vast majority of cases to be 10  to 30nt upstream of the actual 
cleavage site, which is usually at an A or CA residue (reviewed by 
Manley, 1988; Leff and Rosenfeld, 1986; Wahle and Keller, 
1992). Deletion of this sequence has been shown to prevent 
stable 3' end formation of mRNA (Fitzgerald and Shenk, 1981), 
with mutational analysis of the sequences demonstrating an 
absolute requirement for the U at position 3. Mutation of the 
AAUAAA to AAUACA results in an 8 -fold reduction in cleavage 
efficiency, the AAUUAA mutation a 25-fold reduction, and the 
AAUGAA and AACAAA mutations a 50-fold reduction in cleavage 
efficiency (Wickens and Stephenson, 1984). Computer assisted 
analysis, of 269 vertebrate cDNA sequences, compiled the 
following consensus sequence for the poly(A) signal :-
A 9 8  A s 6  U 1 0 0  A 9 9  A 9 9  A 9 8
U l 2
The numbers indicating the percentage frequency of 
occurrence of the nucleotide shown at that position (Wickens, 
1990a).
The only natural variant, AUUAAA which is present in 12% 
of the mRNAs compared, functions nearly as efficiently as the 
canonical sequence (Wilusz et a l ., 1989; Hagenbuchle et al.,
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1980; Jung et al., 1980). While the cleavage reaction requires 
additional sequences, the hexanucleotide appears to be sufficient 
for the polyadenylation reaction (Ryner et al., 1989; Conway and 
Wickens, 1987), with efficient polyadenylation occurring on pre­
cleaved mRNA substrates containing the AAUAAA hexanucleotide 
(Zarkower et al., 1986; Manley et al., 1985; Moore and Sharpe, 
1985). The studies of Wigley et al., (1990) demonstrated that 
there must be a minimum distance of l i n t  between the 
hexanucleotide and the cleaved 3' end to allow polyadenylation to 
occur, and that the 2' hydroxyl of  the hexanucleotide U is required 
for the binding of specific processing factors. They propose that 
on shorter substrates the poly(A) polymerase cannot 
simultaneously contact the specificity factor and the mRNA 3' 
end.
(b) D ow nstream  elements
The realisation that sequences in addition to the 
hexanucleotide were required for efficient 3' end formation arose 
from the observation that the AAUAAA sequence was found 
within protein coding regions where it was apparently never 
utilized. Sequences downstream of the AAUAAA, which enhance 
the efficiency of 3 ’ end formation, have been identified in a 
number of  systems, with the SV40 late poly(A) site receiving 
considerable attention. Deletion analysis has shown that 
sequences between 3 and 60nt downstream of the AAUAAA, of 
the SV40 late poly(A) signal, are required for the efficient 
util ization of the normal polyadenylation site, and a functional 
element has been identified that is contained within the sequence 
AGGUUUUUU (Sadofsky and Alwine, 1984; Sadofsky et al.,
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1985). While Conway and Wickens (1987), agree that sequences 
downstream of the AAUAAA are necessary for 3' end formation, 
their chemical modification analysis, suggests that the critical 
features of  the element are either diffuse or redundant. Further to 
this it has been demonstrated that these downstream elements are 
required not only for cleavage and polyadenlyation but also for 
the accuracy of cleavage (Ryner et al., 1989). It has been 
suggested that the differences observed in these studies result 
from the use of different cell lines. However it has been shown 
that deletion of sequences from 6 nt downstream of the AAUAAA, 
dramatically reduced 3' end formation in both hamster and monkey 
cell lines and in addition deletion of the consensus proposed by 
Sadofsky had no effect on processing efficiency (Gimmi et al.,
1988). Similarly, examination of the rabbit (Gil and Proudfoot, 
1987) and mouse (Chen and Nordstrom., 1992) p globin poly(A) 
sequences has identified elements downstream of the AAUAAA 
which are critical for efficient 3' end formation. In HSV, deletion 
of the region 2 to 20nt 3' of the thymidine kinase gene poly(A) 
signal resulted in a 4-fold decrease in its processing efficiency 
(Cole and Stacy, 1985; Zhang et al., 1986). The transfection 
studies o f  McLauchlan et al. (1985), showed that deletion of 
sequences located around 30nt downstream of the AAUAAA of the 
HSV-2 IE 12 poly(A) signal, containing the consensus motif  
YGTGTTYY (Y=pyrimidine), reduced expression from a CAT 
reporter gene, fused upstream of this poly(A) site, to negligible 
levels. Computer analysis showed that this sequence was present 
in 67% of the mammalian 3' mRNA termini which were examined.
In addition a number of these studies demonstrated that the 
activity of  the downstream element was dependent on its
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proximity to the polyadenylation site. Increasing the natural 
distance of the element from the AAUAAA by 10 to 40 nt 
abrogated any effect the element had on 3 ' end formation (Cole 
and Stacy, 1985; Zhang et al., 1986, Gil and Proudfoot, 1987; 
McDevitt et al., 1986).
It is apparent from the evidence presented in these studies 
that two distinct types of downstream element exist, either GU- or 
U-rich in composition, and studies which examined both the SV40 
early and adenovirus E2A poly(A) sequences, which contain GU- 
and U-rich elements respectively, found them to be functionally 
interchangeable. Sequence compilation analysis has identified U- 
rich TG/ANNNTTTTT (Renan, 1987), AGUUUUUU (Sadofsky et 
al ., 1985), or GU rich YGTGTTYY (McLauchlan et al., 1985; 
Taya et al., 1982) elements to be present in the 3' termini of  the 
majority of mammalian mRNA on which data is available.
(c) U pstream  elements
In a number of studies, sequence elements located upstream 
of the AAUAAA hexanucleotide, have also been shown to affect 
the efficiency of 3' end formation. Mutational analysis of the 
SV40 late mRNA poly(A) sequences has identified a region, 13- 
51nt 5' of the AAUAAA, which influences the efficiency of the 3' 
RNA processing. This region consists of three core elements of 
the sequence AUUUGURA (R=purine) which function in a 
distance dependent and co-operative manner. Increasing the 
distance between the elements and the AAUAAA decreases the 
efficiency of  processing and the effect of multiple copies of  the 
sequence is additive (Schek et al., 1992). Deletional analysis has 
shown that sequences 5' of the poly(A) site of the adenovirus
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major late transcription unit (MLTU) are part of a selector 
element which promotes predominantly L] site usage (DeZazzo 
and Imperiale, 1989). The ground squirrel hepatitis virus (GHSV) 
poly(A) sequences contain elements, located within 107nt 
upstream of the less efficient hexanucleotide variant UAUAAA, 
that increase the efficiency of 3' processing of this site from 
< 1 0 % to 50-60% (Cherrington et a l ., 1992). A number of studies 
of HIV 3’ processing have identified a sequence element, 
(CUUUUUG) 56-93nt 5' of the AAUAAA, which enhances the 
processing efficiency at the 3' LTR poly(A) sequences 
(Valsamakis et al., 1992; Cherrington and Ganem, 1992; 
Gilmartin et al., 1992; Weichs an der Glon et al., 1993). In yeast 
two upstream sequence elements, UAGUAGUA and 
UAGUCUGUA, have been identified which enhance the efficiency 
of 3’ end formation (Hou et al., 1994). In the retroviral systems 
the situation is further complicated by the fact that the genomic 
RNA contains the canonical poly(A) signal at both the 5' and 3' 
ends, production of this RNA requires that the 5' copy must be 
ignored. Processing at the correct 3' end may therefore result 
from occlusion of the 5’ AAUAAA by the proximity of the capsite 
(Weichs and der Glon et al., 1991), or by an increase in 
processing efficiency of the 3' site, mediated by the upstream 
elements (Valsamakis et al., 1992; Gilmartin et al., 1992). In 
addition it has been suggested that both mechanisms operate to 
specify usage of the 3' AAUAAA (Cherrington and Ganem, 1992; 
Weichs and der Glon et al., 1993).
These upstream sequence elements appear to be functionally 
similar and show little or no sequence homology just a general U- 
richness. This has led to the suggestion, unconfirmed as yet, that
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they may function in a manner similar to that of the downstream 
elements, possibly interacting with the same factors (Valsamakis 
et a l ., 1991).
(d) Secondary structure
With computer assistance it is now possible to look at the 
predicted RNA secondary structures of poly(A) sites. As yet, 
only limited information is available on a very few sites. In 
particular the poly(A) sequences of HTLV-1 and HIV -1 have been 
predicted to form stable stem-loop structures, which bring 
essential downstream (HTLV-1) and upstream (HIV-1) elements 
into close proximity to the AAUAAA hexanucleotide (Ahmed et 
al., 1990; Toyoshima et al., 1990; Gilmartin et al., 1992; Seiki et 
al., 1983). This is especially striking in the case of HTLV-1, 
where the polyadenylation site is more that 250nt downstream of 
the only evident AAUAAA. Examination of synthetic poly(A) 
sequence constructs, has demonstrated that insertion of sequences 
which increase the distance between the AAUAAA and a 
downstream GU-rich element, but form a stem-loop structure, 
results in normal util isation of the poly(A) signal, insertion of 
sequences which simply increase the distance with no stable stem- 
loop being formed result in decreased usage (Brown et al., 1991). 
These results are in agreement with evidence which, as previously 
discussed, demonstrates that the distance from the AAUAAA to 
additional upstream or downstream elements is critical for 
efficient usage of the poly(A) site. Examination of the RNA 
secondary structure of the bovine growth hormone poly(A) 
sequences (Woychik et al., 1984) has shown that they are capable 
of forming a stem-loop structure. While no evidence is presented
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that indicates these structures exist in vivo , there is good 
correlation between the position of the stem-loop and the 
observed poly(A) site, with the AAUAAA occupying a s ingle­
stranded hairpin loop just  upstream of a single-stranded region 
containing the site of cleavage and polyadenylation. In histone 
mRNAs, which are not polyadenylated, the presence of a highly 
conserved stem-loop structure, with a six base stem and 4  base 
loop, has been observed, which is thought to provide some of the 
functions of the poly(A) tail found in other mRNAs (Pandey et 
al., 1994; Pandey and Marzluff, 1987; Sun et al., 1992). In 
contrast however, Cherrington and Ganem (1992) have shown that 
a predicted stem-loop structure in the GSHV poly(A) sequences, 
which is within the upstream element, is not necessary for 
efficient util isation of the poly(A) site.
The central theme of these preliminary studies seems to be 
the ability of the RNAs of the poly(A) site to form stem-loop 
structures. However, these predictions do not take into account 
the effect that protein bound to the RNA would have on the 
overall conformation of the structures. Extensive mutational 
analysis will be necessary to evaluate what physiological role if 
any, these structures play in 3' processing.
1.2.3 The biochemistry of  mRNA 3' processing
The establishment of in vitro systems (Moore and Sharpe, 
1984; 1985) which faithfully reproduce the events of  cleavage and 
polyadenylation in crude cell extracts using RNAs that resemble 
authentic in vivo pre-mRNAs, was a huge step forward on the road 
to deciphering the mechanisms and components required for pre 
mRNA cleavage and polyadenlyation.
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By the addition of pre-cleaved mRNAs to in vitro reactions, 
the process of  polyadenylation can be examined uncoupled from 
the cleavage reaction. The inclusion of ATP analogues, such as 
cordycepin (3' dATP), which prevent poly(A) tail elongation allow 
examination of the cleavage reaction in the absence of 
polyadenylation. More recently biochemical fractionation of the 
nuclear extracts, used in these in vitro reactions, has begun to 
provide insight into the nature of the processing factors involved.
(a) C leavage
Efficient cleavage and subsequent polyadenylation of pre- 
mRNAs requires the assembly of a complex consisting of at least 
nine proteins (Zarkower and Wickens, 1987; 1988; Takagaki et 
a l ., 1988; 1990; Christofori and Keller, 1988; Gilmartin and 
Nevins, 1989). At least three separable activities have been 
identified, the poly(A) polymerase (PAP), an activity which 
confers AAUAAA specificity (CPSF) and another which stabilises 
complex formation (CstF).
CPSF : The cleavage and polyadenylation specificity factor, 
variously termed CSF, PF2 and SPF, is required for cleavage as 
well as conferring AAUAAA specificity to the subsequent 
polyadenylation reaction (Bienroth et a l ., 1991; Keller et a l ., 
1991; Weiss et a l ., 1991). The complex consists of four proteins 
of approximately 160kD, lOOkD, 74kD and 30kD (Bienroth et a l ., 
1991; Wahle and Keller, 1992; Keller et a l ., 1991). There is 
however some disagreement between studies regarding the 
existence of the smallest protein, the studies of Gilmartin and
44
In troduc t ion
Nevins (1989), found no such protein and Keller et al. (1991) 
assigned a molecular weight of 35kD.
CstF : Cleavage stimulation factor, or C F 1 , is a complex of 
three proteins of 77kD, 64kD and 50kD (Takagaki et al., 1990). 
This factor is required for cleavage but is dispensable for 
polyadenylation (Takagaki et al., 1989; Gilmartin and Nevins,
1989). While CPSF and PAP are sufficient to reconstitute 
accurate cleavage and polyadenylation, addition of CstF to a 
mixture of the factors significantly enhances the efficiency of 
these events (Takagaki et al., 1989). Binding of CstF to pre- 
mRNA requires the presence of the AAUAAA hexanucleotide, but 
no direct interaction occurs, binding being dependent on 
sequences downstream of the cleavage site (Weiss et al., 1991; 
Takagaki et al., 1990).
(b) Polyadenylat ion
The in vitro addition of the poly(A) tail to the cleaved 3' 
end of mRNA successfully mimics the in vivo reaction and as such 
occurs in two phases : the initial phase the addition of 10 
adenylate (A) residues is slow, the second phase the further 
elongation of the poly(A) tail, with the addition of up to 200 A 
residues, is rapid. The initial phase is AAUAAA dependent 
(Wahle and Keller, 1992) and requires two factors, the poly(A) 
polymerase (PAP) and a factor which confers AAUAAA 
specificity, the elongation phase requiring an additional protein, 
the poly(A) binding protein II (PAB II) (Beinroth et al., 1993; 
Wahle et al., 1993).
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PAP : which has been purified to near homogeneity, exists 
in several chromatographically and electrophoretically distinct 
forms, of 57-60kD, and behaves as a monomer in solution (Wahle, 
1991; Wahle and Keller, 1992). The enzyme can non-specifically 
polyadenylate any RNA in the absence of other factors, with no 
primer specificity except a slight preference for poly(A) or a 3' 
terminal A residue, which is in agreement with the presence of an 
A at the cleavage site of most transcripts (McLauchlan et al., 
1985; Wahle and Keller, 1992). The N-terminal of the enzyme 
contains a ribonucleoprotein particle (RNP) consensus, similar to 
that of  RNA-binding proteins. In addition to being essential for 
polyadenylation PAP is believed to play a role in cleavage of 
some pre-mRNAs (Takagaki et al., 1988; Christofori and Keller, 
1988; 1989).
PAB II  : This 49kD nuclear protein, which behaves as a 
monomer in solution, has a specificity for single-stranded purine 
polyribonucleotides and like PAP, contains an RNP-consensus. 
PAB II is responsible for oligo(A) dependent, PAP catalyzed, 
polyadenylation. Although this can occur in the absence of the 
AAUAAA specificty factor, only a complex formed from PAP, 
PAB II and the specificity factor functions with maximum 
efficiency (Bienroth et al., 1993; Wahle, 1993; Wahle and Keller, 
1992). The properties of the specificity factor will be discussed 
in the following Section.
(c) Complex formation
Formation of the processing complex on pre-mRNA is rapid, 
ATP dependent, and occurs only on RNAs containing the
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AAUAAA hexanucleotide and the appropriate downstream 
elements. It has been proposed that CPSF and PAP form an initial 
complex on the pre-mRNA, via direct interaction with the 
AAUAAA (Gilmartin and Nevins, 1989; Wahle and Keller, 1992). 
This association has been shown to be unstable and transient, the 
subsequent addition of CstF stabilises the complex and thereby 
commits it to processing of the poly(A) site (Weiss et a l ., 1991). 
Since the binding of CstF is dependent on downstream elements 
which are variable in composition, it has been proposed that these 
elements determine the poly(A) site efficiency by variability in 
their capacity to bind CstF and therefore stablise the complex 
(Wahle and Keller, 1992). Two additional factors have been 
described, CFI and CFII, which are required for catalysis of the 
cleavage reaction. These additional factors are as yet only poorly 
characterised (Takagaki et a l ., 1989; Manley et al., 1993).
The mechanisms by which the proteins present in these 
complexes interact with the RNA and each other are not as yet 
understood. However, UV cross-linking analysis of crude nuclear 
extracts and the previously identified CPSF and CstF fractions has 
shown that several proteins bind directly to the RNA. The studies 
of Moore et al., (1988), identified three proteins of 155kd, 6 8 kD 
and 38kD, present in nuclear extracts which were UV cross-linked 
to the adenovrius L3 poly(A) sequences. Cross-linking of the 
160kD and 30kD components of CPSF (Gilmartin and Nevins, 
1991; Keller et al., 1991) and the 64kD component of CstF 
(Takagaki et al., 1990; Wilusz and Shenk, 1988) to pre-mRNA 
substrates has been demonstrated. Isolation and characterisation 
of cDNAs encoding the 64kD and 50kD components of the CstF, 
has further elucidated their roles in complex formation. The N-
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terminus of the 64kD protein, which contains an RNP-consensus, 
has been found to bind RNAs in an AAUAAA dependent manner 
(Takagaki et al., 1992). The 50kD component contains a number 
of transducin repeats, similar to those of the P subunit of  G- 
proteins and the yeast pre-mRNA splicing protein, which may be 
responsible for interactions of the CstF complex with the 
processing factors (Frankel et al., 1991; Takagaki and Manley,
1992).
Taken together these results suggest that complex formation 
requires the direct interaction of specific complex components 
with the RNA substrate and co-operative interaction of the 
components themselves. Such a model of complex formation is 
shown in Figure 1.9 (taken from Takagaki et al,. 1990; Manley et 
a l ., 1993).
1.2.4 The role o f  snRNPs and hnRNPs in 3 f end 
formation
An important and unresolved question is whether or not 
snRNP particles are involved in 3' end formation. In agreement 
with snRNP involvement, anti Sm antibodies directed against a 
common epitope of all U-type snRNPs have been shown to inhibit  
the 3' processing reaction in vitro (Moore and Sharpe, 1984; 1985; 
Sperry and Berget, 1986). However, Berget and Robberson 
(1986), demonstrated that site-directed cleavage of the U l ,  U2, 
U4 and U 6  snRNPs did not affect 3' processing in vitro. In 
addition an RNA fragment containing the AAUAAA sequence has 
been immunoprecipitated by snRNP specific antibodies 
(Hashimoto and Steitz, 1986; Stefano and Adams, 1988). The U l l  
snRNP has also been shown to co-purify with CPSF activity in
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I------------II------ 1
FIGURE 1.9 :
A model representing assembly on pre-mRNA of the 3’ processing 
complex, showing the factors required for cleavage and 
polyadenylation. CPSF : cleavage and polyadenylation specificity 
factor, CstF : cleavage stimulation factor, PAP : poly(A)
polymerase, with two additional poorly characterised cleavage 
factors CFI and CFII. The cleavage site C is indicated by an open 
arrow, m7GpppG : trimethyl cap. (taken from Manley et a l . ,
1993).
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nuclear extracts (Christofori and Keller, 1988). In direct 
contradiction of these findings Bienroth et at., (1991), have 
shown that purified CPSF contains only trace amounts of RNA and 
does not react with antibodies against an snRNP common epitope 
and that the U l l  snRNP does not co-purify with CPSF. They 
further suggest that CPSF may have a propensity for binding 
snRNPs specifically or non-specifically, which may account for 
the previous findings. While unlikely, it remains possible, that an 
snRNP(s) is involved in the cleavage polyadenylation reaction.
The 38kD protein identified by the UV cross-linking studies 
of Moore et a l .9 (1988), has been identified as a heterogeneous 
nuclear ribonucleoprotein particle C (hnRNP) by 
immunoprecipitation. This protein, one of a set which are thought 
to be involved in the packaging and post-transcriptional 
processing of all pre mRNAs (reviewed by Spector, 1993), has a 
strong affinity for RNA and possibly has an important role in 
splicing. However the significance of this finding has still to be 
established.
The exact relationship of the splicing reaction to the 
cleavage/polyadenylation reactions has still to be determined, 
with no clear evidence to suggest whether splicing occurs pre or 
post polyadenylation. There is evidence that splicing can enhance 
polyadenylation, it has been demonstrated that in vitro the 
presence of an intron enhanced the rate of polyadenylation at a 
donwnstream poly(A) site (Niwa et at., 1990) and in addition, 
mutation of the poly(A) site inhibited splicing of the upstream 
intron (Niwa and Berget, 1991). They propose therefore that 
splicing and polyadenylation factors interact to recognise the 
terminal exons containing the poly(A) sequences. However there
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is contrasting evidence which shows that splicing components can 
inhibit polyadenylation. The binding of two molecules of the U1 
snRNP U 1A protein, to the 3’ UTR of U1 mRNA, reduced its 
expression by inhibition of polyadenylation (Boelens et at., 1993; 
Van Gelder et at., 1993). This inhibition has subsequently been 
shown to be mediated by the interaction of the U1A protein with 
mammalian PAP (Gunderson et at., 1994). It remains to be 
determined whether these findings are a general feature of 
splicing and polyadenylation reactions and whether such 
interactions form part of a mechanism by which the two processes 
could influence each other.
1.2.5 mRNA transcription termination
Until recently there was relatively little known about the 
sequence requirements for transcriptional termination, only that 
termination occurred on a stretch of DNA that may extend 
hundreds or thousands of nt downstream of the cleavage site 
(Citron et al., 1984; Le Meur et a t ., 1984; reviewed by Birnstiel 
et a l ., 1985). However, there is now evidence to suggest that 
transcription termination at the 3' end of genes encoding poly(A)+ 
mRNAs, requires two distinct cis-acting sequence elements, the 
poly(A) signal and a downstream transcription pause site 
(Whitelaw and Proudfoot, 1986; Logan et al., 1987).
There are two proposed models for poly(A) signal mediated 
termination of transcription - (a) 3' end cleavage generates an 
unprotected downstream product which is degraded 5' to 3' by 
exonucleases and/or DNA/RNA helicases, thereby destablising the 
transcription complex : (b) the poly(A) signal causes factors 
present in the transcription complex (which prevent termination)
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to be released rendering it prone to termination (reviewed by 
Eggermont and Proudfoot, 1993). Using an in vitro coupled 
polyadenylation-transcription system it was shown that 
transcription termination at the SV40 early polyadenylation region 
was dependent on the presence of a functional poly(A) signal and 
downstream GT-rich element (Miralles, 1991). In addition they 
demonstrated that there was no degradation of the uncapped 5 ' 
transcripts generated by cleavage, lending support to model (b). 
In the same study transcription termination did not occur at the 
adenovirus L3 poly(A) region, suggesting that in this case at least, 
other factors must be involved. It was recently shown (Edwalds- 
Gilbert et a l ., 1993) that the efficiency of termination is directly 
correlated to the efficiency of 3' end formation. Constructs of  a (3 
major globin gene, linked to either the adenovirus L \  or L3 
poly(A) sequences, were tested for the efficiency of transcription 
termination. Transcription termination was more efficient at the 
L3 site which is also the most efficient 3' processing site. There 
is growing evidence therefore to suggest that cleavage/ 
polyadenylation and transcription termination are linked, and that 
the efficiency of both these processes may be related to the 
presence of sequence elements downstream of the poly(A) signal.
While regulation at the level of transcription termination is 
relatively unknown, it has been shown that transcription of one 
gene may down regulate the transcription of another downstream 
gene, which is in the same 5' to 3' orientation (Cullen et al., 1984; 
Proudfoot, 1986). It is possible therefore that the efficiency of 
transcription termination, directed by 3' processing efficiency, 
could control the expression of  some genes.
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1.2.6 mRNA s t a b i l i t y
For cells to respond rapidly to changes in transcription 
rates, mRNAs must be capable of rapid turnover, in addition it is 
important that the mRNAs of constitutive structural genes are long 
lived. Therefore not only must turnover of mRNAs from different 
genes be regulated but mRNAs from the same gene must also be 
regulated, with the mRNAs from eukaryote cells exhibiting a 
range of stabilities which vary over several orders of magnitude 
(Sachs, 1993). The search for sequences which confer stability 
have so far been fruitless, however recent studies have noted that 
the presence of AU-rich sequences, within the 3' UTRs of some 
short lived mRNAs, play a role in their rapid degradation (Shaw 
and Kamen, 1986; Bohjanen et al., 1991; Vakalopolou et al., 
1991). The effect of  these sequences appears to be mediated by 
deadenylation of the poly(A) tails, which is a prerequisite for 
mRNA degradation, with final degradation being carried out by 
exo- or endo-nucleases. However, the exact mechanism of this 
deadenylation has not been determined (reviewed by Sachs, 1993; 
Atwater et al., 1990). The stabilising effect of the poly(A) tail 
has been shown to require the poly(A) binding protein PABP 
(Bernstein et al., 1989), but again the exact relationship of PABP 
binding and stability has not been determined.
1.2.7 Translat ion of  mRNA
The majority of available information on mRNA translation 
has been gained from studies of the translational changes which 
occur during oocyte maturation (Bacharova, 1992; Fox et al., 
1989; Vassalli et al., 1989; Jackson and Standart, 1990; Wickens, 
1990b). A large fraction of mRNAs synthesised in growing
52
In troduc t ion
oocytes are not translated immediately, but remain dormant or 
masked, and stored for future translation (reviewed by Bacharova, 
1992; Wickens, 1990b). In general, stored messages contain short 
poly(A) tails (15-90 adenylate residues), activation is 
accompanied by cytoplasmic polyadenylation and an increase in 
tail length (>150 adenylate residues). Poly(A) tail length appears 
to have a quantitative effect on mRNA translation with short A 
tails dictating low levels of translation (Wickens, 1990b; 
Bacharova, 1992; Vassalli et al., 1989). Cytoplasmic 
polyadenylation requires the separable activities of the PAP, and 
an RNA binding activity that recognises the AAUAAA poly (A) 
signal and a U-rich element, which is located in the 3' UTR of the 
mRNA. This element sometimes referred to as the cytoplasmic 
polyadenylation element has the proposed consensus sequence 
UUUUUNU (Fox et al., 1992; Vassalli et al., 1989; Paris and 
Richter, 1990). These elements therefore resemble the U-rich 
downstream elements (Sadofsky and Alwine, 1984; Sadofsky et 
a\., 1985; Manley, 1988) and upstream elements (Valsamakis et 
al., 1992) identified in a number of eukaryotic mRNAs which are 
required for efficient 3' end formation. It is possible though 
unproven as yet that these elements may be identical in function 
(Fox et al., 1992).
1.2.8 Regulat ion of  3 f processing
Alternative RNA processing is known to be employed in a 
number of instances to generate diversity in gene expression. For 
genes in which alternative protein products are predicted to have 
an important consequence to the cell phenotype, a means of  
selectively regulating mRNA processing is therefore required.
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This regulation may in turn be subject to developmental or tissue- 
specific control. There are a number of well documented 
situations where production of more than one mRNA from a single 
transcriptional unit involves the usage of alternative 3 ' processing 
signals, three of which are described here.
(a) A denovirus  2 major late transcription unit  (M LTU )
The major late promoter of adenovirus 2 initiates synthesis 
of pre-mRNAs that are processed into mRNAs which fall into five 
3' co-terminal families, LI to L5 (Figure 1.10). These mRNAs all 
share a common tr ipartite 5' leader with a capped terminus 
encoded at the RNA init iation site. Interestingly the promoter 
functions at early times of infection producing LI transcripts as 
early as lh pi, prior to DNA replication and the early-late switch 
of viral gene expression at 6 - 8 h. In contrast neither the L2 or L3 
mRNAs are detectable until 5-6h pi (Shaw and Ziff, 1980). A 
number of conflicting theories have been proposed to explain this 
regulation. The first which suggested that transcription 
termination or pausing downstream of the LI site, prevents the 
use of  the L2-L5 sites early in infection, has been ruled out 
(Wilson-Gunn et a l ., 1992; Falck-Pedersen and Logan, 1989). 
The second, proposed that at early times the LI site, which is the 
most 5 ' site, is used preferentially and that the switch at late times 
requires transcription from a replicating viral template. Evidence 
in support of  this has been provided by Falck-Pedersen and Logan 
(1989), who demonstrated that cis-acting and not trans-acting 
factors are involved. This implies that direct interaction of the 
processing machinery with the DNA template occurs and that 
differences in transcription rates could therefore be involved.
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FIGURE 1.10 :
Adenovirus-2 major late transcription unit. L1-L5 are 3' co­
terminal families of mRNAs which have a common triparti te 
5' leader and promoter. Poly(A) sites are indicated by small 
arrowheads (adapted from Shaw and Ziff, 1980). The genome 
posit ion of  these transcripts is given in map units.
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The third, proposed that regulatory elements located upstream of 
the LI site promote its use at early times, and this preferential use 
is mediated by trans-acting factors present in the nuclear extracts 
(Wilson-Gunn et at., 1992; DeZazzo et al., 1991). The study of 
Wilson-Gunn et al., (1992), demonstrated that the preferential use 
of LI was not dependent on transcription. To further confuse the 
picture Mann et al. (1993), while agreeing that regulation is due 
to differences in poly(A) site efficiency, have demonstrated that 
CstF interaction with the LI site is less stable than the L3 
interaction, in addition they found that there was a substantial 
decrease in the level of  CstF activity as adenovirus infection 
proceeded to the late phase. They imply that the L3 site is used 
in preference to the LI site at late times of infection in direct 
contradiction of the findings of Wilson-Gunn et al., (1992), who 
propose that the LI site is the most efficient.
It is not possible at this stage to make a definitive statement 
regarding the mechanism of early to late switch of this 
transcription unit, although there is a strong case for regulation 
being mediated by poly(A) site strength and the differential 
interaction of the five poly(A) sites with the available processing 
factors.
(b) The im m unoglobulin  heavy chain locus
Primary transcripts from the IgM heavy chain (p) 
transcription unit are differentially processed to produce two 
distinct mRNAs in a developmentally-regulated and cell specific 
manner. The membrane (pm) and secreted (ps) forms are 
produced from a single primary transcript which is alternatively 
processed at its 3' end (Figure 1.11). Cleavage at the proximal
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C Pre-ps S (A)n
FIGURE 1.11 :
Representation of the proposed 3’ processing scheme for the 
production of  the membrane bound and secreted forms of the 
immunoglobulin heavy chain p RNA (adapted from Peterson and 
Perry, 1989). VDJ : productively rearranged immunoglobulin 
variable, diversity and joining segments. Cp 1-4 : p Constant 
region exons, S : secretory exons, M : membrane exons, (A)n : 
poly(A) tail. Polyadenylation sites are indicated by large 
arrowheads.
A : IgM pre mRNA
B : membrane bound form of p pre-mRNA, produced by splicing 
of exon M to exon Cp4, with removal of the secretory exon and 
poly(A) site, and cleavage and polyadenylation at the membrane 
poly(A) site (pM pA).
C : secretory form of p pre-mRNA, produced by cleavage and 
polyadenylation at the secretory poly(A) site (pS pA).
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poly(A) site producing ps mRNA, and splicing of the Cp4 exon to 
the M exons, which removes the ps site, producing pm mRNA. 
The relative abundance of these two mRNAs is regulated during 
B-cell maturation, with predominantly pm produced at early times 
and ps predominating in the mature plasma cell. Production of 
these two mRNAs could potentially be regulated at several levels: 
for example, i f  transcription terminated before the pm site, this 
would result in the production of ps mRNAs and this has been 
shown to contribute to ps production in some but not all cell 
lines representative of the mature plasma cell (Guise et at., 1988; 
Galli et al., 1987). Competition for cleavage and polyadenylation 
between the less efficient ps and the efficient pm poly(A) site 
would result in preferential production of pm RNAs under 
limiting conditions and production of ps mRNAs under non­
limiting conditions (Galli et at., 1988). This example pre­
supposes that splicing can occur only after cleavage and 
polyadenylation at the pm site and that the splicing reaction is 
therefore not involved in regulation. However the relative 
kinetics of  splicing vs cleavage/polyadenylation are not 
known at this time. Similarly, competition between
cleavage/polyadenylation at the ps poly(A) site and splicing at the 
suboptimal Cp4 to M exon splice site would result in ps mRNA 
production depending on the relative strengths of these two 
reactions. This assumes that splicing can occur either before or 
after cleavage/polyadenylation at the pm site (Lassman and 
Milcarek, 1992; Petersen and Perry, 1989). Both models however, 
predict that regulation depends on increasing usage of the less 
efficient ps site and that factors involved in the
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cleavage/polyadenylation reaction are therefore limiting in B-cell 
and not limiting in the plasma cell.
(c) The ca lc i ton in /C G R P  gene
Calcitonin or calcitonin gene related peptide (CGRP) arise 
from a single genomic locus in which the primary RNA transcript 
undergoes tissue-specific processing, which results in the 
differential production of calcitonin or CGRP mRNAs. CGRP 
mRNA, which is produced in neuronal cells, results from splicing 
of the first three exons to the 5th and 6 th exons, with use of  the 
distal poly(A) site 3' to the 6 th exon. Calcitonin mRNA, produced 
in thyroid cells, contains the first four exons and util ises the 
poly(A) site immediately 5' to exon 4 (Amara et a l ., 1984) (Figure 
1.12). Expression experiments, using the wild type gene and a 
series of  mutated calcitonin/CRGP genes, have shown that mRNA 
regulation is not determined by poly(A) site selection but by 
choice of  either the exon 4 or exon 5 splice site (Leff et a l ., 
1987). It has been demonstrated that CGRP mRNA production is 
dependent upon the efficient util isation of the intrinsically weak 
calcitonin specific 3' site of  exon 4 (Yeakley et a l ., 1993). This 
tissue specific splicing must reflect differences in the splicing 
machinery of different cells.
(d) The HSV-1 late process ing  factor (LPF)
mRNA transcripts which are 5' co-terminal and util ise 
different poly(A) sites are not an uncommon finding in HSV 
(Wagner, 1985), it has been suggested therefore, that HSV gene 
expression may be influenced by the efficiency of poly(A) site 
usage. In support of this theory McLauchlan et al, (1989, 1992b),
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C Calcitonin 1 2  3 (A)n HeLa
thyroid C
FIGURE 1.12 :
A : organization of the calcitonin/CGRP gene, exons are
represented by open boxes and introns by solid lines.The size of  
the gene (kb) is shown at the top of the figure and the poly(A) 
sites (pA) are indicated by large arrowheads, (A)n poly(A) tail 
(adapted from Yeakley et al., 1993).
B : CGRP is produced in neuronal cells by the splicing of exon 4 
to exon 6 and usage of the poly(A) site immediately 3' of exon 6, 
with removal of  exon 5 and the poly(A) site immediately 3' of  
exon 4.
C : calcitonin is produced in HeLa and thyroid C cells by cleavage 
and polyadenylation at the poly(A) site immediately 3’ of exon 4.
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identified an activity, termed LPF, induced in HSV infected cells 
which selectively increased 3' processing efficiency at an HSV-2 
late poly(A) site (UL38) and did not increase 3' processing 
efficiency at the HSV-2 IE12 poly(A) site, common to the US10 
and US11 genes which are from the IE, early and late temporal 
classes respectively. The original studies examined the in vitro 
and in vivo processing efficiencies of single and tandem 
constructs of the two poly(A) sites (McLauchlan et al., 1989), and 
demonstrated that the LPF induced increase in processing at the 
late site was not due to an increase in RNA stability but was due 
to the effect of  a heat labile, and therefore probably protein, 
component produced during virus infection. Further experiments 
using virus recombinants containing these poly(A) sequences 
confirmed the activity in vivo, and have demonstrated that LPF 
was active from early in infection being apparent by 4h pi. 
Infection in which protein synthesis was prevented by treatment 
with cycloheximide, indicated that gene expression was required 
for LPF activity. Using a range of virus mutants deficient in IE 
gene expression the IE63 gene product was identified as essential 
for LPF activity (Table 1.2). Finally transient transfection 
experiments, where constructs containing either the IE or late 
poly(A) site were co-transfected with an IE63 expression plasmid, 
confirmed that IE63 was required for induction of a five fold 
increase in expression of the construct containing the L poly(A) 
site. Thorough though these studies were it remains to be 
determined whether this virus activity has a more widespread 
effect on HSV poly(A) site processing efficiency other than the 
two examples studied. In addition the fragment sizes of the two 
poly(A) sites examined were quite different, the late poly(A) site
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Virus Virus gene(s) 
expressed
LPF activity
wt HSV-1 (17+) IE, early and late +
ts 1204 None -
tsK IE (non-functional 
IE 175)
+
ts 1207 IE, early +
dl 1403 IE (except IE 110), 
early and late
+
27-LacZ IE (except IE63), 
early and late
-
HSV-1 (F)A325 IE (truncated IE68), 
early and late
+
TABLE 1.2 :
Shows the correlation of LPF activity with virus gene expression 
from wt HSV-1 strain (17-I-) and a range of virus mutants. 
ts 1204 : has a ts lesion in the UL25 gene, virions can bind to 
cells but fail to penetrate and release the capsid into the 
cytoplasm, no viral proteins are produced.
tsK : has a ts lesion in IE 175 and produces only four functional IE 
polypeptides IE 110, IE63, IE68, IE12 and a non-functional IE175. 
/s’1207 : has a ts mutation is the UL39 gene and produces IE and 
early proteins and no late proteins..
<//1403 : has a deletion within both copies of IE 110 and produces 
all IE proteins (except IE 110) and early and late proteins..
27-LacZ : contains a LacZ gene inserted into the 5 untranslated 
leader region of the IE63 gene and produces all IE proteins 
(except IE63), early proteins and some late proteins.
HSV-1 (F) A325 : contains a deletion in the IE68 gene and 
produces all IE proteins, (with a truncated version of IE68), early 
and late proteins.  (Taken from McLauchlan et al., 1992b).
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construct containing sequences 118nt upstream and 141nt 
downstream of the UL38 poly(A) signal and the IE12 poly(A) site 
construct containing sequences 26nt upstream and 62nt 
downstream of the poly(A) signal, it is possible therefore that 
some elements required for LPF regulation of processing were 
missing from the IE site.
There are a number of questions raised by these initial 
studies regarding the range and specificity of LPF activity, the 
involvement of  IE63 and the overall role of this activity in the 
regulation of viral gene expression. It is the purpose of this 
project therefore to address these questions.
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Aims of the project
To determine the range and specificity of LPF activity.
To study the role of  IE63 in:-
a) the LPF mediated increase in 3' processing efficiency of 
selected HSV-1 poly(A) sites
b) the relationship of this activity to the expression of 
proteins from the three temporal classes of HSV-1 genes.
To investigate the properties which determine whether a 
particular HSV-1 poly(A) site responds or does not respond 
to LPF by :-
(a) examination of the protein binding properties of selected 
HSV-1 poly(A) sites using mock infected and HSV-1 
infected nuclear extracts
(b) by analysis of HSV-1 poly(A) site mRNAs for sequence 
and structural elements which may influence 3' processing 
efficiency.
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Chapter 2
Materials and Methods
2.1 Materials
2 . 1.1 Cells
BHK C13 Baby hamster kidney cells were used for the 
propagation and ti tration of both wild type (wt) viruses and 
recombinant viruses.
HeLa cells, derived from a human cervical carcinoma cell 
line, were used for the production of nuclear extracts.
Vero cells, derived from African green monkey kidney, were 
used as a negative control for 27-LacZ infections (Smith et al., 
1992) and for the growth of HSV-1 strain KOS.
Vero 2.2 cells are derived from Vero cells by co-transfection 
of a plasmid containing the neomycin resistance gene (G418), 
under the control of the SV40 promoter, and the plasmid 
pSG130B/S containing the wild type ICP27 (IE63) gene (Smith et 
al., 1992). These cells were used for the assay and growth of 27- 
LacZ.
2.1.2 Bacter ia l  cells
E.Coli K12 strain DH5a (hsd R17, lac U169, gyr A96, t h M ,  
rei A l ,  rec A l ,  end A l ,  supE44, <(>80, 1acZ M15) were used for the 
propagation of plasmids.
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2.1.3 V iruses
HSV-1 (wt) strain 17+ and HSV-1 (wt) strain KOS were 
obtained from stocks maintained in the Institute by Mary Murphy. 
HSV-1 1802 which contains a unique Xba-1 site (Rixon and 
McLauchlan, 1990) a gift from Dr. V. Preston, was used for the 
production of recombinant virus. 27-LacZ the HSV-1 ICP27 
(IE63) insertion mutant was a gift from R.M. Sandri-Goldin. This 
virus was made from HSV-1 strain KOS by insertion of a cassette, 
containing the lacZ gene under the control of the HSV UL39 
promoter, into the 5' untranslated leader region of the ICP27 
(IE63) coding sequences, resulting in inactivation of the IE63 
gene, therefore no IE63 protein is produced (Smith et al ., 1992).
2.1.4 Tissue culture media
BH K -C13 cells were grown in Glasgow's modified eagle's 
medium (GibcoBRL) supplemented with 0.25% sodium 
bicarbonate, 4mM L-glutamine, lOOunits/ml penicill in, 
lOOunits/ml streptomycin, 10% tryptose phosphate broth and 10% 
new born calf  serum (NBCS).
Vero cells were grown as for BHK-C 13 cells, 10% foetal 
calf serum replacing the 10% NBCS.
Vero 2.2 cells were grown as for Vero cells with a 
supplement of  G418 (neomycin) as a selection agent for stable 
transfectants. G418 was omitted during experimental work.
2.1.5 Bacter ia l  culture media
Bacteria were propagated in 2YT broth (88.5mM NaCl2 , 
1.6% (w:v) Bacto tryptone, 1% (w:v) yeast extract). Solid media
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for the isolation of bacterial colonies consisted of 1.5% (w:v) 
agarose in L-broth (1% (w:v) Bacto tryptone, 1% yeast extract, 
177mM NaCl2). Media was supplemented where appropriate with 
ampicillin.
2.1.6 Enzymes
Restriction enzymes and calf  intestinal alkaline phosphatase 
were obtained from Boehringer Mannheim. DNase and RNaisin 
(ribonuclease inhibitor) from Promega. SP6 RNA polymerase and 
DNA T4 ligase from Gibco BRL. Proteinase K from Sigma and 
Taq DNA polymerase from Perkin Elmer.
2.1.7 R adiochem icals
The following radiochemicals were obtained from 
Amersham:- ( a - 32P) UTP, specific activity 800Ci/mmol. 14C 
chloramphenicol (CAT assay grade), specific activity 50-62 
mCi/mmol. 35S dATP, specific activity >1000Ci/mmol. Methyl 
thymidine, specific activity 25Ci/mmol.
2.1.8 Chem icals  and miscellaneous reagents
General chemicals were obtained from Sigma and BDH. 
TEMED from Bio-Rad. The ECL detection system and Rainbow 
coloured protein molecular weight markers from Amersham.
2.1.9 A ntibodies
The following mouse monoclonal antibodies were produced 
in the Institute and were a gift from Dr. A. Cross. Mouse 
monoclonal antibodies were raised against the protein products of 
the following HSV genes IE110, IE175, UL29, US6, US8 and
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UL42. Rabbit polyclonal antipeptide antibodies to HSV UL45 and 
IE63 were produced in the Institute and were a gift of  G. McVey. 
Rabbit polyclonal antibody to purified HSV UL44 was a gift from 
Dr. G. H. Cohen and Dr. R. J. Eisenberg. The rabbit polyclonal 
antipeptide antibody to HSV-2 UL38 was a gift of  Dr. W.S.M. 
Wold (Yei et al., 1990). Peroxidase conjugated goat anti-mouse 
antibody (IgG) was obtained from Sigma and peroxidase 
conjugated protein-A was obtained from Bio-Rad.
2.1.10 Plasmids
pLW2 (Gaffney et al., 1985), was used as a marker of  
transfection efficiency in transient assays. This plasmid carries 
the CAT reporter gene under the control of  the HSV-2 IE12/68 
promoter with the polyadenylation sequences from IE 12 and was a 
gift from Dr. J. McLauchlan.
The constructs generated during this study were based on the 
plasmids pGEMl and pCAT (Promega), and pFJIO (Rixon and 
McLauchlan, 1990).
2.1.11 Commonly used buffers and solutions
LB: 50% (w:v) glycerol, 445mM Tris.,
lOmM EDTA, 445mM Boric acid,
0.1% bromophenol blue,0.1% xylene cyanol.
50x DHS: 1% Ficoll, 1% polyvinylpyrrolidone,
1% bovine serum albumin (BSA).
PBS: 170mM NaCl, 3.4mM KC1, lOmM N aH P 0 4,
2mM KH2P 0 4 (pH7.2).
2X PKB: lOOmM Tris.Cl (pH8.0),
20mM EDTA (pH8.0), 20m MNaCl, 0.4% SDS.
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STET:
20xSSC:
20xSSPE:
TAE:
TBE:
TBS (A):
TTBS:
TE:
TBS(B):
Trypsin:
1% Triton-XlOO, lOmM Tris.Cl (pH8.0),
234mM Sucrose, 50mM EDTA.
3M NaCl, 300mM NaCit (pH7.4).
3M NaCl, 200mM NaH2P 0 4, 20mM EDTA.
40mM Tris., 0.1% acetic acid, 50mM EDTA.
89mM Tris., 2mM EDTA, 89mM Boric Acid.
4mM Tris., lOOmM NaCl (pH7.5).
0.05% Tween-20 in TBS(A). 
lOmM Tris.Cl, ImM EDTA (pH7.1).
140mM NaCl, 30mM KC1, 280mM Na2H P 0 4, 
lmg/ml dextrose, 25mM Tris.Cl (pH7.4),
0.005% (w:v) phenol red, lOOunits/ml penicillin, 
lOOunits/ml streptomycin.
25% (w:v) trypsin in TBS(B).
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2.2 Methods
The methods used in this work were essentially as described 
by Maniatis et al., (1989).
2.2.1 Cell culture
All cell lines were maintained as monolayers in the 
appropriate growth medium (GM), at 37°C in 5% C 0 2.
Harvesting of the cells was performed by washing the cell 
monolayer once in versene, then once with a (1:3) trypsin:versene 
mix. Cell stocks were stored in 1ml aliquots of 108 cells/ml at 
-70°C in a (2:1:2) mixture of serum: glycerol: growth medium.
2.2.2 Plasmid preparation
(a) Small  scale  method
lml of a 10ml overnight culture of bacteria, inoculated from 
a single transformed colony, was centrifuged at 13,000rpm for 
lmin. The pellet was resuspended in lOOpl of STET and 
lysozyme (lmg/ml) and boiled for lmin. The lysate was cleared 
by centrifugation (13,000rpm, lOmin). An equal volume of 
isopropanol was added to the lysate and the precipitated nucleic 
acids pelleted by centrifugation (13,000rpm, lOmin). The pellet 
was washed in 70% ethanol, lyophilised, resuspended in H20  and 
stored at -20°C. Restriction endonuclease digests of  DNA 
prepared by this method included 0.2pl of RNase A (lmg/ml) to 
remove any contaminating RNA, facilitating band visualisation 
following gel electrophoresis.
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(b) Large sca le  method
Bacterial cells were harvested from a 300ml saturated 
overnight culture by centrifugation (5000rpm, lOmin). The cell 
pellet was resuspended in 3ml of pre-lysing solution (25% 
sucrose, 50mM Tris.Cl pH 8.0), 1ml Lysozyme (5mg/ml), 1ml 
250mM EDTA (pH8.0) and left on ice for 5min. After the 
addition of 5ml lysis solution (1% (w:v) Brij, 0.4% (w:v) 
deoxycholate, 62.5mM EDTA, 500mM Tris.Cl) the mixture was 
left to lyse on ice and was finally cleared by ultracentrifugation 
(48,000rpm, 30min). Caesium chloride (0.9gm/ml) and ethidium 
bromide (0.5ml of 5mg/ml) were added to the clear lysate and 
plasmid DNA was banded by ultracentrifugation (40,000rpm, 
64h). Covalently closed circular plasmid DNA was removed from 
the caesium chloride gradient using a hypodermic needle and 
syringe. Ethidium bromide was removed by repeated extractions 
with iso-butanol. Caesium chloride was removed by ethanol 
precipitation, 1/10th volume of 6M sodium acetate and 2.5 
volumes of ethanol were added and the mixture precipitated 
overnight at -20°C. Plasmid DNA was pelleted by centrifugation 
( 13,000rpm, 20min) washed once in 70% ethanol, lyophilised and 
resuspended in H20.
2.2.3 Q uantif ication  of  DNA
Determination of  DNA concentration was performed by 
spectrophotometry as described by Maniatis et a l ., (1989).
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2.2.4 Storage o f  recombinant bacteria
Transformed bacteria were stored as a frozen glycerol stock. 
0.9ml of overnight culture was mixed with 0.1ml sterile glycerol 
and stored at -70°C.
2.2.5 Sequencing of  plasmid DNA
Sequencing of plasmid DNA was performed using Sequenase 
version 2.0 DNA sequencing kit (United States Biochemical). 
This method is based on the dideoxy-mediated chain termination 
method. Denaturation and sequencing of plasmid DNA was 
carried out in accordance with the manufacturers recommended 
protocol. Electrophoresis of  the sequencing products was 
performed on an 8% polyacrylamide gel prepared using Sequagel 
sequencing system reagents (National Diagnostics).
2.2.6 T ransfect ion  o f  BHK-C13 cells
(a) Calcium  phosphate precipation (DMSO)
This method is as described by Stow and Wilkie (1976). 
10pg of plasmid DNA was mixed with 500pl of HBS (0.137mM 
NaCl, 5mM KC1, 0.7mM Na2H P 0 4, 5.5mM D-glucose, 21mM 
hepes pH7.05) containing 10pg calf  thymus carrier DNA. 35pl of  
2M CaCl2 was added and the solution mixed thoroughly. Growth 
medium was removed from a 50mm culture dish containing a 70% 
confluent monolayer of  BHK cells and the calcium DNA 
precipitate used to overlay the cells. The culture plates were 
incubated at 37°C in 5% C 0 2 for 40min after which 4ml of growth 
medium was added and the cells incubated for a further 4h at 
37°C. The medium was removed and the cell monolayer washed 
once in serum free medium. 1 ml of 25% (v:v) DMSO in HBS was
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then added to the cells for exactly 4min after which the cell layer 
was washed carefully three times in serum free medium, overlayed 
with normal growth medium and incubated for a further 48h.
(b) L ipofection
30pl of  Lipofection reagent (Rose et al., 1991), which 
contains 1ml Ptd Etn (L-a-phosphatidylethanolamine dioleoyl) and 
4mg DDAB (dimethyldioctadecylammonium bromide), was mixed 
with 70pil of  HBS (20mM hepes, 150mM NaCl pH7.4). In a 
separate tube 5|ig of plasmid DNA was suspended in lOOjil of  
HBS, both solutions were mixed together and left at room 
temperature (RT) for at least lOmin. The transfection mixture 
was then added to 2ml of Optimem (low serum medium, Gibco 
BRL) and was used to overlay a 50mm culture dish containing a 
70% confluent monolayer of BHK cells. After incubating the 
cells at 37°C for 4h, 2ml of GM containing 20% NBCS was added 
to the monolayer and the cells incubated for a further 48h. The 
Lipofection reagent was a gift from C. Addison.
2.2.7 Standard cloning techniques
(a) R estr ict ion  endonuclease  digestion
Restriction endonuclease digests were performed using the 
buffers and conditions recommended by the suppliers.
(b) P ur if icat ion  of  DNA fragments
Purification and isolation of DNA fragments was carried out 
on low melting temperature (LMT) agar gels using the method 
described by Garabedian et a l ., (1993). Samples suspended in 
loading buffer (LB) were electrophoresed on LMT agarose gels at
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6V/cm for 1 h. The gels consisted of TAE and the appropriate 
percentage (0.7-1%) LMT agarose and 0.5pg/ml ethidium bromide. 
The DNA fragments were visualised by long wavelength UV light 
and the band containing the DNA fragment excised. Three 
volumes of 200mM NaCl and 20mM EDTA were added to the gel 
slice and heated to 68°C to melt the agar. DNA was removed
from the mixture by phenol extraction (x2) followed by
phenol/chlorofrom extraction (xl) .  The DNA was finally
recovered by ethanol precipitation.
2.2.8 Polym erase chain reaction - PCR
(a) O ligonucleot ide  primers
For each of the regions of HSV-1 DNA to be amplified by 
PCR, two 30mer primers (one 5’ and one 3' to the sequence 
required), were designed according to the recommendations of  
Innis and Gelfand, (1990). Each primer contained a 10 nucleotide 
5' degenerate end encoding an appropriate restriction 
endonuclease site which would allow simple cloning of the 
fragment into the required vector, pGEMl. The oligonucleotides 
were produced in the Institute on a Cruachem PS250 DNA
synthesiser.
(b) D eprotect ion  o f  oligonucleotides from the synthesis  
column
A 2ml disposable syringe containing 1.5ml concentrated 
ammonium hydroxide was attached to one end of the column and a 
second empty 2ml syringe was attached to the other end of the 
column. One column volume of ammonium hydroxide was gently 
pushed into the column which was then left at RT for 20min.
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Another column volume of ammonium hydroxide was then pushed 
into the column and left a further 20min. This procedure was 
repeated until all the ammonium hydroxide had been pushed 
through the column. The ammonia solution was then pushed back 
and forth through the column several times, mixing the solution 
thoroughly. Deprotection of the oligonucleotide was carried out 
by incubation of the mixture in a securely capped vial at 55°C for 
5h, followed by overnight lyophilisation.
(c) O ligonucleot ide  purificat ion
Half of  the lyophilised aliquot of oligonucleotide was 
resuspended in sample loading buffer (90%(w:v) deionized 
formamide, 89mM Tris., 2mM EDTA, 89mM boric acid) and 
was heat denatured at 90°C for lOmin, then cooled on ice. The 
sample was loaded onto a polyacrylamide gel (15% acrylamide, 
0.6% bis.acrylamide, 42% urea, in TBE) and electrophoresed at 
30w for lh. Tracking dye (0.1% bromophenol blue, 0.1% xylene 
cyanol in formamide) was loaded in parallel with the sample to 
allow the progress of  the oligonucleotide down the gel to be 
followed. The oligonucleotides were visualised by shadowing 
with long wavelength UV light then cut from the gel and shredded 
finely. The DNA was eluted from the gel into 200pl H20  by 
incubation in a shaking incubator at 37°C for 2h. The mixture 
was filtered through a Spin-X column, phenol/chloroform 
extracted and the oligonucleotides recovered by ethanol 
precipitation. The concentration of the oligonucleotides was 
determined as described in Maniatis et al., (1989) using the 
following formula.
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Concentration (juM) = OO260
lOx length of oligonucleotides
All oligonucleotides were resuspended in sterile H20  at a 
concentration of 50pmol/pl.
(d) P o lym erase  chain reaction - PCR
PCR was carried out using Taq DNA polymerase, under the 
conditions recommended by Innis and Gelfand (1990). The 
reaction mixture consisted of the following, PCR buffer (no 
MgCl2), lOOpM of each dNTP (dATP, dCTP, dGTP, dTTP), lOOng 
DNA template, 50pmol of  each oligonucleotide primer, ImM 
MgCl2, 2.5 units Taq DNA polymerase, in a total volume of lOOjil 
of sterile H20 .  The optimal concentration of MgCl2 was 
determined by examination of a range of concentrations between 
l-4mM. The reaction mixture was covered with a layer of  mineral 
oil and amplification carried out on an automated PCR machine 
(Hybaid, Omnigene). The following conditions were used in all 
cases, further optimisation of the system was not required.
The PCR program used was as follows:- 
Step 1 95°C 5min
2 50°C lmin 30sec denaturation 1 cycle
3 72°C 2min
4 95°C lmin lOsec
5 55°C lmin 30sec amplification 30 cycles
6 72°C 2min
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1 95°C lmin lOsec
8 55°C lmin 30sec extension 1 cycle
9 72°C 5min
To check that the correct size of fragment had been 
produced a lOjil aliquot of  the PCR product was run on a 1% 
agarose gel (TBE), containing 0.5pg/ml ethidium bromide and the 
DNA visualised using short wave UV light. DNA was retrieved 
from the remainder of the PCR product by phenol/chlorofrom 
extraction followed by ethanol precipitation.
2.2.9 Ligation  o f  DNA fragments
DNA fragments with cohesive ends were produced in two 
ways. (a). PCR products were cleaved with the appropriate 
restriction endonucleases according to the enzyme site encoded in 
the primers, ethanol precipitated and reconstituted in lOpl H20 .
(b). 10pg plasmid DNA was cleaved with restr iction 
endonucleases and the appropriate fragment purified from a LMT 
gel. Vector plasmid DNA was cleaved with restriction 
endonucleases to generate compatible cohesive ends. To prevent 
reannealing of the vector plasmid ends, after cleavage was 
complete, the digest was treated with 25units CIP (calf  intestinal 
phosphatase) at 37°C for 30min. The appropriate fragment of 
vector DNA was then purified as before. DNA fragment and 
vector plasmid were mixed in ligation buffer (50mM Tris.Cl 
pH7.6, lOmM MgCl2, 10mm DTT, 5mM ATP, 50pg/ml BSA, 
5 units T4 DNA ligase) at a ratio of  10:1 and incubated overnight 
at 16°C.
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2 .2.10 Transform ation  of  E.coli
(a) Preparation  of  com petent  bacteria for  
e lectroporat ion
This method follows the Bio-Rad manual recommendations. 
10ml of  a saturated overnight culture of  bacteria was added to 1L 
of 2YT broth and grown at 37°C in a shaking incubator until the 
ODsoo reached 0.6. The cells were transferred to pre-cooled tubes 
and centrifuged at 4,000rpm for 15min. The supernatant was 
discarded and the pellet resuspended in 1L ice cold sterile H20 .  
This step was repeated once more, the pellet resuspended in 20ml 
ice cold 10% glycerol, centrifuged once again and the pellet 
finally resuspended in ice cold 10% glycerol to give a total 
volume of 0.5ml. This suspension was divided into 40pl aliquots, 
frozen on dry ice and stored at -70°C.
(b) Transform ation  - E lectroporation
Transformation of ligated plasmid DNA was carried out after 
heat inactivation of the ligase enzyme at 65°C for lOmin (Ymer, 
1991). l-3 | i l  of the ligation mixture was added to 40pl of 
competent cells, transferred to a cold 0.2mm electroporation 
cuvette and one pulse of 12.5KV/cm (time constant 4-5msec) 
applied to the cuvette. The cells were immediately resuspended in 
lml 2YT broth and the suspension incubated at 37°C for lh. 
Solid medium plates containing ampicillin, were inoculated with 
100 | l x 1  aliquots and incubated overnight to allow the formation of 
colonies.
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2.2.11 Preparation  and assay of  virus
(a) Preparation  o f  virus stocks
Monolayers of BHK cells in 2L roller bottles were infected 
with HSV at a moi of 0.003 pfu/cell in 40ml GM. The virus 
infected cells were incubated at 31°C for 3-4 days until complete 
CPE (cytopathic effect) was observed. The cells were shaken into 
the GM and pelleted by centrifugation (1500rpm, lOmin). To 
concentrate the cell released virus (CRV) the supernatant was 
further centrifuged (12,000rpm, 2h) the pellet resuspended in 5ml 
GM and sonicated for approximately 5min. The pellet of  cell 
associated virus (CAV) from the initial low speed centrifugation 
step was resuspended in a small volume of GM, sonicated briefly, 
centrifuged at low speed, and sonicated twice more until the cell 
clumps were dispersed. Both the CRV and CAV viral suspensions 
were checked for sterility, titrated on BHK cells and stored at 
-70°C.
(b) Titration  o f  virus
Serial ten fold dilutions of virus samples were made in PBS 
with 10% NBCS. Duplicate tissue culture plates (50mm) of  BHK 
monolayers were infected with 400pl aliquots of the 10~4 to 10“9 
dilutions. GM was removed from the plates and the virus left to 
adsorb to the cells for lh  at 37°C. The inoculum was then 
removed and the cells overlayed with 4ml of Eagle’s A+B 
containing 0.5% agar and 10% NBCS. The cells were incubated at 
37°C for 3-4 days to allow plaques to develop. Before staining 
with Geimsa the cells were fixed and the virus killed with 2ml 
glutaraldehyde solution (Cidex). The plaques were then counted 
and the virus titre established.
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(c) Preparation  and purification of  v iral  DNA
10 2L roller bottles of BHK monolayers were infected as 
before (0.003pfu/cell). Once CPE was complete the cells and 
virus were shaken into the GM and centrifuged (2,500rpm, 30min, 
4°C) to remove cell debris. The supernatant was further 
centrifuged (12,000rpm, 2h, 4°C) and the pellet resuspended in 
lml Eagle's A+B and placed overnight on a rotary mixer at 4°C. 
The virus suspension was then separated on a 5-15% ficoll 
gradient (12,000rpm, 2h, 4°C). The tight lower band of virion 
DNA was removed by dripping through a disposable syringe 
needle. Virion DNA was mixed with Eagle's A+B and this 
suspension pelleted by centrifugation (15,000rpm, 2h, 4°C)
(Rixon et a l ., 1988). The pellet was resuspended in 100 j l x I  TE, 
treated with Proteinase K (50jLig/ml) and 0.5% SDS for lh  at 37°C 
(Stow and Wilkie, 1976), phenol/chloroform extracted three 
times, ethanol precipitated overnight and resuspended in 50p,l 
H20. The DNA concentration of the sample was estimated by 
running an aliquot alongside known DNA standards on a 0.7% 
agarose TBE gel.
2.2.12 Production  and assay of  recom binant virus
(a) Construction  and screen ing  of  recom binant virus
Plasmid DNA cleaved with Xba-1 was electrophoresed on a 
0.7% LMT agarose TAE gel and the appropriate fragment isolated 
and purified. The plasmid DNA fragment (approximately 0.5fig) 
was ligated to Xba-1 digested HSV-1 1802 DNA (approximately 
0.5pg). Half  of the ligation mix was used to transfect a 
monolayer of BHK cells (50mm culture plate), using either the 
calcium phosphate precipitation or Lipofection method. The cells
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were overlayed with 4ml GM and left at 37°C for 2-4 days until 
plaques were seen. A mini preparation of virus stock was made 
from the transfection plate by scraping the cells into the GM. 
Titrations were performed on this stock and single plaques picked 
and resuspended in 200pl PBS containing 10% NBCS. Further 
mini stocks of virus were made by infecting BHK monolayers (1 
well of a 24 well Lindbro cell culture plate containing 5 x l 0 5 
cells). These mini virus stocks were assayed for CAT activity and 
positive plaques went through further rounds (2-3) of purification, 
to produce a preparation of homogeneous virus. Stocks of virus 
were made as described previously using aliquots of  the mini
virus stock (approximately 107pfu/ml) to infect five 2L roller
bottles of  BHK cells. The final stock of virus was tit rated as 
described previously. One set of  duplicate titration plates was 
stained for the presence of  (3-galactosidase (the P-galactosidase 
gene is carried on the plasmid DNA insert). Comparison of  the
virus titres from both sets of plates confirmed the purity of  the
stock.
(b) C hloram phenico l  acetyl transferase  (CAT) assay
BHK cells were infected at a moi of 10 pfu/cell with the 
aPpropriate virus. The cells were harvested at 2, 4, 8, 12, 18 and 
24h post infection, washed once in PBS, scraped into 1ml of PBS, 
pelleted (13,000rpm, 2min) and resuspended in 50pl of 250mM 
Tris.Cl pH7.8. The cells were lysed by freeze thawing three times 
on dry ice and cell debris removed by centrifugation (13,000rpm, 
5min). Extracts were assayed for CAT activity using the solvent 
extraction method of Seed and Sheen, (1988). lOpl of  extract was 
added to 40pl of  reaction mix (0.05pCi 14C chloramphenicol,
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0 .5 mM butyryrl co-enzyme A and 200mM Tris.Cl pH7.8) and 
incubated at 37°C for lh. 200pl of a solution of TMPD and 
mixed xylenes (2:1) was added to each reaction tube, mixed 
thoroughly and centrifuged (13,000rpm, 2min) 180pl of  the top 
layer containing the butyrylated form of the chloramphenicol was 
added to 5ml scintillation fluid and the counts per minute (cpm) 
measured. CAT activity was expressed as the percentage 14C 
chloramphenicol converted to the butyrylated form per pg of 
protein per hour.
(c) Thym idine  kinase (TK) assay
Cell extracts were prepared as described in the previous 
method by lysis of the cells in either CAT buffer (250mM Tris.Cl 
pH7.8) or thymidine kinase assay (TK) buffer (20mM Tris.Cl 
pH7.5, 2mM MgCl2, lOmM NaCl, 6.5mM p- mercaptoethanol, 
0.5% (v:v) NP40). lOpl of extract was added to 40pl of  reaction 
mix to give final concentrations of  lOOmM sodium pyrophosphate 
pH6.0, lOmM MgCl2, lOOpM dTTP, 5mM ATP, lOOpCi/ml methyl 
•^ H thymidine. The mixture was incubated at 30°C for 2h. The 
reaction was terminated by the addition of  lOOmM EDTA and 
33pM thymidine and heating to 90°C for 4min. After cooling on 
ice for 5 min the mixture was centrifuged (13,000rpm, 2min) and 
the supernatant spotted onto filter paper discs (Whatman's DE81). 
The discs were washed three times in 4mM ammonium formate 
pH4.0 with lOmM thymidine at 37°C, then twice in 100% ethanol. 
The discs were dried, placed in 5ml scintillation fluid and the cpm 
of 3H thymidine measured. TK activity was expressed as cpm/pg 
protein.
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2.2.13 In vitro mRNA processing
(a) Preparation  of  nuclear extracts
HSV infected or mock infected nuclear extracts were made 
in parallel using the small scale method of Lee and Green, (1990). 
HeLa cells were grown in 140mm culture plates to 70% 
confluency and either infected for 8h with lOpfu/cell of  the 
appropriate virus in 3ml GM or mock infected with 3ml of GM. 
Cells were harvested in PBS and pelleted by centrifugation 
(2,000rpm, 5min, 4°C). The pellet was washed once in 30 
volumes of  PBS, resuspended in 1 pack cell volume (PCV) of 
buffer A (lOmM hepes pH8.0, 1.5mM MgCl2, 10mM KC1, ImM 
DTT) and left to swell on ice for 15min. The cells were lysed by 
passing the suspension through a narrow-gauge needle 5-8 times 
(produces approximately 80% lysis). A crude nuclear pellet was 
produced by centrifugation of the lysate (13,000rpm, 20sec). 
Nuclei were resuspended in two thirds of  the original PCV in 
buffer C (20mM hepes pH8.0, 1.5mM MgCl2, 25% (v:v) glycerol, 
420mM NaCl, 0.2mm EDTA, ImM DTT, 0.5mM PMSF (phenyl 
methyl sulphonyl fluoride)) and incubated at 4°C for 30 min on a 
rotary mixer. The suspension was centrifuged (13,000rpm, 30min, 
4°C) and the supernatant aliquoted and stored at -70°C.
(b) In vitro transcr ip t ion / labe l l ing  of  plasmid DNA
Precursor RNAs for in vitro polyadenylation reactions were 
synthesised using SP6 RNA polymerase and labelled with 32P 
UTP. Plasmid DNA was linearised by cleavage with EcoRl and 
approx ljug of DNA was incubated in a reaction mix of SP6 
buffer, 2.5mM DTT, 2pg BSA, O.lmM each NTP (ATP, CTP, 
GTP, UTP), 12.5pM CAP ( ^ G ^ ' l p p p ^ ' l G ) ,  3 units ^Nais in ,
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20pCi 32P UTP and 15 units SP6 RNA polymerase for, lh  at 
37°C. The labelled precursor mRNA was purified by 
phenol/chloroform extraction followed by chloroform extraction 
and concentrated, with tRNA as a carrier, by ethanol precipitation 
overnight at -20°C. The precipitated precursor mRNA was 
resuspended in H20  to give an activity of 200 counts per second 
(cps) per pi.
(c) Gel purif icat ion  of  precursor  mRNA
When required, precursor mRNAs were further purified by 
electrophoresis of  the radio-labelled mRNA on a 6% acrylamide 
gel. The band of radioactive mRNA was localised by short 
exposure of  the gel to X-ray film. The band was excised and the 
mRNA eluted from the gel by incubation overnight at RT in 
elution buffer (400mM NaCl, 50mM Tris.Cl pH7.5, 0.1% SDS, 
O.lpg/ml Proteinase K). Gel was removed from the sample by 
centrifugation through a Spin-X column. Precursor mRNA was 
then purified and concentrated as above.
(d) In vitro process ing  o f  precursor  mRNA
In vitro processing reactions were performed using 11 pi of 
nuclear extract incubated with ImM cordycepin (3' dATP), 5mM 
creatine phosphate, 2.5mM Tris.Cl pH7.6, l - 2 x l 0 4 cpm of RNA 
and 2.5% PEG, at 30«C for 2h (McLauchlan et a l ., 1988). RNA 
was isolated for analysis as follows: lOOpl of  2x PK buffer, 50pg 
of Proteinase K and 40pg yeast tRNA were added to the reaction 
mix and the volume adjusted to 200pl with H20 .  Proteinase K 
digestion was performed at 37°C for 15min. The RNA was
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purified by phenol/chloroform extraction and ethanol 
precipitation.
(e) A nalys is  o f  the in vitro processing products
The RNA precipitate obtained as described above was 
resuspended in 6pl of  loading buffer (98% formamide. 0.02% 
(w:v) xylene cyanol, 0.025% (w:v) bromophenol blue, lOmM 
EDTA pH8.0) and the products of the in vitro processing reaction 
separated on a 6% acrylamide gel. The bands of processed and 
unprocessed mRNA were visualised by auto-radiography or by the 
use of a Molecular Dynamics Phosphorimager. The relative 
quantities of  processed and unprocessed mRNA were determined 
by quantification of the radioactivity present in each band using 
phosphorimage technology.
2.2.14 Southern blotting
(a) Random prime labell ing  o f  probe
Labelling of the DNA probe was carried out using the Mega­
prime DNA labelling system of Amersham in accordance with 
manufacturers recommendations. 25ng of DNA was used for each 
probe which was labelled with 32P ATP (50pCi/reaction).  The 
probe was purified from unincorporated ^2p ATP by passage 
through a Sephadex G50 column.
(b) T ransfer  o f  DNA
Southern blotting was performed essentially as described by 
Southern, (1975). 2-3pg of  viral DNA, either HSV-1 1802 or
recombinant virus DNA, was digested with BamHl. The digest 
was electrophoresed on a 0.7% agarose TBE gel, at lOOmV for
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5-6h. Pre-heating of the digest to 56°C for 2-3min disrupted any 
pairing of cohesive ends. The DNA was then denatured by 
soaking the gel in buffer (1.5M NaCl, 0.5M NaOH) for 45min. 
The gel was neutralised by soaking in buffer (1M Tris.Cl, pH7.5, 
1.5M NaCl) for 30min. Transfer of  the DNA to a nylon membrane 
(Hybond-N, Amersham) took place by capillary action, overnight 
in 20xSSC. The DNA was cross-linked to the membrane by UV 
light using a UV Stratalinker 1800 ( 120mJ/30sec).
(c) D N A:DNA hybridizat ion
The membrane was incubated in pre-hybridization buffer 
(5xSSPE, 4xDenhardt's (DHS), 0.5% SDS) for lh  at 65°C in a 
rotary oven (Hybaid maxi-oven). The radiolabelled probe was 
added in fresh hybridization buffer and the membrane incubated 
overnight at 65°C. After hybridization was complete the 
membrane was washed at 65°C in successive changes of 
decreasing concentrations of SSPE buffer with 0.1% SDS (2xSSPE 
to O.lxSSPE). The membrane was then wrapped in cling film to 
prevent drying and autoradiographed.
2.2.15 Protein  extraction and W estern blotting
Mock infected or HSV (lOpfu/cell) infected cells were 
harvested by washing and pelleting in PBS. Protein was extracted 
by boiling the cell pellet for 5 min in boiling mix (4% SDS, 
125mM Tris.Cl pH6.7, 39% (v:v) glycerol, 0.002% (w:v)
bromophenol blue, 2% (v:v) p—mercaptoethanol). Proteins were 
separated by electrophoresis on 8-12% SDS-polyacrylamide gels. 
Transfer of  the proteins to a nitrocellulose membrane was carried 
out overnight at 100mA in blott ing buffer (25mM Tris., 192mM
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glycine, 20% (v:v) methanol), using Bio-Rad blotting apparatus. 
Free protein binding sites on the membrane were blocked by 
incubation in TBS containing 5% dried milk, for 4-5h. This and 
all subsequent incubations and washing were carried out with 
gentle agitation. The membrane was then washed thoroughly in 
TBS with 5% tween-20, before being incubated overnight with the 
appropriate dilutions of specific primary antibodies in TBS-tween. 
Three lOmin TBS-tween washes removed the excess primary 
antibody, the membrane was then incubated for lh  with a 1:1000 
dilution of  the appropriate secondary antibody in TBS-tween, 
either protein-A HRP or goat anti-mouse HRP conjugate. 
Detection of  antibody labelled proteins was performed using the 
ECL detection kit of  Amersham in accordance with the 
recommended protocol. Membranes were stripped of  antibody and 
reprobed as follows. Incubation at 50°C in stripping buffer 
(lOOmM (3-mercaptoethanol, 2% SDS, 62.5mM Tris.Cl). The 
membrane was then washed at least three times (10 mins) in TBS- 
tween, blocked in 5% dried milk and TBS and reprobed as 
described previously.
2.2.16 RNA-protein  UV cross-linking
Nuclear extracts were prepared as for in vitro 
polyadenylation, and were finally dialysed for 3h against binding 
buffer (60mM KC1, 20mM hepes, ImM MgCl2, 10% glycerol), 
with 3 changes of  buffer during that time (Vakalopolou et a l ., 
1991). The protein concentrations of the HSV infected and mock 
infected nuclear extracts were estimated by Bradfords (1976) 
method and equilibrated to 10-15 pg/pl. Radiolabelled precursor 
mRNA was prepared as before and reconsti tuted in binding buffer
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to give an activity of 300cps/p,l. The following reaction mixture 
was incubated for 30min at RT (8 j l x I  binding buffer, lp l  
radiolabelled precursor mRNA and lp l  nuclear extract). The 
mRNA and proteins were irreversibly cross-linked using UV 
irradiation, 250mJ/cm^ (Bohjanen et al., 1991). Unprotected 
RNA was removed by digestion with RNase A (lmg/ml, for 15min 
at 37°C). An equal volume of protein boiling mix was then added 
and the mixture boiled for 5min. The proteins, radiolabelled with 
mRNA, were separated on a denaturing SDS-acrylamide gel and 
visualised using a Phosphorimager. Rainbow coloured, protein 
molecular weight markers were run alongside the samples on each 
gel to give an estimation of the protein sizes.
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Chapter 3
Results
3.1. The effect of an HSV-1 induced factor
(LPF) on the in vitro processing efficiencies
of selected HSV-1 poIy(A) sites
3.1.1 Introduction
In the last few years considerable attention has been paid to 
the mechanisms of mRNA 3' end formation (Manley, 1988; 
Gilmartin and Nevins, 1989; Wahle and Keller, 1992). The 
complex picture emerging from these studies indicates great scope 
for regulation of these events. One example of a regulatory role 
for 3' mRNA processing is the production of the immunoglobulin 
p mRNAs during B-cell maturation. The switch from production 
of the membrane bound form of IgM to production of the secretory 
form of IgM appears to result, at least in part, from alternative 
poly(A) site selection (Galli et a l ., 1988; Petersen and Perry, 
1989; Lassman and Milcarek, 1992; for review see Guise, 1989). 
Another well documented example of post-transcriptional 
regulation of  gene expression is found in adenovirus where the 
differential use of the LI and L3 poly(A) sites of the major late 
transcription complex, at early and late times respectively in the 
virus growth cycle, has been described (Falck-Pedersen and 
Logan, 1989; Wilson-Gunn et a l ., 1992; Mann et al., 1993).
Studies of HSV have identified a virus induced factor, LPF, 
which selectively increases the efficiency of 3’ processing at the 
Poly(A) site of a late gene of HSV-2 (UL38), but does not
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increase 3' processing efficiency at another poly(A) site common 
to the US10, US11 and US12 genes which are members of the 
early, late and immediate-early, gene classes of  HSV-2 
respectively (McLauchlan et at., 1989). The aim of this study is 
the determination of the specificity of LPF activity by 
examination of  a range of HSY poly(A) sites.
In vitro processing systems, which faithfully cleave and 
polyadenylate exogenous pre-mRNA at the authentic poly(A) site, 
have allowed analysis of the mechanisms and components required 
for 3' end formation of RNA (Moore and Sharp, 1984; 1985). In 
this way, the regulation of gene expression can be examined at a 
post-transcriptional level without the additional influence of 
transcriptional regulation. In the following experiments the in 
vitro processing efficiencies of  a range of poly(A) sites have been 
examined using an in vitro processing system. The poly(A) sites 
selected, were from representative members of the different 
temporal classes of  HSV-1 genes, the IE, early and late gene 
classes. Individual plasmids containing these poly(A) sites were 
constructed to produce runoff  precursor mRNA transcripts from a 
phage SP6 promoter. Analysis of the effect of  virus infection on 
the processing efficiencies of  these poly(A) sites was studied by 
incubation of  precursor mRNAs with mock-infected or HSV 
infected nuclear extracts, which contain all the soluble 
components required for efficient cleavage and polyadenylation.
3.1.2 HSV-1 poly(A) sites
Poly(A) sites from the IE 110 and IE63 HSV-1 genes were 
chosen to represent the IE class of HSV-1 genes. IE110 is a 
trans-inducer of IE, early and late genes and IE63 (UL54) is a
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multifunctional protein involved in the regulation of late gene 
expression. The early class of HSV-1 genes was represented by 
the poly(A) sites of  the UL23 and UL29 genes. UL23 encodes the 
enzyme thymidine kinase and UL29 encodes the major DNA 
binding protein. The late class of HSV-1 genes was represented 
by the poly(A) sites of the UL38 and UL44 genes. UL38 encodes 
a protein component of the virion, and is the HSV-1 equivalent of 
the HSV-2 late poly(A) site used in the studies of McLauchlan et 
al., (1989; 1992b), while UL44 encodes glycoprotein C a virion 
surface glycoprotein (McGeoch et al., 1985). The poly(A) sites 
chosen therefore represent genes of  each of the temporal classes 
of HSV-1 (Roizman and Sears, 1993).
The HSV-1 genome map (McGeoch and Schaffer, 1992) of 
Figure 3.1 shows the map locations, in kbp, of the six selected 
poly(A) sites . The duplicated tandem poly(A) signals of  IE110 
are situated at positions 5638, 5678, l*Ofa*tl and 120734 (Perry et 
al., 1986). The locations of  the other poly(A) signals are as 
follows : IE63 at position 115277 (Whitton et al., 1983), UL23 at 
positions 46613 and 46626 (McKnight, 1980), UL29 at position 
58414 (Quinn and McGeoch, 1985), UL38 at position 86016 
(Anderson et al., 1981) and UL44 at position 98663 (Frink et al., 
1983). The IE110, IE63, UL23, UL29 and UL38 poly(A) sites are 
all utilised by single RNA transcripts. The UL44 poly(A) site is 
also uti l ised by the 3’ co-terminal UL45 transcript,  UL45 has 
recently been classed as a late gene (Visalli and Brandt, 1991; 
1993). Transcripts, corresponding to read through of the poly(A) 
sites of UL23, UL29 and UL38 have been isolated but no protein 
or function has as yet been assigned to them (Figure 3.1).
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FIGURE 3.1:
A diagram o f  the genetic content o f  HSV, adapted from 
McGeoch and Schaffer (1992).  (A) Scale o f  the 152kbp DNA 
sequence. (B) Representation o f  the D N A  sequence features:- 
Locations o f  the polyadenylation sites are indicated by small 
vertical arrows, locations o f  the HSV-1 poly(A) sites selected  
for examination in this study are indicated by large arrowheads 
and the gene designations are in bold type : locations and 
directions o f  proposed protein coding reading frames are 
indicated by broad arrows : immediate-early (IE, a)
genes ; early (p) genes yasgfr ; early-late ( y l )  Wo ; and
true late (y2) genes ®  ; genes o f  unknown temporal c lass are
white. (C) Gene designations. (D) Rightward and (E) Leftward 
transcribed RNA species  : reasonably well characterised
transcripts are shown as solid lines and poorly characterised 
transcripts or hypothetical transcripts are shown as dashed 
lines. Positions o f  major families o f  short tandem reiterations 
are shown as filled boxes beneath the gene layouts and are 
marked "R". or i ;  origin o f  replication.
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Resu l ts
3.1.3 Construction o f  plasmids for in vitro  3 ’ mRNA  
processing reactions
(a) Poly(A) site size
To ensure inclusion of all possible elements required for 
efficient 3' end formation, an RNA fragment of around 450nt, 
spanning a region approximately 225nt upstream and downstream 
of the conserved hexanucleotide poly(A) signal AAUAAA, was 
chosen for processing. This fragment size includes the poly(A) 
site and would also include any upstream or downstream elements 
that might be required for efficient cleavage at the poly(A) sites, 
such as the previously described upstream U-rich elements 
(Valsamakis et al., 1992; Gilmartin et al., 1992; Cherrington and 
Ganem, 1992; Schek et al., 1992) and GU- or U-rich downstream 
sequences (McLauchlan et al., 1985, Manley, 1988; Sadofsky and 
Alwine, 1984; Sadofsky et al., 1985).
(b) PCR am pli f ica t ion  of  se lected  poly(A) sites
PCR was chosen as a simple and efficient means of 
generating poly(A) site fragments of uniform size which could 
easily be cloned into the required plasmid vector. All fragments, 
with the exception of IE110, were approximately 450nt in length. 
The high G+C content of the DNA sequences around 200nt 
upstream and downstream of the IE 110 poly(A) signal render them 
unsuitable for use as PCR primer templates. Primers were 
therefore designed to complement areas outwith these regions, 
generating a larger 553nt fragment. Primers used for PCR 
amplification of the six test poly(A) sites are shown in Table 3.1. 
The 5' degenerate ends of  the primers contain restr iction 
endonuclease sites which allowed easy cloning of the fragments
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into the vector pGEMl, used for the production of run-off  
transcripts. Primers used for amplification of the poly(A) site 
fragments of IE110, IE63, UL23, UL29 and UL38, encode a 
Hindlll  site in the upstream primer PI and a BamHI restr iction 
site in the downstream primer P2 (Figure 3.2). As discussed later 
choice of these sites facilitated construction of the plasmid 
vectors used in the production of the recombinant viruses (Results 
3.2.2 b). As the UL44 poly(A) site DNA fragment contains an 
internal Hindlll  site, primer PI contains a PstI site and primer P2 
an EcoRI site, (Figure 3.2). The six poly(A) site DNA fragments 
were produced from a template of HSV-1 strain 17+ DNA by 30 
cycles of  PCR.
(c) C loning of PCR amplif ied  poly(A) site DNA
The PCR amplified poly(A) sites of IE110, IE63, UL23, 
UL29 and UL38, were digested with Hindlll and BamHI and 
ligated to the vector pGEMl which had been pre-cleaved with 
Hindlll and BamHI. Similarly the UL44 poly(A) site fragment 
was digested with PstI and EcoRI and ligated to pGEMl pre­
cleaved with PstI and EcoRI. The PCR primers were designed to 
produce DNA fragments which could be cloned into the pGEMl 
vector such that the SP6 promoter could be used to produce 
poly(A) RNA transcripts in the correct 5' to 3' r ightward 
orientation (Figure 3.2). The plasmids constructed in this way 
were termed pGllO ,  pG63, pG23, pG29, pG38 and pG44
respectively. The DNA inserts in all six plasmids were sequenced 
using primers to both the SP6 and T7 promoters which flank the 
insert. Only one mismatched nucleotide was found in the poly(A) 
sequence of UL23, this G for T mismatch occurred 98nt 3' to the
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p G E M l
2865 bps
IE63 IE110 UL23 UL29 UL38 poly A s i t e s
UL44polyA s i t e
I  I
7 18 20 22 23 24 28 34 39 41 50 52
H in d lll BspMI PstI Sail AccI HincII Xbal BamHI Aval Sami SacI EcoRI
FIGURE 3.2:
Construction o f  plasmids pG llO , pG63, pG23, pG29, pG38  
and pG44. Poly(A) site fragments from the IE110, IE63,  
UL23, UL29 and UL38 HSV-1 genes were inserted at the 
Hindlll  and BamHI sites of  the poly cloning region o f  
p G E M l. The UL44 poly(A) site fragment was inserted at the 
PstI and EcoRI sites of  the poly cloning region o f  p G E M l.
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poly(A) signal, and was not considered to be of significance to 
these studies (see Results 3.4.4 a) DNA sequences obtained from 
the other poly(A) fragments were identical to the predicted 
sequences.
3.1.4 In vitro synthesis  of  precursor mRNA
The pGEMl 3' processing plasmids described above were 
used to produce run-off  mRNA transcripts. Plasmids were 
linearised by single cut digestion at the EcoRI site approximately 
220nt 3' of the poly(A) signal: termination of transcription by SP6 
RNA polymerase was effected when the enzyme reached the 5’ end 
of the DNA template strand.
While most (Moore and Sharp, 1985; Conway and Wickens, 
1987) but not all (Gilmartin et a l ., 1989) investigators have 
reported that 5’ capping of nuclear mRNA is not essential for 3' 
processing, capped substrates are generally more stable in nuclear 
extracts. Hence, to obtain a capped substrate the dinucleotide cap 
analogue m^GpppG was included in these in vitro transcription 
reactions.
Transcription of the linearised poly(A) site plasmids with 
SP6 RNA polymerase in the presence of ^2p labelled UTP resulted 
in production of a single species of radiolabelled precursor mRNA 
around 450nt in length.
3.1.5 S tandardisation  o f  the 3 f processing reaction
Mock infected (MI) and HSV-1 infected (INF) nuclear 
extracts were prepared by the method of Lee and Green (1990). 
The basal levels of  3' processing activity of extracts used varied 
from one paired set of  MI and INF nuclear extracts to another,
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this observation has been made by other workers (R. McWilliams ; 
Dr. A. Phelan, unpublished data), and is likely due to differences 
in the condition of the cells at the time of extract preparation. 
The following measures were therefore taken to ensure that valid 
comparisons of the processing efficiencies of the test poly(A) 
sites could be made.
Nuclear extracts were prepared from monolayers of  MI and 
INF HeLa cells, seeded and harvested in parallel. In vitro 
processing was carried out with paired sets of these extracts. 
The reconsti tuted volumes and therefore the concentration of the 
nuclear extracts were determined by the packed cell volume of the 
initial cell suspension. Protein concentrations of the nuclear 
extracts, measured by the method of Bradford (1976), were found 
to be similar in both MI and INF extracts (Table 3.2). All 
extracts were used to process a control plasmid pSAU5, 
(McLauchlan et a l ., 1989), which contains the HSV-2 IE12
poly(A) site (IE) 5' in tandem to the HSV-2 UL38 late (L) poly(A) 
site, inserted into the multicloning site of pGEMl, under the 
control of the SP6 promoter (Figure 3.3). Initial studies, which 
identified the HSV induced processing factor LPF, demonstrated 
an alteration in the processing efficiencies of  the SAU5 poly(A) 
sites. The processing efficiency of the L site increased markedly 
and that of the IE site decreased slightly when processing was 
carried out with INF nuclear extracts : all extracts used in this 
study showed this change in 3’ processing (Figure 3.4 and Table
3.3). Each pair of  extracts was used to process as many of the 
test poly(A) sites as possible, each extract being used to process 
at least four of  the six test poly(A) sites examined.
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PROTEIN CONCENTRATION OF HeLa CELL NUCLEAR EXTRACTS
EXTRACT No. Extracts Mean Cone, (ng/yl) Range of Cone.
MOCK INFECTED 6 7.45 5.25-9.4
HSVINFECTED 6 7 4.75-8.2
TABLE 3.2:
Mean protein concentrations o f  a sample o f  six mock infected  
and HSV infected HeLa cell  nuclear extracts used in the in 
v i tro  processing reactions. Protein concentration measured by 
the method o f  Bradford is expressed as pg protein/pl of  
extract.
SAU5 RNA (400nt)
,--------------- , IE LATE
SP6 promoter______________▼ ____________________________
--------------------------------------------------- ►259nt
►73nt
FIGURE 3.3:
Diagram o f  the tandem arrangement o f  poly(A) sites in the 
control plasmid pSAU5. The HSV-2 poly(A) site common to 
US10, US11 and US12 (IE) is 5’ to the HSV-2 UL38 poly(A)  
site (L). Production o f  run off mRNA transcripts is under the 
control o f  the SP6 promoter. Cleavage at the IE site produces  
mRNA species o f  73nt, cleavage at the L site mRNA species  
of 259nt.
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3.1.6 In vitro 3 fprocessing
Radiolabelled precursor RNAs, corresponding to RNA 
transcripts from the test poly(A) sites, were cleaved in vitro by 
incubation with either MI or INF nuclear extracts, cordycepin and 
creatine phosphate, for 2h at 30°C. The reaction mixture was 
then treated with proteinase K to remove any proteins bound to 
the RNA. Under normal conditions, the products of 3' end 
formation of a single precursor are of varying sizes, depending on 
the length of poly(A) tail added. These products, when separated 
on a polyacrylamide gel, appear as a smear and determination of 
processing efficiencies o f  the poly(A) sites under these conditions 
is difficult. Accurate cleavage was therefore assayed in these 
studies by substitution of ATP with cordycepin (3' dATP) an 
analogue of ATP - addition of the cordycepin residue to the 
cleaved 3' terminus of RNA prevents further elongation of the 
poly(A) tail. While inclusion of cordyecepin is known to reduce 
the overall efficiency of precursor cleavage this effect is 
universal and does not depend on the individual properties of  the 
precursor and as such will have no influence on the outcome of 
these studies (McWilliams, unpublished data; Moore and Sharpe, 
1985). To prevent addition of ATP present in the nuclear extracts 
to the cleaved RNA, ATP was depleted by pre-incubation of the 
extracts at 30°C for 20min. A source of energy other than ATP 
was therefore required to allow the cleavage reactions to proceed 
and creatine phosphate, which has a higher phosphate group 
transfer potential than ATP, was used. Transfer of the phosphoryl 
group being catalysed by the endogenous creatine phosphokinase 
of the nuclear extracts (Moore and Sharp, 1985). The efficiency 
of substrate RNA cleavage was facili tated by the inclusion of PEG
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in the in vitro cleavage reactions (J. McLauchlan, personal 
communication), this effect appeared to be due to concentration of 
trans-activating factors by reducing the apparent reaction volume.
Typical 3' RNA processing of the test poly(A) sites resulted 
in a mixture of  uncleaved precursor RNA (approximately 400nt) 
and cleaved precursor product (200-250nt), appearing as discrete 
bands when separated on polyacrylamide gels. In vitro 3' RNA 
processing of the control plasmid pSAU5 produced a mixture of  
uncleaved precursor RNA (400nt), RNA cleaved at the IE poly(A) 
site (73nt) and RNA cleaved at the L poly(A) site (259nt) (Figure
3.4).
3.1.7 The cleavage eff ic iencies  o f  selected HSV-1  
poly(A) sites are increased by LPF
(a) A utorad iography
Products of  the in vitro 3' processing reactions of the six 
test RNAs were separated by electrophoresis on 6% 
polyacrylamide gels and the radiolabelled bands of uncleaved and 
cleaved precursor mRNA were visualised by autoradiography. 
Figure 3.4 shows a typical autoradiograph obtained from these 
processing reactions. The processing efficiencies of  the HSV-1 
UL38 and UL44 late poly(A) sites were consistently increased 
with INF nuclear extracts. By contrast, the HSV-1 poly(A) sites 
of IE110, IE63, UL23 and UL29 showed no discernable change in 
processing efficiency when processed with either MI or INF 
nuclear extracts. The controls of pSAU5 showed the predicted 
increase in processing efficiency at the L poly(A) site and little or 
no change in processing efficiency at the IE poly(A) site with INF 
nuclear extracts.
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(b) Q uantif icat ion  of  3 ’ processing data
Quantification of the 3’ processing efficiencies of the six 
poly(A) sites was performed using a Molecular Dynamics 
Phosphorimager. The total level of radioactivity present in the 
uncleaved precursor and cleaved product bands was measured by 
volume integration. This measures the total radioactive counts 
within a delineated area of the gel minus the background 
radioactivity which was determined for individual bands by 
measurement of  an area of the gel nearest to the band being 
counted. Processing efficiency was expressed as the % of 
precursor RNA cleaved during the in vitro processing reaction, 
using the following formula.
Processing efficiency = *Cleaved Product counts x 100
Total counts
Total counts = counts in uncleaved precursor band plus 
counts in *cleaved product band
* These values were adjusted to account for U content of  the 
cleaved band relative to each uncleaved precursor band, assuming 
that efficiency of  32p UTP incorporation was proportional to the 
U content. A sample calculation is given below:-
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Uncleaved precursor RNA (UL38) * * lOOUs * *
cleaved product * 51Us *
RNA tail degraded and lost * * *
The number of Us present in the cleaved product can therefore be 
expessed as a % of the total number of Us present in the 
uncleaved precursor, in this case 51%.
uncleaved precursor RNA = 267470 (radioactive counts) 
cleaved product (actual) = 13223 (radioactive counts)
(adjusted) = 13223 x 100 
Us in cleaved product 51
=25927.5
PROCESSING EFFICIENCY= 25927.5
25927.5+267470
=  8 . 8 %
Quantification of the RNA processing efficiencies eliminates 
apparent effects caused by differences in sample loading of the 
polyacrylamide gels. The processing efficiency of each poly(A) 
site was determined a minimum of six times using six different 
paired MI and INF nuclear extracts. Results are shown in Table 
3.3 and Figure 3.5 A,B,C,D. The 3' processing efficiencies of the 
UL38 and UL44 precursors were consistently increased when 
processing was carried out with INF nuclear extracts. The mean 
processing efficiency of UL38 showed an 81% increase and that 
of UL44 showed a 61.5% increase above that obtained with the MI 
nuclear extracts. The IE63, UL29 and UL23 precursors showed 
some slight differences in processing efficiencies when processed 
with INF nuclear extracts - the mean processing efficiency of
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FIGURE 3.5 (A):
The % 3' RNA processing efficiencies o f  the control plasmid  
SAU5 poly(A) sites. IE: HSV-2 IE12 poly(A) site, L: HSV-2  
UL38 poly(A) site. Graphical representation o f  the results  
presented in Table 3.3. Y-axis : % processing efficiency. X- 
axis : the number o f  individual processing reactions carried 
out. MI - mock infected nuclear extract, INF - HSV-1 infected  
nuclear extract.
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FIGURE 3.5 (B):
The % 3' RNA processing eff iciencies  o f  the poly(A) sites o f  
the HSV-1 IE genes IE110 and IE63. Graphical representation  
of the results presented in Table 3.3. Y-axis : % processing  
efficiency. X-axis : the number o f  individual processing  
reactions carried out. MI - mock infected nuclear extract, INF 
- HSV-1 infected nuclear extract.
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FIGURE 3.5 ( C Y
The %  3 ’ RNA processing efficiencies o f  the poly(A) sites o f  
the HSV-1 early genes UL23 and UL29. Graphical 
representation o f  the results presented in Table 3.3. Y-axis : 
% processing efficiency. X-axis : the number o f  individual 
processing reactions carried out. MI - mock infected nuclear 
extract, INF - HSV-1 infected nuclear extract.
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FIGURE 3.5 ( D Y
The % 3 ’ RNA processing eff ic iencies of  the poly(A) sites o f  
the HSV-1 late genes UL3S and UL44. Graphical 
representation o f  the results presented in Table 3.3. Y-axis : 
% processing efficiency. X-axis : the number o f  individual  
processing reactions carried out. MI - mock infected nuclear 
extract, INF - HSV-1 infected nuclear extract.
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FIGURE 3.6:
3' processing eff iciencies  o f  the test poly(A) sites using mock  
infected nuclear extracts. The percentage processing  
efficiency is expressed as the mean o f  the set o f  results 
presented in Table 3.3.
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IE63 decreased slightly (13%), that of  UL29 decreased slightly 
(9.2%) and that of  UL23 increased slightly (23%) from the mean 
processing efficiencies obtained in the MI nuclear extracts. The 
processing efficiencies of the control pSAU5 poly(A) sites were 
as expected, the mean processing efficiency of  the L site 
increased by 100% and that of the IE site decreased slightly 
(17%) when processing was carried out with INF nuclear extracts. 
Statistical analysis of the data, using a two sided p-test based on 
the binomial distribution, confirmed that the increase in 
processing efficiency of the three late sites produced in the INF 
extracts, was significant. The analysis also confirmed that the 
processing efficiencies of the other poly(A) sites were not 
significantly different in either MI or INF extracts.
Variability in processing activities of  different nuclear 
extracts was noted throughout and this can be seen in the 
graphical representation of the processing efficiencies given in 
Figure 3.5 A,B,C,D.
3.1.8 Processing  eff ic iencies  of  selected HSV-1  
poly(A) sites with MI nuclear extracts
Examination of the processing efficiencies of the six test 
HSV-1 poly(A) sites with MI nuclear extracts revealed striking 
differences in the basal levels of processing efficiency of these 
sites. The mean processing efficiencies, using MI extracts, of  the 
UL38, UL44 and pSAU5 L poly(A) sites were lower than the mean 
processing efficiencies of the IE110, IE63, UL23, UL29 and SAU5 
IE poly(A) sites (Figure 3.6). The poly(A) sites which respond to 
LPF therefore appear to be inherently less efficient than those 
which do not respond.
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3.1.9 Discussion
These in vitro studies have confirmed that an HSV-1 induced 
factor, termed LPF, alters the 3’ processing efficiencies of  certain 
HSV-1 poly(A) sites. The action of LPF appears to be selective, 
only the processing efficiencies of the late poly(A) sites of  HSV-1 
(UL38 and UL44) are increased with INF nuclear extracts. The 
processing efficiencies of the poly(A) sites from the IE110, IE63, 
UL23 and UL29 genes of  HSV-1 are unaffected by LPF. We have 
shown by in vitro studies that the HSV-1 poly(A) sites which 
respond to LPF are less efficient processing sites than those 
which do not respond to LPF.
Examples of post-transcriptional regulation of gene 
expression, in which poly(A) site choice is influenced both by the 
inherent poly(A) site strength and the concentration of processing 
factors, have been described in other systems. In adenovirus, the 
switch from early to late gene expression is thought to be 
regulated by poly(A) site selection. There are currently two 
theories concerning the mechanisms of this selection; the first 
proposes that poly(A) site choice is determined by its spatial 
arrangement. At early times of infection the LI poly(A) site, of 
the major late transcriptional unit, being the most 5’ site, is used 
preferentially. Later in infection, by an as yet unidentified 
mechanism, RNA cis-acting sequences override this preference 
and all poly(A) sites are used equally efficiently (Falck-Pedersen 
and Logan, 1989). While Wilson-Gunn et al., (1992), suggest that 
regulatory elements in the LI site are required for its selective 
use at early times. The second theory proposes that poly(A) site 
selection is determined by the differing strengths of the poly(A) 
sites. Mann et al., (1993), propose that at late times, when one of
L
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the RNA processing factors is present at a limiting concentration, 
the late L3 poly(A) site being the strongest site is used in 
preference to the weaker LI site. A second example is found 
during B-cell differentiation, which requires a switch from the 
production of  membrane bound (pm) to the secretory (ps) form of 
IgM, this switch is thought to be regulated by poly(A) site choice. 
In the mature B-cell the pm site is used preferentially whereas in 
the terminally differentiated plasma cell the ps site is used 
preferentially. Two main models exist to explain this change in 
poly(A) site usage. In the first, poly(A) site choice is dependent 
on the relative strengths of the two poly(A) sites (Galli et al., 
1987), use of  the weaker of  the two sites, ps, is increased in 
plasma cells due to an increase in concentration of the processing 
factors present. In the second model, cleavage and 
polyadenylation at the ps site competes with splicing at a 
suboptimal 5' splice site (Lassman and Milcarek, 1992; Petersen 
and Perry, 1989). Like the first model, an increase in cleavage 
efficiency at the ps poly(A) site results in its preferential use. 
Transcription termination is thought to play an additional role in 
IgM secretion, termination occurring 3' to the ps site more 
frequently in plasma cells than B-cells, thereby increasing the 
number of mRNA transcripts containing only the ps poly(A) site 
(Guise et al., 1989; Peterson and Perry, 1989).
I present two explanations of  the LPF associated increase in 
3’ processing efficiencies at the UL38 and UL44 poly(A) sites. 
Firstly, there could be structural or sequence elements present in 
the responding poly(A) sites and absent from the non-responding 
poly(A) sites which interact directly with LPF or LPF induced 
factor(s). These factors could be the cell derived processing
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components or factors which can either substitute for them or 
stabilise their interactions. Secondly, LPF could increase the 
processing efficiencies of all virus poly(A) sites, and the poly(A) 
sites at which this would be apparent would be those which 
function sub-optimally in the absence of LPF activity. In this 
study we have been able to show that the three poly(A) sites 
which resond to LPF are inherently less efficient. It is perhaps 
not coincidental that the sites which respond to LPF are from 
genes which are expressed only at late times of infection, this 
could be a means of regulating their expression. Any generalised 
increase in processing efficiency again could be brought about by 
the direct involvement of LPF with the processing machinery of 
the cell either by increasing the level of  processing components, 
substituting for them or stabilising their activity. LPF could thus 
give a boost to the processing efficiencies of all poly(A) sites at 
late times of infection when levels of  cell derived processing 
factors are declining.
9 9
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3.2 T h e  in vivo  e f f e c t  o f  L P F
3.2.1 Introduction
The in vitro experiments described in the previous Section 
were designed to examine effects of LPF on the processing 
efficiencies at selected HSV-1 poly(A) sites. Processing 
efficiency was determined by the measurement of cleavage 
efficiency without the additional influence of posttranscriptional 
events such as polyadenylation, splicing and translation of mRNA : 
events which could have a dramatic effect on the regulation of 
gene expression in vivo. It was important therefore to confirm 
that the LPF effect was not an artefact of  the in vitro assay, but a 
genuine phenomenon ongoing during virus infection in vivo. 
Previous in vivo studies, carried out by McLauchlan et a l ., (1989; 
1992b), used virus recombinants to confirm their in vitro findings, 
these recombinant viruses contained a CAT reporter gene fused 
upstream of the IE and late poly(A) sites used in their in vitro 
studies, which were present either singly or in tandem. 
Examination of the mRNA species produced from these 
recombinant viruses (McLauchlan et al., 1989) and comparison of 
the levels of CAT activity obtained during infection with the virus 
recombinants (McLauchlan et al., 1992b) demonstrated that LPF 
functioned in vivo to increase 3' mRNA processing at the HSV-2 
UL38 late poly(A) site above that obtained at the IE poly(A) site.
In the following experiments a number of virus recombinants 
were used to confirm these in vivo studies utilising the previously 
constructed vFJ7, vFJIO (Rixon and McLauchlan, 1990) and 
vSAU3 (McLauchlan et al., 1992b) virus recombinants (Figure 
3.7) and a newly constructed virus recombinant vFJM38. Viruses 
vFJ7 and vSAU3 both contain promoter sequences from the HSV-2
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early UL40 (the small subunit of the ribonuclease reductase) gene, 
linked to the CAT reporter gene, with poly(A) site sequences from 
HSV-2 IE12 and HSV-2 UL38 genes respectively. Viruses 
vFJM38 and vFJIO both contain promoter sequences from the 
HSV-2 IE68/12 gene, linked to the CAT reporter gene, with the 
poly(A) site sequences from HSV-1 UL38 and HSV-2 IE12 genes 
respectively. Using vFJ7 and vSAU3, differences in post- 
transcriptional regulation of viral gene expression due to 
differential use of the inserted poly(A) sites was studied. In the 
following experiments, CAT activity of the four recombinant 
viruses was compared over a time course of infection and 
standardised against viral thymidine kinase levels.
The original aim of this study was to produce a series of 
recombinant viruses with the CAT reporter gene under the control 
of the HSV-1 IE68/12 promoter, with the HSV-1 poly(A) sites of 
UL38, UL44 and IE63. These HSV-1 poly(A) sites would 
represent sites which differed in their response to LPF. 
Unfortunately, due to lack of time, construction of the UL44 and 
IE63 poly(A) site recombinant viruses was not completed.
3.2.2 Construction o f  the expression plasmid  
pFJM38
(a) M utation of  pFJIO
The expression plasmid pFJM38 which contains the HSV-1 
UL38 late poly(A) site was constructed from the plasmid pFJIO 
(Figure 3.8). Plasmid pFJIO had previously been used in the 
production of  the vFJIO virus recombinant (Rixon and 
McLauchlan, 1990), and contains the HSV-2 IE68/12 promoter 
fused upstream of the CAT reporter gene with the downstream
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FIGURE 3.8 :
The CAT expression plasmid pFJM38 was constructed 
from the plasmid pFJIO which contains the HSV-2 IE68/12 
promoter (Pr) sequences fused upstream of the CAT 
coding region, which is upstream of the HSV-2 IE12 
poly(A) site (PI).  The LacZ cassette contains an SV40 
early promoter fused upstream of the p-galactosidase 
coding region, and the SV40 early poly(A) site (P2) 
(McLauchlan et a l ., 1990). After the initial mutation of 
the extra AATAAA sequence at map position 3954 to 
GATACA, the plasmid was further modified by removal of 
the HSV-2 IE 12 poly(A) site and the CAT coding region 
as a Hindlll/BamHI restricted fragment. pFJM38 was 
generated by insertion of the Hindlll/BamHI restricted 
poly(A) site of the HSV-1 late UL38 gene followed by 
insertion of the Hindll l  restricted CAT coding region of 
the plasmid pCAT into the now unique Hindlll  site. B : 
BamHI restriction site, H : Hindlll  restriction site, pA38 : 
HSV-1 late UL38 poly(A) site, * : Position of extra 
AATAAA sequence. Positions given in bp given in 
parenthesis are relative to the pFJIO plasmid map.
Xbal
8483bp LacZ
Xbal
CAT
Xbal 1P2
* (3954)
(4082) B
Xbal
Xbal
AMP
Pr CAT
Xbal
pA38
TT AAUAAA r> 
n  C I 3 8  B
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CAT ^acZ
Pr pA38
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H CAT H
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HSV-2 IE12 poly(A) site sequences. Examination of the DNA 
sequence of pFJIO revealed the presence of the hexanucleotide 
sequence AATAAA at position 3954-3959. Although this 
sequence was 320nt downstream of the designated test poly(A) 
signal, pAl (Figure 3.9) it was possible it could be used as an 
alternative poly(A) signal and thereby interfere with the in vivo 
assessment of  the test poly(A) signal. This additional downstream 
AATAAA sequence was therefore mutated to GATACA using the 
PCR based method of Higuchi et al ., (1988), (Figures 3.9 and 
3.10). PCR primers compatible with the unique restr iction sites 
of MscI (PI)  and BsiWI (P2), located 520nt 5' and 560nt 3' to the 
hexanucleotide respectively, were designed. Mismatched primers, 
P3 and P4 , were designed to introduce the GATACA mutation to 
the AAUAAA hexanucleotide (Figure 3.9 and Table 3.4). PCR 
was performed as described in Materials and Methods using the 
plasmid pFJIO as the DNA template. Combinations of primers PI 
with P3 and P2 with P4 were used to perform an initial round of 
PCR. Primers PI and P3 amplified a DNA fragment from the 5f 
MscI position up to and including the mutated hexanucleotide. 
Primers P2 and P4 amplified a DNA fragment from the 3' BsiWI 
position up to and including the mutated hexanucleotide. The 
PCR products were gel purified and reconstituted in H2 O - equal 
volumes of the two PCR products were mixed together and having 
overlapping compatible regions, at the mutated poly(A) site, were 
annealed to each other; extension of this product was carried out 
by a second round of PCR, the two annealed fragments acting as 
primers. The entire BsiWI/MscI restricted plasmid fragment 
incorporating the mutated hexanucleotide was amplified by
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A.
 ► ^— ? extra
MscI pAl SV40pA AATAAA______________ BsiWI
(4475) (3770) (4000) (3954) (3395)
B.
PI P4
MscI (480)__________ AATAAA (600^________BsiWI
GATACA P2
P3
FIGURE 3.9 :
A : The map positions (in bp) of the test poly(A) site 
pAl, the SV40 early poly(A) site and the extra 
AATAAA sequence located on the MscI/BsiWI 
restricted fragment of plasmid pFJIO.
B : The positions of the primers used in the generation 
of the AATAAA to GATACA mutation. The predicted 
fragment sizes (bp) generated by the initial round of 
PCR are given in parenthesis.
AATAAA BsiWI
B. THBcT
BsiWI
c.
+- - y r
p i
D. MscI GATACA BsiWI
  ----------------V --------------------------- 1 - P2
FIGURE 3.10:
Diagram of the method used to introduce the GATACA 
mutation to the extra AATAAA sequence in the plasmid 
pFJIO. A: using primer PI in conjunction with primer P3 
(containing the mutation) and primer P2 in conjunction 
with primer P4 (containing the mutation) the two halves of 
the DNA fragment were amplified in an initial round of 
PCR (B). C: the two overlapping ends of the fragments 
(containing the mutation) produced in B were allowed to 
anneal. D: Extension and amplification of this product 
was carried out by a second round of PCR using the PI 
and P2 primers flanking the DNA fragment.
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inclusion of primers PI and P2 in this second round of PCR. A 
detailed description of this method is given in Figure 3.10.
The vector pFJIO was digested with BsiWI and MscI and the 
backbone fragment gel purified. The BsiWI/MscI digested PCR 
product, containing the mutated hexanucleotide, was then ligated 
to the plasmid backbone to produce the plasmid pFJM. DNA 
sequencing of pFJM confirmed the mutation and correct insertion 
of the fragment.
(b) Cloning of  express ion  vector pFJM38
The plasmid vector pFJM38 was constructed by insertion of 
the HSV-1 UL38 poly(A) site fragment of pG38 into the 
expression plasmid pFJM (Figure 3.8). The plasmid pFJM carries 
the CAT reporter gene, under the control of the HSV-2 IE68/12 
promoter, fused to the HSV-2 poly(A) site fragment of IE 12. The 
p-galactosidase coding sequence under the control of an SV40 
early promoter, fused to an SV40 early poly(A) site fragment, lies 
in a non overlapping and opposite orientation immediately 
adjacent to the CAT gene. Expression from the P-galactosidase 
gene was used as a marker for successful insertion of the plasmid 
fragment into the viral DNA during the production of recombinant 
virus. The CAT coding sequences and the HSV-2 IE12 poly(A) 
site sequences were removed from pFJM by cleavage with Hindlll  
and BamHI restr iction endonucleases. The Hindlll /BamHI 
fragment from pG38 was then ligated into the pFJM vector 
backbone. The unique Hindlll  site produced by this procedure 
was used for insertion of the Hindlll  restricted CAT coding 
sequences from the plasmid pCAT, resulting in production of the 
plasmid pFJM38. Restriction endonuclease mapping confirmed
103
R esu l ts
the correct insertion and orientation of the pG38 and pCAT 
fragments.
3.2.3 Production o f  recombinant virus vFJM38
The Xba-1 restricted fragment of pFJM38 containing the 
CAT gene and P-galactosidase gene was ligated to Xba-1 
digested HSV-1 1802 viral DNA. The unique Xba-1 site of HSV-1 
1802 is located in the BamHI z fragment of the viral genome 
(Rixon and McLauchlan, 1990), this allows insertion of the 
plasmid fragment into a non-essential region of the viral genome. 
The recombinant virus was put through three rounds of plaque 
purification and the titre and purity of the virus stock determined. 
Southern blot analysis of  BamHI digested viral DNA was used to 
confirm the presence of  the inserted and wt UL38 poly(A) sites 
(Figure 3.11)..
HSV DNA exists as four equimolar forms due to inversion of 
the short and long genome segments (Hayward et al., 1975 ; 
Delius and Clements, 1976). The fragments produced by Xba-1 
digestion of HSV-1 1802 would therefore arise from all four 
isomeric forms. As ligations were performed with unseparated 
DNA fragments all possible recombinations of fragments would 
occur. No recombinant viruses generated by this procedure with 
genome structures different from wt virus were detected in the 
original studies (Rixon and McLauchlan, 1990).
3.2.4 CAT activity  o f  the recombinant viruses
The four recombinant viruses vFJ7, vSAU3, vFJIO and 
vFJM38 were used to infect BHK cells at a moi of lOpfu/cell. 
Cell extracts were prepared in CAT buffer at 2, 4, 8, 12, 18 and
104
FIGURE 3.11:
A : The position in basepairs (bp) of the unique Xba-1 
site of HSV-1 1802 which is located within the BamHI z 
fragment of the US genome region, in the intergenic 
region between the poly(A) sites of the US10, US11 and 
US12 genes and the US8 and US9 genes. IRs internal 
repeat sequences, TRs terminal repeat sequences.
B : Diagram of the relative positioning of the pFJM 
Xba-1 restricted insert within the BamHI z fragment of 
the virus genome, B-BamHI restriction sites, X-Xba-1 
restriction sites. The inserted UL38 poly(A) sequences 
are located on a 1.235Kb fragment of the inserted DNA. 
C : Southern blot analysis of the BamHI digest of the 
virus recombinant vFJM38 and wt 1802 HSV-1 DNA. 
BamHI digestion of the viral DNA produces a 6.5Kb 
fragment containing the wild type UL38 poly(A) 
sequences and a 1.235Kb fragment containing the UL38 
poly(A) sequences from the plasmid pFJM. Lane A wild 
type virus, lane B vFJM38 virus.
A .
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B.
B
c. A B
♦ 6.5Kb
— 1.235Kb
TRs
U S 8______
US9 -----
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24h pi and each extract assayed for both CAT activity and TK 
activity. Protein concentrations of the extracts were measured by 
Bradfords assay and CAT activity expressed as % CAT activity/pg 
protein and TK activity as cpm/pg protein.
(a) Thym idine kinase (TK) assay
Direct comparison of differences in the CAT activities of  the 
recombinant viruses, due solely to differences in the poly(A) sites 
of the CAT constructs, requires that the recombinant viruses have 
similar rates of  growth. Growth of the recombinant viruses was 
therefore monitored by measurement of TK activity, TK, an early 
protein of HSV, reaches peak expression at 5-7h pi (Roizman and 
Sears, 1993). To allow parallel measurement of the two activites, 
virus infected cell extracts were prepared in CAT assay buffer. 
CAT extraction buffer was chosen in preference to TK lysis 
buffer, the high salt concentration and presence of detergent in 
the latter making it an unsuitable medium for the measurement of 
CAT activity. To ensure that this method of extract preparation 
would not impair the measurement of TK activity, comparisons of 
the TK activity of  HSV-1 strain 17+ infected BHK cell extracts 
prepared in either TK lysis buffer or CAT extraction buffer were 
made. The results are shown in Figure 3.12. TK activity was 
found to be comparable in both buffers, both in the timing of TK 
expression and the levels of activity attained. In the following 
experiments, TK activity was therefore measured from extracts 
produced in CAT extraction buffer.
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FIGURE 3.12:
Comparison of the viral TK activites of cell extracts 
prepared in either TK lysis buffer (TK)-®- or CAT 
buffer-*- over a 24h time course of infection. TK activity 
is expressed as counts per minute per 10 jul of cell extract.
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(b) C hloram phenico l  acetyl transferase  (CAT) assay
The level of CAT activity present in the recombinant virus 
infected cell extracts was initially determined over a 24h time 
course of infection (data not shown). Production of CAT protein 
from the recombinant viruses proved to be very efficient and by 4 
h pi the CAT activity present in undiluted extract was found to be 
outwith the detection range of the assay system. A range of 
dilutions of  infected cell extracts (1:10 to 1:200) was therefore 
made to allow accurate determination of CAT activity. By 18h pi, 
dilution of the extracts up to 1:1000 was required. Stability of 
the CAT protein, at this dilution, could not be guaranteed 
therefore accurate determination of CAT activity under these 
conditions was not feasible. In the following experiments, 
measurement of recombinant virus CAT activity was carried out 
over a 12 h time course of infection. Mock-infected extracts, 
which have no measurable CAT activity present, were used as 
negative controls.
3.2.5 In vivo dem onstration of LPF activity
Comparison of the TK activities of the recombinant viruses, 
vFJ7 and vSAU3, confirmed that the two viruses had similar 
growth rates. The results of three separate experiments are shown 
in Figures 3.13 A,B,C (lower panels). Determination of CAT 
activity produced from these two viruses showed that vSAU3, 
containing the HSV-2 UL38 late poly(A) site, consistently 
produced higher levels of CAT activity than vFJ7, which 
contained the HSV-2 IE12 poly(A) site. This difference in CAT 
activity was apparent from early in infection (2-4h pi) (Table 3.5 
and Figures 3.13 A,B,C upper panels). This finding was in
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FIGURES 3.13 A. B AND C :
Upper panels : graphical representation of the CAT 
activities of the two recombinant viruses vSAU3 □  
containing the HSV-2 late UL38 poly(A) site and 
vFJ7 I  containing the HSV-2 IE12 poly(A) site, 
compared during three separate experiments.
Lower panels : Graphical representation of the TK 
activity of these viruses compared during the above 
CAT activity experiments.
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CAT ACTIVITY OF RECOMBINANT VIRUSES
Viruses Experiment
No.
Hours post infection
2 4 8 12
vFJ7 1 0.015 2.65 20 34
2 0.014 4.9 20 21
3 0.04 4 15 32
Mean 0.023 3.85 18.3 29
S.D. 0.012 0.92 2.36 5.7
VSAU3 1 0.23 14.5 40.3 44
2 0.045 11 39 36
3 0.07 15 23 40
M ean 0.115 13.5 34.1 40
S.D. 0.08 1.8 7.9 3.3
vFJIO 1 2.2 0.7 4.7 27.3
2 0.025 2.1 12 43
3 0.4 2.5 37 39
M ean 0.875 1.77 17.9 36.4
SD 0.95 0.77 13.8 6.66
VFJM38 1 0.08 0.03 2.5 15.6
2 0.015 0.11 10.5 20
3 0.2 0.3 11 27
M ean 0.098 0.15 8 20.9
S.D. 0.077 0.11 3.9 4.7
TABLE 3.5:
CAT activities of the four recombinant viruses, vFJ7, 
vSAU3, vFJIO and vFJM38, measured at 2, 4, 8 and 12 h 
pi. CAT activity is expressed % CAT activity per jug 
protein. The mean and standard deviation of the results of 
three experiments are noted.
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agreement with the data of McLauchlan et al., (1992b) which 
demonstrated similar differences in the CAT activities of  these 
viruses. The results confirm that the increase in CAT activity of 
vSAU3 can be attributed to the presence of the HSV-2 UL38 late 
poly(A) site and not to any difference in growth rates of the two 
viruses.
Comparison of the TK activities of  the recombinant viruses 
vFJIO, containing the HSV-2 IE12 poly(A) site and vFJM38, 
containing the HSV-1 UL38 poly(A) site, demonstrated 
differences in the growth rates of these two viruses. For some 
unknown reason TK activity was consistently lower and enzyme 
production was delayed in vFJM38 infected cells (Table 3.5 and 
Figures 3.14 A,B,C lower panels). Hence, because of the 
differences in growth rates a valid comparison of the CAT 
activities of these two viruses could not be made. Therefore no 
significance was placed on the finding that the CAT activity of 
vFJIO was higher than that of vFJM38 (Table 3.5 and Figures 3.14 
A,B,C upper panels).
3.2.6 D iscussion
The results presented in this section confirm the original in 
vivo studies of  McLauchlan et a l ., (1989; 1992b), and demonstrate 
that LPF functions in vivo. We have in addition demonstrated that 
the increased level of CAT activity found in vSAU3 is due to 
increased usage of the late poly(A) site. Monitoring of the 
growth rates of  the recombinant viruses, by measurement of TK 
expression, ruled out any possibility that differences in the 
growth rates of  vFJ7 and vSAU3 were responsible for the 
increased CAT activity of  vSAU3. The LPF effect was therefore
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FIGURES 3.14 A. B and C :
Upper panels : Graphical representation of the CAT 
activities of the two recombinant viruses vFJIO ■  
containing the HSV-2 IE12 poly(A) site and vFJM38 □  
containing the HSV-1 UL38 poly(A) site compared during 
three separate experiments.
Lower panels : Graphical representation of the TK activity 
of these viruses compared during the above CAT activity 
experiments.
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detectable in vivo from early in the virus cycle and this result  is 
in agreement with the data of McLauchlan et al., (1989; 1992b) 
which shows that LPF activity requires the expression of an HSV 
IE gene (IE63).
It has not been possible to fulfil the original aim of 
extending these studies. Poor growth of the vFJM38 has 
prevented comparison of CAT expression in this virus. In an 
attempt to identify the cause of this problem a comparison of the 
TK levels of the parent virus HSV-1 1802, vFJIO and vFJM38 was 
made. The parent virus and vFJIO showed comparable levels of  
TK activity while vFJM38 again showed decreased levels of  TK 
activity. (Figure 3.15). Low TK activity was not therefore a 
characteristic of  the parental virus stock used in the preparation 
of vFJM38. Further investigation of this problem was deemed 
impractical due to the time constraints of  the project.
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FIGURE 3.15:
Comparison of the TK activities of the two 
recombinant viruses vFJIO I  , vFJM38 □  and the 
parental virus stock HSV-1 (1802) □  .
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3.3 The HSV-1 protein IE63 : it’s effect on LPF 
activity and viral protein expression
3.3.1 Introduction
The studies of McLauchlan et a l ., (1992b), demonstrated 
that LPF, evident from early times of infection, required the 
expression of the HSV-1 gene IE63 for its activity. The 
polypeptide product of the IE63 gene has in addition been shown 
to influence the efficiency of 3’ processing at selected poly(A) 
sites - transfection experiments demonstrated that IE63 could 
activate or repress expression of synthetic target genes, dependant 
on the mRNA processing signals present (Sandri-Goldin and 
Mendoza, 1992). The polypeptide product of IE63 is known to be 
required for late gene expression of HSV-1 (Roizman and Sears, 
1993; Sacks et a l ., 1985) but the mechanism of this effect is as 
yet undetermined. Studies using mutant viruses, deficient in IE63 
expression, have indicated that while late gene expression of 
these viruses was reduced or absent, the defect was not at the 
level of  de novo transcription of mRNA (Smith et a l ., 1992). This 
suggests that IE63 acts, at least in part, post-transcriptionally to 
regulate late gene expression.
The following experiments examine firstly the influence of 
IE63 on LPF activity and secondly the effect of IE63 on viral 
protein expression. The relative 3' processing efficiencies of the 
previously defined range of poly(A) sites and viral protein 
expression in the presence and absence of the IE63 polypeptide 
have been examined using the IE63 insertion mutant virus 27- 
LacZ. An insertion in the leader sequence of the IE63 gene of
109
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this virus prevents production of the polypeptide product from 
this gene (Smith et al., 1992).
3.3.2 IE63 is required for LPF activity
(a) In vi tro  3 f process ing  reactions
Radiolabelled precursor mRNA was synthesised from the 
plasmids pGllO , pG63, pG23, pG29, pG38 and pG44 as detailed 
in Section 3.1.4. Sets of  MI, HSV-1 strain KOS infected and 27- 
LacZ infected HeLa cell nuclear extracts were prepared in parallel 
as described previously. HSV-1 strain KOS is the parental virus 
strain used in the production of the mutant virus, 27-LacZ (Smith 
et al., 1992). In total, 2 or 3 in vitro processing reactions were 
carried out on the six test poly(A) sites, quantitative analysis was 
therefore not practical. The extracts were standardised as 
described previously, each extract being used to process as many 
of the poly(A) sites as possible (a minimum of five poly(A) sites 
per extract). The products of  these reactions, which consisted of 
a mixture of  uncleaved and cleaved radiolabelled precursor 
mRNA, were separated as before on 6% polyacrylamide gels and 
the bands visualised by autoradiography.
(b) The IE63 protein  can a ffect  the 3 ’ processing  
ef f ic ienc ies  of  se lected  HSV-1 genes
Figure 3.16 shows a typical autoradiograph of the in vitro 3' 
processing efficiencies of the IE110, IE63, UL23, UL29, UL38 
and UL44 poly(A) sites. The late poly(A) sites of UL38 and UL44 
were processed three times and in each case the level of 3' 
processing efficiency was increased using the KOS infected 
nuclear extract, above that of  the MI extract. The level of  3
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processing efficiency of these two late poly(A) sites was
decreased in the 27-LacZ infected extract to a level below that
obtained with the KOS infected extract and was similar to the MI 
processing levels. Little change was noted in the 3' processing
efficiencies of  the IE63, IE110, UL23 and UL29 poly(A) sites
when processing was performed with either MI, KOS infected or 
27-LacZ infected nuclear extracts. The results of the in vitro  3' 
processing reactions demonstrated that expression of the HSV-1 
gene IE63 is required for the LPF associated increase in 
processing efficiencies of the late poly(A) sites of  UL38 and 
UL44. The processing efficiencies of the IE63, IE110, UL23 and 
UL29 poly(A) sites, which have previously been shown to be 
unresponsive to LPF, are unaffected by the presence or absence of 
the polypeptide product of the IE63 gene.
3.3.3 Exam ination  o f  v iral protein expression in
cells infected with the IE63 insertion mutant 
virus 27-LacZ
(a) Prote in  ex trac ts
Protein extracts were made from Vero cells infected with the 
IE63 insert ion mutant 27-LacZ. This virus mutant does not 
express IE63 enabling the examination of viral protein expression 
in its absence. Protein extracts of  control infections were 
prepared in parallel.  Vero cells infected with HSV-1 strain KOS, 
the parental  strain of  the mutant virus, provided the postive 
control, showing the protein profile expected of a wt infection. A 
second control of  2.2 cells infected with 27-LacZ, was also 
prepared - 2.2 cells are the complementing cell line for the 27- 
LacZ insert ion mutant virus, they carry the IE63 gene under the
1 11
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control of  an HSV-1 IE promoter and expression of IE63 in this 
cell line requires transactivation by Vmw65 either by infection or 
transfection. Protein expression differing from wt, which is not 
due to the IE63 mutation in 27-LacZ virus, would be evident using 
this control.
Infections were carried out over a 24h time course and cells 
harvested at 2, 4, 8, 12, 18 and 24h pi. Mock infected controls 
were harvested with the 24h time point. Viral and cellular 
proteins were extracted from the cells by lysis and separated on 
11% or 12.5% SDS denaturing polyacrylamide mini-gels. Protein 
size was estimated by comparison with protein molecular weight 
markers.
(b) A nt ib od ies
Primary antibodies to the polypeptide products of  the HSV 
genes IE110, IE63, IE175, UL29, UL38, UL42, UL44, US6, US8 
and US11, were used for identification of the viral proteins 
produced in the extracts described above. Antibody dilutions, 
optimal for use in Western blot analysis, were those recommended 
by the antibody donors (see Materials). Calibration of the 
antibodies to allow absolute protein quantification was not carried 
out. Using the enhanced chemiluminescence detection system, 
changes in protein levels would be undetectable once saturation of 
the system was reached. Taking into account these limitations, 
use o f  this system would allow gross changes in protein 
expression to be detected and compared under the three infection 
conditions outlined.
1 12
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(c) W estern  Blot
Western blot was performed on the protein mini-gels as 
described in Methods. Secondary antibodies conjugated to HRP 
were used for visualisation of the protein-antibody complexes, 
using the ECL detection system. Reactive protein bands were 
visualised by exposure of these membranes to X-ray film for 1- 
5min.
3.3.4 IE63 expression is required for the synthesis  
of  selected late viral proteins
(a) Im m edia te -ear ly  protein expression
The 63kD protein product of the IE63 gene (Ackerman et 
al., 1984) was detectable during wt infection from 4h pi. During 
27-LacZ infection of the complementing cell line, IE63 expression 
was detectable from 8h pi. Virus transactivators are required to 
switch on the IE63 gene of the complementing 2.2 cells, however 
there is a delay in IE63 expression under these conditions, which 
is perhaps due to the integration of the IE63 gene into the host 
cell genome. No IE63 expression was seen in the non­
complementing Vero cell line, confirming the mutant phenotype of 
27-LacZ (Figure 3.17 panel A).
Expression of the llOkD protein product of the IE110 gene 
(Ackerman et al., 1984) was detectable from 4h pi under all three 
infection conditions (Figure 3.17 panel B). While IE110 protein 
was detectable,  from 4h pi, in the absence of IE63, there was a 
marked reduction in the level of expression. It is possible that 
whilst IE110 expression has no absolute requirement for IE63, its 
absence leads to a reduction in the efficiency of  IE 110 expression. 
In support o f  this finding was the observation of a slight but
113
CO
w
Oh
£
O
M(4h
u
t" -
W
t - H
0 3
a
cd
§
o
▼—H 
t- H
W
COvo
Wi—i 
C/3
d
o
<D
bo
>C/5
ffi
(D
43
H
a
o
,3h
<4H
g
o
• ?-H
C/3
C/3
D
(-4
O h
XD
g
• iH
CD
4 ->
O
3-1 
O h
<HH
O
C/3
• t—<
C/3
c
cd
4-H
0
1 1 ' "<
o
g
VhD
4—<
C/3
CD
N
cd
cd
hJ
■
r -
(N
oin
CD
>
C/5
o
&
C/3
<D
CD
o
3-H
CD
>
03
CD
4 ->
o
C*-H
a• t—H
C/5
O
cd
j- h
H
C/3
I
>
C/5
ffi
a
o
, * H
<4H
T3
CD
3h
cd
O h
D
3-h
O h
<D
Vh
CD
£
C /3
4 ->
CD
ed
3-h
4 ->
X
CD
CD
+ H
o
3—
Oh
O h
'O '
(N
03
g
cd
00
(N
00
c\
•o-
c\
(N
4 ->
cd
<N
CN
^3
C N
C/3
”d
CD
(N
CM
03
CD
4-H
0.CD
<4H
g
• r-H
N
cd
cd
• J
1
o
CN
0 3
G
cd
Ou
D
>
33
o
(N
C/3
CD
CD
o
Vh
CD
>
0 3
CD
4->
O
C+H
G
<D
43
4 - >
C+H
O
< £
<D
CD43
G
<D
A
0 3
G
cd43
D
H—<
o
3-H
Oh
O
3—
H—>
g
o
o
0 3
(D
H—*
CD
C+H
>
• t-H
bQ
C/3
• t-H
G
• ^ H
CD
D
3 -h
C/3
4 3 4 4
cd 4—> CD
C/3
4 —>
CD
cd
3 - i
G O
CD
3-h
cd
O h
B
4 - *
X G u
<D • f^H
D
4 3
4 - *
G
<D
>  
• ^ H
o
3-h
4-H
CD bO G
0 3
• t"H C/3• ^ H
O
cd
C/5
bo G
G • CD
o CD4—> >
I d o 4-H
i-H •
G O h
C/5
o
G
3->
4 - 4
C/3 O h
c /3 CD4 - 4
3—i C O
CD 4 3 VO
hX
3>h
CD
cd
< D
C-t-H
w
cd
B
t - H
O
4 3 4 —»
bo 4 3• ^ H
D bD• ^ H .1 .V
£ CD
3-i £
cd 3— G
* G
cd •  t-HD
o
D
o
G
CD
CD
4 -H
o
3->
O h
B O
G
a 3-h
cd
•  —H
D
4 - *
O
3-i
O h
0 3
CD
4 H
o
•
0 3
J 3
IS
CD
<HH CD
O 3-h
O h bo
G
O
• i-H
CD
4 3
G  
• ^
4-H
CD4 H  
• tH H Cd
C/5 D
o . 3-h
O h CD
3 -h
I
C/3
D G C/343 bD Ot .
H c £
*—
CD
I
«
. O n n o
©  ^ .  O n
o  r - no
(N  ON
JO 3in
H
U
O  t >  NO T t
<N  ON
m
NO
I CONO
o
1—H 
t- H
a
cq
R esu l ts
apparent reduction in the level of IE110 expression during 27- 
LacZ infection of the complementing cell line, at 4h and 8h pi, 
which could be due to the previously mentioned delay in IE63 
expression in this cell line. The smaller proteins seen in this blot 
are thought to be degradation products of IE110, a common 
finding in whole cell protein extracts of the kind used here (R. 
Everett personal communication).
Expression of the 175kD protein product of the IE175 gene 
(Ackerman et al., 1984) was detectable from 2h pi in 27-LacZ 
infection of both the complementing and non-complementing cell 
lines (Figure 3.17 panel C). IE63 appears to have no effect on 
expression the IE175 protein. Due to technical problems no wt 
infection profile is available.
However these results are not compatible with other studies 
which examined protein expression in ts virus mutants deficient in 
IE63 expression. These studies demonstrated that over expression 
of IE175 did occur (Sacks et al., 1985; Smith et al., 1992) and 
that overexpression of IE110 did not occur (Sacks et al., 1985) at 
NPT.
(b) Early  protein  express ion
Expression of the 130kD protein product of the UL29 gene 
(Weller et al., 1983), the major HSV DNA binding protein, was 
detectable from 8 h pi, in both wt infection of Vero cells and 
mutant virus infection of 2.2 cells. During mutant virus infection 
of Vero cells, UL29 expression was detectable at 8h and 12h pi
although the level of expression was reduced. This would suggest
that while there is no absolute requirement for IE63 it may be
required for maximal expression (Figure 3.18 panel A).
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Expression of the 65kD protein product of the UL42 gene 
(Gallo et al., 1989), a DNA binding protein, was detected from 8h 
pi in wt infection. There appeared however to be a delay in 
expression during the 27-LacZ infection, while UL42 protein was 
detected at 8h pi in both the mutant virus infected extracts the 
level of expression was reduced below that of the wt infected 
extracts. This effect was seen in both the complementing and 
non-complementing cell lines and may not therefore be attributed 
entirely to a lack of IE63. It may be that there is a requirement 
for IE63 during expression of UL42, and the previously noted 
delay in IE63 expression in the complementing cell line may have 
an effect on the efficiency of UL42 production (Figure 3.18 panel 
B). Alternatively, the 27-LacZ mutant could have another 
deficiency which affects UL42 production - this was thought 
unlikely due to the specific nature of the mutation induced in 27- 
LacZ.
The products of  US6 (Glorioso et al., 1983), present as the 
50kD precursor and 58kD mature form of glycoprotein D, were 
detected at 2h pi with an increase in protein expression being 
evident around 8h pi. No difference in this pattern of protein 
expression was seen in either the presence or absence of IE63 
(Figure 3.19 panel A).
Glycoprotein E the 59kD protein product of US8 
(Longnecker et al., 1987) which has been classified as an early- 
late protein was similarly detectable from 2h pi, with an increase 
in production at 8h pi. Absence of IE63 had no effect on the 
expression of glycoprotein E (Figure 3.19 panel B).
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(c) Late protein  expression
Expression of the 54kD protein product of  the UL38 gene, a 
capsid protein of the virion, (Rixon et al., 1990) was detected from 
12h pi in both the wt and complemented viral mutant infections. 
In the absence of IE63 no UL38 protein was detected (Figure 3.20 
panel A).
Similarly the 21/22kD protein products of the US11 gene, 
components of the virion, (MacLean et al., 1987) were detected at 
12h pi in the presence of IE63 and were undetectable in the 
absence of IE63 (Figure 3.20 panel B). With a reduction in 
expression at 12h pi in the complementing cell line.
The 92kD protein product of the UL44 gene, glycoprotein C 
(Glorioso et al., 1983), was detected at 12h pi in the presence of 
IE63 and was undectable in the absence of  IE63 (Figure 3.21 
panel A).
A slightly different picture appeared for the protein product 
of the UL45 gene (Figure 3.21 panel B), an 18kD late protein 
(Visalli and Brandt, 1991; 1993). The 18kD protein was
detectable from 4h pi with expression increasing from 8h pi. In 
the absence o f  IE63 the 18kD protein was detectable from 4h pi, 
however little or no increase in expression was seen at 8h pi, only 
a slight increase being noted at 24h pi. IE63 appears therefore to 
be required for efficient expression of the UL45 protein.
It could be argued that the effects seen here could be due to 
reduced infection efficiency of Vero cells with the mutant virus. 
However, for several reasons this was not felt to be the case. The 
ablility of 27-LacZ virus to adsorb to and penetrate into cells, is 
not thought to be reduced below wt levels. This is corroborated 
by the protein profiles produced by 27-LacZ infection of the
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complementing cell line, which taking account of  the delay in 
IE63 expression, was almost identical to wt infection in every 
case but one, that of UL42. In addition, each protein gel was 
stripped and reprobed with antibodies generated against proteins 
which did not show a reduction or lack of protein expression in 
the absence of  IE63, thus removing any variation between blots 
due to poor extracts or inefficient protein transfer.
3.3.5 D iscussion
The present studies have confirmed the requirement of  IE63 
expression for the LPF associated increase in 3' RNA processing 
at the poly(A) sites of  selected HSV-1 genes, the late genes of 
UL38 and UL44. This increase in processing occurs, as 
previously stated, in the absence of any influence due to 
transcriptional regulation. IE63 mediated increases in poly(A) 
site use could therefore have a role in the post-transcriptional 
regulation of  late gene expression. However, some HSV poly(A) 
sites are shared by genes of  both early and late classes, for 
example the late UL35 gene shares the same poly(A) site as the 
UL33 early gene and the UL34 gene, of unknown class. The late 
gene o f  US11 shares the poly(A) site of US10 (early) and US12 
(immediate-early). Only this latter situation has been considered 
in this study where protein expression from US 11 has been shown 
to require IE63 expression. However in vitro studies on the HSV- 
2 equivalent of  this poly(A) site (the IE site on the control 
plasmid SAU5) have shown that LPF, which requires IE63 
expression for its activity (McLauchlan et al., 1992b), does not 
upregulate 3’ processing efficiency at this poly(A) site. Thus, the 
influence of  IE63 on post-transcriptional mechanisms cannot
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therefore be the sole means of regulation of L gene expression. It 
may be that posttranscriptional regulation is additional to other 
means of  regulation such as transcriptional control.
Analysis of  viral protein expression during infection with 
the IE63 insertion mutant, 27-LacZ, has shown that IE63 is 
required for the expression of selected late viral proteins, namely 
US11, UL38 and UL44. Expression of the late protein product of 
UL45, also appears to be reduced in the absence of IE63. The 
gene encoding UL45 is co-terminal with that of  UL44, sharing the 
same poly(A) site, the reduction rather than absence of UL45 
protein indicates that IE63 is required for efficient expression, 
low levels of  protein being produced in the absence of IE63. 
These results are in agreement with the general pattern of 
expression observed in other studies which showed a reduction in 
late gene expression (UL48, glycoprotein B) and in particular true 
late gene expression (glycoprotein C, UL38), in the absence of 
IE63 (Sacks et al., 1985; Smith et al., 1992; Rice and Knipe, 
1988).
IE63 is known to be involved in the switch from early to late 
gene expression, but the exact mechanism of this regulation has 
not been determined. The function of the IE63 gene product has 
been investigated by a number of  research groups, and the results 
produced have provided conflicting evidence regarding the role of 
IE63 in the regulation of  viral gene expression. The variability of 
these results is likely to be due to differences in the analysis 
systems used and the multifunctional nature of this protein. There 
is evidence, provided by transient transfection studies, for IE63 
mediated regulation of gene expression being at the 
transcriptional level (McCarthy et al., 1989) and at the
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posttranscriptional level (Sandri-Goldin and Mendoza, 1992; 
Smith et al., 1989). There is evidence both for (McCarthy et al., 
1989; Rice et al., 1993) and against (Sacks et al., 1985) the 
involvement of  IE63 in viral DNA synthesis. Late gene 
expression in HSV is associated with the onset of  viral DNA 
replication (Roizman and Sears, 1993), IE63 could therefore 
affect late gene expression by an indirect effect on DNA 
synthesis. In the absence of IE63, the major DNA binding protein 
UL29 (ICP8) has been shown to be conformationaly altered and it 
has been suggested that this prevents formation of active DNA 
replication complexes (Curtin and Knipe, 1993). However 
detection of conformational changes in the protein would depend 
on the specificity of the antibody and may not be detected by the 
UL29 antibody used here. The study of Curtin and Knipe, (1993) 
in addition showed that low levels of DNA replication occurred 
even in the absence of IE63 and this was dependent on the cell 
cycle of  the infected cell. It is possible that the low level of 
expression of three of the proteins studied here (UL42, UL29 and 
UL45) was a result  of low levels of DNA synthesis occurring in a 
small population of cells.
Our results suggest that IE63 may be required for maximal 
expression of UL42 (part of the DNA polymerase) and UL29. It is 
possible that IE63 could influence DNA synthesis by this route. 
If there is no absolute requirement for IE63 in UL42 and UL29 
expression there may be a subtle regulation, dependent on the 
timing of  expression of the three proteins.
Other studies (Sacks et al., 1985), have noted an 
accumulation of early proteins in the absence of IE63. However, 
due to the limitations of the Western blot analysis carried out
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here, accumulation of proteins above the saturation level of the 
detection system would not be detected.
120
R esu l ts
3.4 Sequence, structure and protein binding 
properties of HSV-1 poly(A) sites
3.4.1 Introduction
The formation of the 3' end of mRNA requires specific 
endonucleolytic cleavage of the precursor mRNA and the 
subsequent addition of approximately 200 adenylate residues. 
RNA sequence requirements for efficient cleavage and 
polyadenylation include the conserved AAUAAA hexanucleotide 
poly(A) signal located 10-30nt upstream of the cleavage site, and 
a downstream U-or GU-rich element (McDevitt et al., 1986; 
Sadofsky and Alwine, 1984; Sadofsky et al., 1985; Manley, 1988; 
Conway and Wickens, 1987; Gil and Proudfoot, 1987). Consensus 
sequences have been proposed for these downstream elements 
YGTGTTYY (McLauchlan et al., 1985), TTG/ANNNTTTTTT 
(Renan, 1987), and RGUUUUYRR (Sadofsky et al., 1985).
Recent studies have indicated an additional requirement for 
elements upstream of the poly(A) signal for efficient cleavage and 
polyadenylation of mRNA from yeast (Hou et al., 1994), HIV 
(Valsamakis et al., 1992; Gilmartin et al., 1992; Cherrington and 
Ganem, 1992), ground squirrel hepatitis virus (GHSV)
(Cherrington et al., 1992) and the SV40 late poly(A) signal
(Schek et al., 1992), consisting of amorphous GU- or U-rich
regions. Indeed pyrimidine rich sequences, which are present in 
the functional regions of  many mRNA molecules are emerging as 
important motifs in a variety of aspects of RNA metabolism 
(review by Morris et al., 1993), including regulation of 
translation of  mRNA (Shaw and Kamen, 1986; Bohjanen et al., 
1991; Vakalopolou et al., 1991), pre-mRNA splicing (Frendeway 
and Keller, 1985; Ruskin and Greene, 1985), cytoplasmic
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degradation and polyadenylation of mRNA (Fox et al., 1992; 
Vasalli et al., 1989; Paris and Richter, 1990).
The spatial arrangement of these elements is also critical for 
efficient poly(A) site usage. Increasing the distance between the 
AAUAAA signal and the downstream element, beyond 40nt, 
decreases the efficiency of poly(A) site usage (McDevitt et al., 
1986; Gil and Proudfoot, 1987). Recently several studies have 
shown that there is a requirement for secondary structure features 
in the 3' end formation of certain mRNAs. For example, 3’ end 
formation of the major histone mRNAs requires the presence o f  a 
conserved stem-loop structure and a 3' purine rich region for 
efficient endonucleolytic cleavage (Pandey et al., 1994). In 
HTLV-1, polyadenylation occurs >250nt 3' to the poly(A) signal, 
the formation of a stable stem-loop structure from the intervening 
sequence bringing the AAUAAA and GU-rich element into close 
proximity, allowing polyadenylation to occur (Seiki et al., 1983). 
Using synthetic poly(A) site constructs Brown et al., (1991) 
demonstrated that insertion of sequences, which increase the 
distance between the AAUAAA and GU-rich element of the 
poly(A) site, do not inhibit polyadenylation provided they form a 
stable stem-loop structure which brings the two elements together. 
The efficiency of poly(A) site usage could therefore be influenced 
by the presence or absence of essential sequence elements, the 
spacing of these elements in relation to the AAUAAA 
hexanucleotide and the overall two dimensional conformation of 
the poly(A) site RNA.
Components of the protein complexes required for 3 end 
processing o f  mRNA have recently been identified (reviewed by 
Manley, 1988) and complex formation involves the association of
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at least nine proteins. The CPSF complex, consisting of four 
proteins of 160kD, lOOkD, 73kD, and 35kD, is thought to bind to 
the AAUAAA hexanucleotide poly(A) signal (Keller et a l ., 1991; 
Wahle and Keller, 1992; Gilmartin and Nevins, 1989), CPSF-RNA 
binding appears to be stabilised by the subsequent binding of the 
cleavage stimulation factor (CstF or CF1), a complex of three 
77kD, 64kD and 50kD proteins. Binding of CstF appears to be 
dependent on the hexanucleotide motif and the presence of a 
downstream sequence element (Wahle and Keller, 1992; Gilmartin 
and Nevins, 1989; Weiss et a l ., 1991; Zarkower and Wickens, 
1988). UV cross-linking analysis has shown that both the 160kD 
and 30kD components of  the CPSF and the 64kD component of 
CstF are directly bound to pre-mRNA poly(A) site sequences. 
The ability of  the pre-mRNA to bind these proteins, which is 
related to the efficiency of complex formation, could therefore be 
used as an indication of the efficiency of poly(A) site usage.
In the following experiments a comparison of the RNA- 
protein binding capacities of the six test HSV poly(A) sites, in MI 
and INF nuclear extracts, was determined using the technique of 
UV RNA-protein cross-linking. In addition the poly(A) RNA 
sequences of  all HSV-1 genes were examined for the presence of 
possible GU- or U-rich elements. Finally a study was made of the 
positioning of the sequence elements of  the six test poly(A) sites, 
within the predicted two dimensional RNA structure.
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3.4.2 Examination of  the protein binding properties  
of selected HSV-1 poly(A) sites
(a) N uclear  extracts
Mock infected and HSV infected HeLa cell nuclear extracts 
were prepared in parallel as described previously. The extracts 
were dialysed against the binding buffer to be used in the cross- 
linking assay thus lowering the salt concentration and facilitating 
binding of protein to RNA. Protein concentrations of the paired 
extracts were determined by Bradford’s assay and normalised 
before performing the binding assay, adding 10-15pg of protein to 
each reaction. To allow a valid comparison of the protein-RNA 
binding patterns of the poly(A) sites, each pair of MI and INF 
extracts was used in binding reactions with as many of the test 
poly(A) sites as possble (at least four per extract).
(b) UV cross- l ink ing  of RNA-prote in  complexes
UV irradiation covalently cross-links proteins to nucleic 
acid at their point of contact, the complexes formed are resistant 
to heat, detergent and alkali treatments and therefore highly stable 
(Pelle' and Murphy, 1993).
(c) P rote in -R N A  complex formation
MI and INF nuclear extracts were mixed at RT with 
radiolabelled precursor mRNA transcribed from the range of 
pGEMl plasmids, containing the HSV-1 poly(A) sites, described 
in Section 3.1. All soluble components required for cleavage and 
polyadenylation of the precursor mRNAs were supplied in the 
nuclear extracts. UV irradiation of the mixture covalently cross- 
linked any proteins closely bound to the RNA and any RNA
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unprotected by bound protein was removed by RNaseA digestion. 
The protein-RNA complexes were separated on denaturing 
polyacrylamide gels and the protein bands thus radiolabelled with 
RNA, visualised using a Molecular Dynamics Phosphorimager. 
The molecular weights of the protein bands were estimated by 
comparison with protein molecular weight markers.
3.4.3 The protein-RNA binding patterns o f  selected  
HSV-1 poly(A) sites
Typical phosphorimages of the protein-RNA complexes 
produced by UV cross-linking are shown in Figures 3.22, 3.23 and 
3.24. Variability of extract activity has already been noted in 
Section 3.1.5 and was again evident in these studies. However a 
consistent pattern of protein-RNA binding did emerge from the 
experiments carried out.
Three groups of proteins were consistently observed on the 
protein gels. Firstly, a triplet of protein bands (A) of 
approximately 90-150kD which are most clearly demonstrated in 
Figure 3.23. Secondly, a protein band (B) of just under 69kD 
most clearly seen in Figure 3.22, and finally a protein band (C) of 
just under 46kD most clearly demonstrated in Figure 3.22. Very 
similar binding patterns were observed for each precursor with a 
general overall increase in protein-RNA binding noted in the 
infected nuclear extracts. Different extracts showed this 
differential binding to a greater or lesser extent but the increased 
binding was always seen and was particularly apparent in the case 
of band C the <46kD protein. Since the experiments were 
standardised as much as possible by the addition of equal 
concentrations of  MI and INF extract proteins to a constant
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amount of precursor, it is likely that this increase in binding is a 
genuine phenomenon. A number of fainter bands present in some 
gels and absent from others were noted, the appearance and 
disappearance of these fainter bands seems to be an accepted 
problem of this technique. Protein band A consistently appeared 
as a triplet and in addition bands B and C appeared as doublets. 
This phenomenon has also been observed by others (Dr. C. 
Phillips personal communication) and may reflect different 
phosphorylated or processed forms of the same protein. The RNA 
binding capacities varied between sets of  paired extracts, for 
example in Figure 3.22 the binding of the protein A triplet was 
very weak compared to that seen in Figures 2.23 and 3.24, and 
binding of protein B was more consistent in Figure 3.22 than 
Figures 3.23 and 3.24. This is most likely due to the variations in 
extract activity noted throughout this study, however, the RNA- 
protein binding patterns of the test poly(A) sites were consistent 
within individual experiments.
The IE 110, IE63, UL23 UL29 and UL44 poly(A) site RNAs 
each bound the three protein groups A, B and C equally well and 
showed similar increases in protein binding in INF nuclear 
extracts. The exception to this binding pattern was the UL38 
poly(A) site where the binding of proteins A and B was generally 
comparable to the other poly(A) sites, however in all experiments 
carried out the binding of protein C was either very weak or 
absent.
3.4.4 Com parison of HSV-1 poly(A) site sequences
A comparison of  the RNA sequences of  all HSV poly(A) site 
regions was carried out using the vax programme Lineup. Each
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region was searched by eye for the presence of sequences such as 
the GU- or U-rich elements described by McLauchlan et a l ., 
(1985); Renan, (1987) and Sadofsky et al., (1985), or indeed any 
GU- or U-rich tracts. The sequences were aligned with respect to 
the AAUAAA hexanucleotide and were grouped according to the 
temporal class of  the gene to which they belong, Figures 3.25 and 
3.26 show the RNA sequences downstream and upstream of  the 
AAUAAA respectively. Included in these alignments are the 
HSV-2 IE12 and UL38 poly(A) site sequences which form the IE 
and late poly(A) site constructs from the studies of McLauchlan et 
al., (1989).
(a) PoIy(A) site  downstream elements (DSEs)
Examination of the HSV RNA sequences downstream of  the 
poly(A) signals revealed a number of possible GU- or U -r ich  
elements (DSEs). Of the 47 poly(A) site sequences examined all 
but two contained GU-rich elements, with 19 (40%) of poly(A) 
sites containing one or more element which conformed to the 
consensus YGUGUUYY of McLauchlan et al., (1985), and 21 
(47%) containing one or more element conforming to the core of 
the consensus, RRGUUUYRR, identified by Sadofsky et al., 
(1985) (Figure 3.25 and Table 3.6). The poly(A) site sequences 
of the UL19 and UL31/32 genes which have no GU-rich element 
contain instead a U-rich element. Because of the overall nature of 
the sequences and locations of the GU-elements it would be 
unwise to place too much emphasis on these consensus sequences. 
These GU- or U-rich regions are present in a variety of forms 
either as single elements of approximately 7nt, in tandem with 
other GU- or U-rich elements or as extended tracts of up to 26nt.
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Table 3.6 :
Shows the sequence composition of the GU- and U-rich downstream elements 
identified within the poly(A) sites of all known HSV-1 genes (McGeoch et al., 
1988) and the HSV-2 poly(A) sites of IE 12 and UL38. Showing the idstance 
(in nt) of the most 5' nucleotide of each region from the U of the AAUAAA 
hexanucleotide. Sequences corresponding to the consensus YGUGUUYY of 
McLauchlan et al., (1985) are underlined.
HSV g e n e
a  E 1 1 0
I E 17  5
I E 6 3 
I E 6 8
IE12
I E 12 H S V - 2 
U L 8 / 9  
UL2 3  
U L 2 7 / 2 8
U L 2 9
UL3 0
U L 3 9 / 4 0
UL4 2
U L 4 9 / 4 9 A
UL5 0
y i  U L l l / 1 4  
US 5 /  7
U L 1 / 2
U L 1 / 3
U L1 5
U L 1 6 / 1 7  
U L 1 8 / 2 0
UL 1 9
U L 2 1
UL2 4
U L 2 4 / 2 5
U L 3 3 / 3 5
U L 3 6
U L 3 7
U L 4 1
UL 4 8 
U L 5 1  
US 2 
US 3 /  4 
US 8 /  9
y2  U L 10
UL2 2
U L 3 1 / 3 2
UL3 8
UL3 8  H S V - 2
U L 4 4 / 4 5
U L 4 6 / 4 7
a n  U L 4 / 5  
U L 6 / 7
UL 4 3
U L 5 2 / 5 3
UL5 5
G U / U - e l e m e n t  d l s t .
U U U A C U U U U U G U A U G U U U U
UGUGU UGG
GUUUUG
G U UGU UUA
G U G U U G U C C U U C U U U
GUUUGU
g u g u u u g g g g g u u u
u u u u
UUUUAU
G U GUC UU
U U U G U G U G U U G U U
GUGUG UG
G G G U G U U G G G U C  G U U U G U  IT 
G G G GUGUU
U U U U G G U U U G U U U G U U U G G U
U U U U G U G U G U G U G G G
U U G U U U G U G U U
GUGGG UUU
UUUGGGU
U U G U A U U C U U G U
U U G UA U UG
G U G U G G U U C A U U G U G U G G
G G G U U C G U G U A U U U C C U U U
G G U G U U G G
UUUGU UU
GUUUG U
U G U G U G U A G U U G U U U A U G U U G G
G U G U C G U U U U U
U A U UA U UU
G U G UA U GU
UU U CU U U
UGGUU
GG U GA U G
U U U G G C U G G U U G U U G U U G
G G U G U C G U C U G U U
G U GUU G
U G G U U G U G U G G U A U G U G C G U G G G U G G
U GU GU G U
U U U G G G U U G G G U U U C U G U G U U
U U C U U U A U
UU GU G UG U
G U G U G U U A UU UU
U U G G U G U A U G U U C U U U U U U U A U U
G U G U U U A U U
G U U G G U G U G U U G G U C U U U U A U U
G U G U G U U G U U C U C G G U G U U
UGGUU
C U U U U U G
C U U U U A U
GGUUG U
U U U G G U G G U G G U G G G G G
G U G U U UU
G U G U G U U U U G U G U U U G U G G G
G U G G U C U G U U U C U C U
U U U G A U U U U G G U C U U U U
G G UG G U
U G G G U G U U U U U G G G G U G U
U U G GG U U
U G UUG U
A U U U U U G
G U U U G U G U U U
G U G GU G U
U G G U G U G U G G
U G U G G U U U G U U U G U U
U U U G C U U U
U U UUU
G U G U U G U A A C G U C C U U U  
G U G G U G U G U U U G G C G U G U G U C U C U G  
U G U G G U G U U U U U G U U U A U U U U U  
G U G U U C U U U U U
UUGU G U G U U U A U U A U U U U G G G U  
U U U A U G U G U U A U U U A U U  
G G U U U U G U U U
U U G G U G G G U G G G U G G C U G U G U
G G U G U G U G
U U A U G G U G U
G U G G U G U G A G U U U U G U G G
3  * o f
6
3 1
22
3 5
3 3  
21  
8 2
4
1 7  
2 9
24
34  
11  
10  
33  
5 7
25
3 9
18
2 9
5 
37  
7 3
25  
43
8
2 7  
3 7
8
2 6
3 7  
13
4 1 
15  
3 3  
65
40
3 0  
5 1  
33  
24  
4 1
28
4 1
3 0  
2 9  
4 1 
5 1  
63
3 1  
4 7
7
24  
2 8  
7 9
7 
33  
4 
2 1
38
6
2 5  
3 7  
15  
65
6
2 6  
2 3
42
3 2  
54  
25
7
5 6
2 7
18
2 9
AAUAAA
R esu l ts
The distance from the U of the hexanucleotide to the first nt of 
the nearest downstream element varies considerably, ranging from 
6-42nt, with the majority of  elements falling within the 2 0 -3 5 nt 
group (Table 3.6). Two of the test poly(A) sites fall outwith this 
group, the extensive U-rich element of the efficient IE110 poly(A) 
site lying only 6 nt 3' of the AAUAAA and the extensive GU 
element of the less efficient UL44 poly(A) site lying 42nt 3’ of 
the AAUAAA. There is however no definitive pattern either in 
the nt composition of the element or the distance of the element 
from the AAUAAA among the poly(A) sites studied. The general 
summary of  the data shown in Table 3.6 indicates that each of  the 
poly(A) sites contains a GU- or U-rich element approximately 20- 
35nt 5' of the hexanucleotide and further no relationship between 
poly(A) sites from the same temporal class of  gene is apparent.
The point mutation which occurred during the construction 
of the UL23 poly(A) site pGEMl plasmid is located within a U- 
rich tract l l l n t  downstream of the AAUAAA (data not shown). 
These extended U-rich tracts were observed in a minority of 
poly(A) sites of  all temporal classes, the variable nature of these 
tracts and the position of the mutation make it unlikely that the G 
for U substitution would affect processing of the RNA.
(b) Poly(A)  site upstream elements (USEs)
A similar examination of the upstream regions of the HSV 
poly(A) sites revealed the presence of a number of U- rich 
elements (Figure 3.26). Each element consisting of a tract of  3-4 
Us is present either singly or in multiples of 3-4 copies. The 
distance of  the most 3' nt of these elements from the U of the 
hexanucleotide varied widely, the closest located 3nt and the
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Resu l ts
farthest 98nt distant from the AAUAAA. A certain similarity to 
the sequence AUUUA was noted, multiple copies of which are 
found in the 3' UTRs of mammalian mRNAs and are thought to be 
involved in the regulation of cytoplasmic mRNA half  life (Shaw 
and Kamen, 1986; Vakalopolou et al., 1991). Again each poly(A) 
site sequence displayed certain similarities, U-rich tracts being 
present upstream of the poly(A) signals in the majority (70%) of 
poly(A) sites examined. Extended sequence data (up to 150nt 
upstream of  the hexanucleotide) available for three of the USE 
negative poly(A) sites UL29, UL38 and UL44, revealed similar 
elements to be located more than lOOnt 5’ of  the hexanucleotide, 
it is possible therefore that an extended search of the remaining 
USE negative sequences would result in a similar finding. At a 
sequence level however, the number and position of these 
elements appears to have no relationship to the efficiencies of  the 
test poly(A) sites determined in the previous sections, or their 
ability to respond to LPF.
3.4.5 Secondary structure comparison of HSV-1  
poly(A) site RNAs
The secondary structures of the six test HSV-1 poly(A) site 
RNAs were predicted using the GCG program Fold, run on a VAX 
computer. The Fold program predicts a secondary structure of 
minimum free energy for an RNA molecule based on the 
algorithims of  Zucker (Jaeger et a l ., 1990). The more negative 
the free energy value of the predicted structure the greater its 
stability.
Figures 3.27 A-E show the stem and loop structures 
predicted for each poly(A) site RNA sequence. Positioning of the
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poly(A) signal and the DSEs within the two dimensional structure 
was examined. In five of the six poly(A) site RNAs (UL38, UL23, 
UL29, IE110, UL44) the poly(A) signal is found on a loop or 
bulge of RNA, this correlates well with the studies of Woychik, et 
al., (1984) which identified a similar structure for the poly(A) 
site of  the bovine growth hormone. Examination of the RNA 
secondary structures o f  a selection of HSV poly(A) sites (22 in 
total), revealed that in all but one site the poly(A) signal was 
located on a loop or bulge of RNA (data not shown). The length 
of the stems supporting these loops are variable, ranging from the 
short four base paired stem of UL38 to the long forty-four base 
paired stem of IE110. The exception to this is the two 
dimensional structure of the IE63 poly(A) site RNA where the 
poly(A) signal is located on the stem of the stem loop structure. 
However it must be emphasized that these two dimensional 
structures are only predictions of the possible conformations of 
the RNA and do not take into account the effect proteins bound to 
the RNA would have on the overall structure.
The downstream sequence elements described above (GU- 
and U-rich DSEs) were found either on the same stem-loop 
structure as the poly(A) signal (IE110, UL23, UL44) or on an 
adjacent stem structure (IE63, UL38, UL29).
Some unique features were noted in the predicted structures 
of the UL38 and UL44 poly(A) sites : the UL44 poly(A) signal 
was located on the opposite side of the stem structure overlapping 
the GU-rich DSE, and the predicted two dimensional structure of 
the UL38 poly(A) site appeared as a complex arrangement of  ten 
stem loops, compared to the 5-6 stem loop structures of the other 
poly(A) sites. The possible relationship of these observations to
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FIGURE 3.27 A:
The predicted secondary structure of the IE 110 poly(A) 
site RNA, predicted using the VAX Fold program. 
pA : poly(A) signal AAUAAA. GU: GU-rich downstream 
element. U : U-rich downstream elements.
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FIGURE 3.27 B:
The predicted secondary structure of the IE63 poly(A) site 
RNA, predicted using the VAX Fold program. 
pA : poly(A) signal AAUAAA. GU: GU-rich downstream 
element. U : U-rich downstream elements.
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FIGURE 3.27 C:
The predicted secondary structure of the UL23 poly(A) 
site RNA, predicted using the VAX Fold program. 
pA : poly(A) signal AAUAAA. GU: GU-rich downstream 
element. U : U-rich downstream elements.
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FIGURE 3.27 D:
The predicted secondary structure of the UL29 poly(A) 
site RNA, predicted using the VAX Fold program. 
pA : poly(A) signal AAUAAA. GU: GU-rich downstream 
element. U : U-rich downstream elements.
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FIGURE 3.27 E:
The predicted secondary structure of the UL38 poly(A) 
site RNA, predicted using the VAX Fold program. 
pA : poly(A) signal AAUAAA. GU: GU-rich downstream 
element. U : U-rich downstream elements.
G U
-S*4
FIGURE 3.27 F:
The predicted secondary structure of the UL44 poly(A) 
site RNA, predicted using the VAX Fold program. 
pA : poly(A) signal AAUAAA. GU: GU-rich downstream 
element. U : U-rich downstream elements.
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the 3' processing efficiencies of  these two sequences will be 
discussed in the following section
The location of the USEs on the poly(A) site stem loop 
structures showed no obvious pattern and were not included in 
this examination.
3.4.6 D iscussion
The results of the protein-RNA binding studies presented 
here suggest that virus infection increases binding of selected 
proteins to the mRNAs of the HSV-1 test poly(A) sites. The 
increase in protein binding occurs with three sets of proteins, A 
(90-150kD), B (<69kD),and C (<46kD). The size of  the protein A 
triplet (90-150kD), is similar to the components of  the CPSF and 
this raises the possibil ity that it could be part of  this complex, 
and indeed the 160kD and 30kD CPSF proteins have been shown 
by UV cross-linking analysis to be closely bound to pre mRNA 
substrates (Gilmartin and Nevins, 1991; Keller et al., 1991). 
CstF is required for the formation of a stable complex with CPSF, 
without which cleavage and polyadenylation could not proceed 
efficiently. The 64kD component of CstF has also been shown to 
be UV cross-linked to poly(A) site mRNA in a number of  studies 
(Takagaki et al., 1990; Moore et al., 1988; Wilusz and Shenk, 
1988) and contains a ribonucleoprotein type (RNP) RNA binding 
domain (Manley et al., 1993). The size of  protein B also suggests 
it could be the 64kD component of CstF. Binding of the 64kD 
component of CstF appears essential for complex formation, and 
indeed protein B of these studies was bound consistently by all 
poly(A) site mRNAs examined. Protein C showed the most 
obvious increase in binding in the INF extracts. The size of this
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protein (<46kD) suggests it could be related to either the PAP 
which has been reported to be between 40kD and 60kD 
(Christofori and Keller, 1988; Takagaki et al., 1990) or the 38kD 
protein identified by Moore et al., (1988). The study of Moore 
identified three proteins of  155kD, 6 8 kD and 38kD, UV cross- 
linked to the L3 poly(A) site of adenovirus a pattern very similar 
to the RNA-protein binding demonstrated here. The 38kD protein 
of Moore's studies was identified by immunoprecipitation to be 
the C protein of  the heterogeneous ribonucleoprotein particles. 
Although we can only speculate at this time as to the identity of 
proteins A, B and C, the observations presented here suggest they 
could be those of the polyadenylation and cleavage complexes. 
However these proteins remain to be formally identified by 
Western blot analysis.
Analysis of  the HSV poly(A) site RNAs has shown that the 
majority contain predominantly GU-rich elements 20-35nt 
downstream of the poly(A) signal. However no pattern of element 
composition or posit ioning is evident to demarcate the different 
temporal classes of  HSV genes. A number of studies have carried 
out similar analysis of mammalian and viral poly(A) sites and 
identified comparable GU-rich elements (McLauchlan, et a 1., 
1985; Renan, 1987; Sadofsky, et al., 1985). The presence of  such 
elements would therefore seem a general feature of both viral and 
mammalian poly(A) sites.
The upstream elements identified from analysis of  the 
poly(A) site RNA sequences showed no pattern in either the 
location relative to the poly(A) signal or copy number within the 
sequence, indeed a number of the poly(A) sites contained no such 
elements within the lOOnt region studied. These U-rich elements
132
Resul ts
resembled sequences identified in some mammalian mRNAs, GM- 
CSF, c-fos and c-myc, which confer instability on the mRNA and 
promote their rapid turnover (Shaw and Kamen, 1986; 
Vakalopolou et al., 1991). It is possible that these elements 
perform a similar role in the HSV transcripts. This study however 
was designed to examine the processing efficiencies of the 
poly(A) sites and the relationship of LPF in the promotion of 
poly(A) site usage and in addition it has previously been shown 
that mRNA stability does not influence the LPF mediated increase 
in poly(A) site usage (McLauchlan et al., 1989). Therefore no 
importance has been placed on the presence of these elements in 
relation to the current investigation.
The features that make the UL38 and UL44 poly(A) sites 
inefficient 3' processing sites in MI extracts and able to respond 
to LPF remain to be identified. The observations presented here 
have produced some suggestions for further investigation. UL38 
does not appear to bind protein C which could be one aspect of  its 
inefficiency. There could be several reasons for this lack of 
binding - the UL38 poly(A) site, like other poly(A) sites, contains 
a GU-rich DSE which is positioned within the normal distance 
downstream of the hexanucleotide, if  these elements are required 
for efficient 3' mRNA processing, the proteins involved must 
either bind to an as yet unidentified sequence absent in UL38, or 
binding to the GU-rich DSE must be inhibited in some way. The 
complex nature of  the secondary structure, the proximity and 
number of  stem loops present in the UL38 RNA may result in an 
inhibition of binding of protein C.
The protein binding pattern of the UL44 poly(A) site 
displays no obvious dissimilarity to that of  the other poly(A)
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sites. However, sequence comparisons have shown that the 
extended GU-rich DSE overlaps the poly(A) signal on the stem 
loop structure. It is possible therefore that the UL44 poly(A) site 
can bind all the necessary proteins but the correct arrangement of 
proteins within the polyadenylation complex is prevented. In 
addition, the distance of the DSE, from the AAUAAA, was 
greatest in this site which may affect the efficiency of poly(A) 
site use. A number of HSV-1 poly(A) sites were identified from 
the sequence anlaysis which contained similar distance constraints 
of the GU-DSE and AAUAAA, it would be of interest to measure 
the processing efficiency of these sites to determine the 
significance of this observation.
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Chapter 4
General discussion
During HSV infection viral genes are expressed in a tightly 
regulated manner and a number of viral gene products act as 
regulators of the temporal expression of the three classes of viral 
genes, IE, early and late. Expression of the IE class of genes is 
stimulated by a component of  the virus tegument, Vmw65, the 
product of a late HSV gene, UL48. Expression of the early and 
late gene classes requires synthesis of  the IE proteins IE 175, 
IE110 and IE63 with perhaps IE6 8 , late gene expression has an 
additional requirement for viral DNA synthesis to be ongoing. 
The roles of the IE proteins in the induction of  early and late gene 
expression are not fully understood. However it has been noted 
that the co-operative interaction of IE 175 and IE 110 is required 
for the most efficient induction of a number of viral genes, and 
IE63 has also been shown to co-operate with IE175 and IE110 in 
the regulation of early and late gene expression, repressing early 
genes activated by the IE175/IE110 combination and enhancing 
activation of late gene expression. These IE proteins may also be 
capable of autoregulating their own expression, IE 175 and IE63 
deficient virus mutants both show increased levels of  IE proteins, 
suggesting that both proteins are involved in the downregulation 
of the IE protein pool. Recent interest has focused on the 
influence that post-transcriptional events may have on the 
regulation of viral gene expression. McLauchlan et al., (1989) 
identified a factor, termed LPF, which was capable of increasing
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the 3' processing efficiency at the poly(A) site of a late gene of 
HSV-2, while having no effect on another HSV-2 poly(A) site. 
Post-transcriptional events which influence and regulate gene 
expression have been described in a number of systems, two of 
which, the adenovirus and IgM heavy chain systems, involving the 
differential usage of poly(A) sites have already been discussed in 
detail. It would seem likely that LPF, which is capable of 
selectively increasing HSV poly(A) site usage could by analogy 
be able to regulate viral gene expression.
LPF can influence gene expression at a post- 
transcriptional level. Using an in vitro assay designed to 
measure the efficiency of mRNA 3' cleavage, which was taken as 
an indication of 3' processing efficiency of the poly(A) site, the 
processing efficiencies of a selection of  HSV poly(A) sites were 
measured. Our studies showed that the HSV induced activity, 
LPF, could significantly increase the in vitro 3' processing 
efficiencies of  two HSV-1 poly(A) sites and one HSV-2 poly(A) 
site while having no significant effect on the in vitro 3' 
processing efficiencies of another four HSV-1 and one HSV-2 
poly(A) site. The poly(A) sites which responded to LPF belong to 
the late class of  HSV genes and the poly(A) sites which did not 
respond belong to the IE and early classes of  genes. LPF 
therefore appears to be acting selectively to increase 3' processing 
of the late class of HSV genes and it is possible that a function of 
LPF is the post- transcriptional regulation of late gene expression 
in HSV infection.
There is however a caveat to this hypothesis,  the HSV-2 
poly(A) site which did not respond to LPF is util ised by US 12 an
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IE gene, US10 an early gene and US11 a late gene of HSV-2. It 
is therefore not simply that LPF can increase the 3' processing of 
all late poly(A) sites, thereby enhancing late gene expression, 
additional factors must also play a part. In this study the 3' 
processing efficiencies of the selected HSV poly(A) sites were 
examined in the absence of any influence that transcriptional 
control might exert. It is possible therefore that enhancement of 
late viral gene expression requires additional factors which 
complement control mediated post-transcriptionaly via selective 
enhancement of  poly(A) site processing efficiency.
One interesting feature of  the poly(A) sites examined was 
the inefficient basal processing activity of  the poly(A) sites which 
responded to LPF. If  weak poly(A) sites were a general, although 
obviously not exclusive feature of late poly(A) sites, this could be 
a means of regulating gene expression. It is possible that the role 
of LPF is to increase the processing efficiencies of  inherently 
weak poly(A) sites or LPF may effect a general increase in the 
processing efficiency of all poly(A) sites. It may be that in v i tro , 
the only sites at which this is apparent are those which are weak 
processing sites. In this way the role of  LPF could be to somehow 
give a boost to viral gene expression as the cellular proteins 
required for these 3’ processing reactions decline as viral 
infection progresses.
The in vivo activity of  LPF, originally demonstrated by 
McLauchlan, et al., (1989; 1992b), has been confirmed, showing 
that LPF is active from early times of  infection and that the in 
vitro increase is mirrored in vivo. In vivo the activity of  the LPF 
responsive HSV-2 poly(A) site was increased above the level of 
the non-responsive poly(A) site. However in vitro the enhanced
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processing efficiency of the responsive poly(A) site did not attain 
the level of the non-responsive site, while this could be due to the 
constraints of the in vitro assay, it is also possible that additional 
factors influence processing efficiency in vivo. Regardless of the 
explanation it is obvious that LPF can function in vivo to 
selectively enhance gene expression.
The 3* processing efficiencies of HSV poly(A) sites vary.
It is clear from the in vitro data presented here that the poly(A) 
sites of  HSV genes have different 3' processing efficiencies, with 
the UL38 and UL44 poly(A) sites appearing inherently weak. 
Analysis of the sequences surrounding the poly(A) signal of all 
functional HSV-1 poly(A) sites has given no clear evidence of 
sequence variations which could account for these differences in 
3' processing efficiencies. All poly(A) sites examined contain 
GU- or U-rich elements downstream of the poly(A) signal, with 
the majority located 20-35nt downstream of the poly (A) signal. 
It has been shown in other systems that increasing the distance 
between the poly(A) signal and the downstream elements can 
drastically reduce processing at the poly(A) site. It was noted 
that the UL44 GLNelement lies 41nt downstream of the poly(A) 
signal, it is possible therefore that this could be responsible for 
its inefficiency. The downstream elements of a small number of 
other HSV-1 early and early-late poly(A) sites are also located 
around 41nt downstream and it is therefore by no means an 
exclusive property of the poly(A) sites of true late genes. It 
would be interesting to determine the processing efficiency of 
these other sites and to see whether a reduction of the GU-element 
- poly(A) signal distance would result in an increase in processing
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efficiency at the UL44 site. The GU-element of  the UL38 poly(A) 
site lies within the normal distance range, this proposed distance 
effect therefore cannot be the sole factor determining processing 
efficiency. LPF could therefore function by either stabil ising 
what might be an inefficiently formed processing complex or by 
bringing the two elements (GU and AAUAAA) to within a 
functional distance of each other.
Analysis of  the predicted secondary structures of  HSV-1 
poly(A) site RNAs showed that the majority of  poly(A) sites (26 
out of  the 28 examined) are located on single stranded regions of 
RNA, present as loops or bulges within stem-loop structures. 
While there is no evidence that these structures exist in vivo it is 
interesting that the poly(A) signal is consistently located on a 
region of single stranded RNA. Perhaps recognition by the 
processing complex is facilitated by the prominent positioning of 
the AAUAAA or the proteins involved bind ssRNA preferentially. 
However it should be kept in mind that binding of any proteins to 
the RNA, not jus t  those involved in 3' processing, would have an 
effect on the overall conformation of the structure, and this has 
not been taken into account in these predictions. Again no 
obvious features of  the secondary structures single the UL38 and 
UL44 poly(A) sites out to be different from the other poly(A) 
sites examined. There is a slight possibil ity that the UL38 
poly(A) site secondary structure, which appears more complicated 
than the other poly(A) sites, forming a greater number of  stem- 
loops, prevents the ready access of  the processing complex. It is 
possible therefore that LPF could function by changing the 
conformation of the structure to a more favourable or accessible 
form or enhance binding of the processing complex either by
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direct of  indirect interaction with the RNA or cellular processing 
proteins.
The protein-RNA UV cross-linking studies showed a 
distinctive pattern of protein binding. The sizes of the protein 
bands correlate well with the sizes of proteins known to be part of 
the CPSF and CstF components required for formation of the 
mRNA processing complex. These proteins have been shown by a 
number of studies to be UV cross-linked to pre mRNA substrates. 
However formal identification of the proteins by Western blot 
analysis remains to be carried out. HSV infection produced a 
general increase in the binding of these proteins to all the test 
poly(A) site RNAs examined, with the exception of the smaller 
<46kD protein which did not bind to the UL38 poly(A) site. 
Moore et al., (1988) identified a similarly sized protein, UV 
cross-linked to the adenovirus L3 poly(A) site, as an hnRNP C 
protein. It has recently been proposed that hnRNP proteins may 
play an active role in the splicing and transport of mRNA from the 
nucleus to the cytoplasm in addition to packaging pre-mRNA 
molecules. However the significance of  the binding or lack of 
binding of such a protein in determination of the processing 
efficiency of a particular poly(A) site is unclear.
The evidence presented in these studies suggests that the 
efficiency of poly(A) site usage is determined by the individual 
differences of  particular poly(A) sites. The role of LPF could be 
the induction of a generalised increase of  processing components, 
either by stimulating their synthesis or by increasing their  
stability, thereby increasing the relative concentrat ions of the 
processing components in the cell extracts. While the general 
picture of  host cell protein synthesis during HSV infection is one
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of declining levels, exceptions to this rule have been 
demonstrated. During HSV-1 and HSV-2 infection in cell culture, 
an accumulation of stress response proteins has been shown 
(Notarianni and Preston, 1982; La Thangue et al., 1984). It is 
possible therefore for virus infection to induce the accumulation 
of certain cell proteins. Alternatively LPF may stabilise the 
processing complex either directly by protein-protein interaction 
or indirectly by post-translational modification of the components 
to a more stable form, thus increasing the likelihood of complex 
formation, which could produce the observed increase in protein 
binding without an actual increase in synthesis of the protein 
components.
IE63 : a central role in the virus life cycle? The studies of 
McLauchlan et al., (1992b), demonstrated that the IE63 gene 
product was required for LPF activity and the current studies have 
shown that IE63 is required for the increase in processing 
efficiency at both the LPF responsive HSV-1 late poly(A) sites. A 
lack of IE63 had no effect on the processing efficiencies of the 
four remaining non-responsive HSV-1 poly(A) sites. IE63 is 
known to be required for late gene expression and there is 
evidence that IE63 can enhance late gene expression both 
transcriptionally and post-transcriptionally. Further, there is 
evidence both for and against viral DNA synthesis requiring IE63 
expression, which could have a knock on effect on late gene 
expression. The processing data presented herein supports the 
theory that IE63 exerts a post- transcriptional influence on late 
gene expression. Analysis of  the profile of  viral protein 
expression from an IE63 deficient virus mutant, showed that IE63
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was required for the expression of the true-late US11, UL38, 
UL44 and UL45 HSV genes. While expression of the early-late 
gene US8, the early gene US6 and IE gene IE175 was unaltered. 
Interestingly the other genes affected by the lack of IE63 
expression are either involved in DNA synthesis (UL29 and UL42) 
or known to have a regulatory role (IE 110). This latter group of 
proteins did not display an absolute requirement for IE63 
expression but rather the level of protein expressed was reduced 
or delayed in the absence IE63. It is possible therefore that IE63, 
via an effect on these proteins, could disrupt the normal sequence 
of events required for efficient DNA synthesis and activation of 
gene expression. Indeed other studies have shown that IE63 can 
alter the electrophoretic mobility of the UL29 and the IE 175 
proteins, presumably by some post-translational modification. 
This proposed role for IE63 in the efficient induction of viral 
DNA synthesis could help to explain the finding that IE63 is 
required for US 11 expression while having no effect on the 3’ 
processing efficiency of the US 11/US 12/US 10 poly(A) site. IE63 
may therefore have a dual role in gene expression.
Recent studies (Phelan et al., 1993) have shown that during 
HSV infection the components required for splicing (snRNPs) 
form distinct foci within the infected cell and that IE63 is 
required for this localisation. In addition transfection studies 
have shown that IE63 represses the 3' processing of a poly(A) site 
immediately downstream of an intron. If  the processes of splicing 
and polyadenylation are linked, which remains a possibility if  
unproven at this time, IE63 could thus affect the 3' processing of 
intron containing transcripts. During HSV infection however 
there is little need for splicing to occur, it would make sense
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therefore for these foci to be inactive sequestrations of snRNPs. 
It is not known however if  these snRNP foci are active or 
inactive.
It is difficult to believe that one protein can exert so many 
different influences on viral replication. Although it has been 
shown that the IE63 protein has a number of different functional 
domains, including activation, repression, a putative DNA binding 
region and nuclear localisation signal. It is more likely that IE63 
influences the different aspects of  viral replication by one central 
means, for example an ability to regulate other viral proteins by 
some post-translational mechanism. A mechanism which could in 
the case of 3' processing serve to enhance production of or 
stablise the protein components of the processing complex, and 
could enhance production of or activate the proteins required for 
viral DNA replication or affect the intracellular transport and 
correct localisation of these proteins as appears to be the case 
with the splicing components. Recent studies have demonstrated 
that IE63 and IE 175 affect the cellular localisation pattern of 
IE110, with IE175 promoting and IE63 inhibiting nuclear 
localisation (Zhu et al., 1994). In addition the correct 
intracellular localisation of UL29 has been shown to require IE63 
expression (Curtin and Knipe, 1993). One post- translational 
event which has been shown in other systems to have such a 
universal effect is the phosphorylation and dephosphorylation of  
proteins (Hunter and Karin, 1992; Kwon and Hecht, 1993). In 
fact the aberrant phosphorylation of the cellular RNA polymerase 
II during HSV infection has been shown to alter the localisation 
and activity of this protein to the advantage of the virus (Rice et 
al., 1993). IE63 is i tse lf  phosphorylated with the phosphate
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cycling on and off during the virus replication cycle (Wilcox et 
al., 1980). However no relationship between the different 
phosphorylated forms and the activities of IE63 has been 
established, and no data is available which shows whether IE63 
has i tself  any phosphokinase or phosphatase activity. 
Alternatively IE63 could affect the activity of viral or cellular 
kinases or phosphatases.
In summary IE63 appears to play a central role in the 
regulation of viral gene expression, however the exact means 
whereby IE63 exerts its influence on gene expression is unknown. 
The evidence presented here suggests that at least part of the 
mechanism is an ability to increase the processing efficiencies of  
selected poly(A) sites, perhaps by generally increasing the 
concentration or stability of the protein components required for 
efficient 3! processing, with specific deficiencies in individual 
poly(A) sites making them targets for regulation. It is clear that 
this is not the whole story and that IE63 may have an additional 
role in regulation of viral DNA synthesis.
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Future work
1. Determine whether IE63 alone is directly responsible for 
LPF activity by using purified IE63 protein in the in vitro 
3' processing reactions.
2. Carry out Western blot analysis on the protein bands A, B 
and C, which were shown to bind to the test poly(A) sites, 
using antibodies to the components of  the 3’ processing 
complex.
3. Determine whether inefficient 3' processing is a general 
feature of the poly(A) sites of  the class of true late HSV-1 
genes.
4. Perform deletion analysis to determine if  the GU-rich 
elements are required for efficient 3’ processing and/or the 
protein binding properties o f  the test poly(A) sites.
5. Determine whether the inefficiency of 3' processing at the 
UL44 poly(A) site is due to the distance between the 
poly(A) signal and GU-rich element and further compare the 
3' processing efficiencies of  those additional poly(A) sites 
which have GU-rich elements >41nt downstream of the 
poly(A) signal.
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Chapter 5
The mutagenic properties o f  HSV 
5.1.1 Introduction
The association of HSV-1 with head and neck cancers and 
HSV-2 infection with an increased risk of  cervical cancer has 
been based on serological and epidemiological studies. It was 
found that a greater number of  women with cervical cancer had 
circulating antibodies against HSV-2 than women without the 
disease (Naib et al., 1969) and in addition HSV-2 has been 
isolated from cervical cancer cells and HSV-2 antigen 
demonstrated in these cells by immunofluorescence (Royston and 
Aurelian, 1970; Aurelian et al., 1970). Patients with head and 
neck cancers have also been shown to have higher levels of  
antibody to HSV-1 than control subjects (Larsson et al., 1991; 
Kumari et al., 1982; Shillitoe et al., 1982). These serological 
studies have not identif ied any antibody response that is unique to 
cancer patients, this coupled with the widespread nature of the 
disease makes it difficult to provide direct evidence of a causative 
role for HSV in the aetiology of cancer. However it remains a 
strong possibil ity that HSV is involved at some point in the 
multistage process of  oncogenic transformation. HSV infection 
may therefore have a role in the initiation of pre-cancerous 
changes or progression of pre-cancerous cells to a more 
tumourigenic phenotype induced by other factors such as exposure 
to carcinogens, UV light, smoking (Dokko et al., 1991; Johnson, 
1982; Park et al.,  1990), or other infectious agents such as human
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papillomavirus (HPV). While there is strong evidence of an 
association between certain types of HPV (types 16 and 18) and 
cervical cancer it is known that infection by itself  is not sufficient 
for malignant development (reviewed by Zur Hausen, 1991) and 
other co-factors, of which HSV infection may be one, are required 
(Di Paolo et al., 1990; Guis and Laimonis, 1989; Wymer and 
Aurelian, 1990; Iwasaka et al., 1988). The relationship of these 
factors to init iation or progression of neoplastic transformation is 
unknown.
HSV proteins have been shown to be expressed in some 
tumour cell lines (Jariwalla et al., 1986; Lewis et al., 1982) and 
viral RNA (Collard et al., 1973; Copple and McDougall, 1976) 
and DNA (Frenkel et al., 1976; Galloway et al., 1980) have been 
detected in some tumours. In addition HSV-1 and HSV-2 have 
been shown to be capable of  transforming rodent cells to a 
malignant phenotype (Rapp and Duff, 1973; Takahashi and 
Yamanishi, 1974). There is no evidence however that 
maintenance of the transformed state requires either the continued 
expression of a particular HSV protein or that viral DNA is 
retained or expressed. Indeed HSV infection almost always 
results in cell lysis and death, for cellular transformation to result  
from HSV infection therefore this cycle of  events would have to 
be aborted. This obviously rare event may result in the al teration 
of the infected cell in such a way as to contribute to the 
progression towards malignancy. This has led to the hypothesis 
that HSV acts in a hit-and-run manner to induce the changes 
which result  in transformation of  the cell (reviewed by Galloway 
and McDougall, 1983; Macnab, 1987).
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FIGURE 5.1 :
Shows the locations of the morphological transforming 
regions within the HSV genome (given in map units). 
The blocks indicate the positions of mtrl, mtrll and 
mtrll l  along the prototype arrangement of the HSV 
genome.
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5.1.2 Morphological transformation regions of HSV
Transfection studies have identified three separate regions 
of  the HSV genome which are associated with the morphological 
transformation of cultured cells. HSV-1 contains one 
morphological transforming region (mtr I) and HSV-2 contains 
two such regions (mtr  II and mtr III) (Figure 5.1).
mtr I Camacho and Spear (1978) showed that a fragment of  
Xba-1 digested HSV-1 DNA was capable of  transforming hamster 
embryo cells. This transforming fragment (Xba-1 f) was located 
between map units 0.3 and 0.45 on the HSV-1 genome. This 
finding was subsequently confirmed by Reyes et al., (1979) who 
identified the Bglll  i fragment, map units 0.311-0.45, as the 
transforming region.
mtr II The mtr II of  HSV-2 has been mapped to the Bglll  n 
fragment, map units 0.58-0.625 (Reyes et al., 1979; Macnab and 
McDougall, 1980; Galloway and McDougall, 1981). The coding 
sequences of the UL41 (VHS) gene lie within this region, however 
expression of this protein was not detected in cells transformed by 
this fragment (Galloway et al., 1984). Analysis of this DNA 
fragment to determine the minimal region required for 
transformation has produced conflicting results, with both the left 
hand (Galloway et al., 1984) and right hand regions of the mtr II 
implicated (Pilon et al., 1989).
mtr III The second morphological transforming region o f  
HSV-2 confusingly called mtr III, maps within the Bglll  c 
fragment, map units 0.54-0.58, of  the HSV-2 genome (Peden et 
al., 1982; Jariwalla et al., 1983). The left hand 64% of the Bgl 
lie fragment has been shown to immortalise rat cells (Jariwalla et 
al., 1983) and the right hand 30% can induce neoplastic
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transformation of immortalised rat cells (Jariwalla et al., 1986). 
Leading to the hypothesis that the Bglll  c fragment contains 
independent immortalising and transforming functions (Jariwalla 
et al., 1986). The minimum region that is capable of neoplastic 
transformation of immortalised cells maps within the PstI c 
fragment, map units 0.562-0.57 (Ali et al., 1991).
5.1.3 Possib le  mechanisms of  transform ation
Several theories have been put forward in explanation of the 
hit-and-run mechanism of HSV mediated cell transformation.
(a) A ct ivat ion  o f  ce l lu lar genes
Transformation could result from the constitutive induction 
of cellular genes involved in growth regulation. While HSV 
infection results in the shut off of host macromolecular synthesis 
the expression of a limited number of  proteins is stimulated. 
Cellular heat shock proteins have been shown to accumulate in 
HSV infected cells (La Thangue, 1984; Notarianni and Preston,
1982) and a specific set of  three polypeptides o f  90kD, 40kD and 
32kD are expressed in transformed cells and are identical to ones 
induced by HSV infection (Macnab et al., 1985). It is possible 
therefore for the virus to induce the aberrant and perhaps 
unregulated expression of  cellular genes which could result in 
transformation of the cell.
(b) A ct ivat ion  of  endogenous virus
The early studies of  Hampar (Hampar et al., 1976; Boyd et 
al., 1978), showed that HSV infection of cells transformed by 
Maloney murine sarcoma virus led to activation of  the endogenous
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virus. The sequences of  HSV -1 which are capable of inducing 
retroviruses have been localised to DNA regions which correspond 
to map units 0.29-0.32, 0.46-0.49 and 0.92-0.97, the first of 
which overlaps with mtr I (Boyd et a l ., 1980). It is not clear 
however i f  the two functions coincide. Endonuclease digestion of 
the TK gene (UL23), which overlaps the 0.29-0.32 region, was 
shown to inactivate the induction of retroviruses. However other 
regions (0.46-0.49 and 0.92-0.97) of the HSV-1 genome can also 
reactivate the endogenous virus and the role of TK in induction is 
therefore unclear.
(c) A m plif ica t ion  of  ce l lu lar  sequences
HSV infection has been shown to induce the amplification of 
integrated SV40 genes present in transformed hamster (Schelhofer 
et al., 1983;) and human cell lines (Schelhofer et al., 1986) in a 
manner similar to chemical carcinogens (Lavi, 1981). HSV can 
also amplify human papillomavirus sequences resident in cervical 
carcinoma cell lines (Brandt et al., 1987). This observation could 
explain the proposed synergistic role of  HPV and HSV in the 
init iation and/or progression of  cervical cancer. While it is not 
clear how HSV mediates amplification of these integrated viral 
sequences it has been shown to be dependent on continued viral 
replication and in particular requiring the HSV genes involved in 
viral DNA replication (UL30/UL42, UL29 and UL5/UL8,/UL52) 
(Danovich and Frenkel, 1988).
(d) M u tagenes is  o f  ce l lu lar  genes
One way in which a hit-and-run mechanism might operate is 
by increasing the frequency of mutations in cellular DNA, and
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there is strong evidence that mutations play a fundamental role in 
cellular transformation and carcinogenesis (reviewed by Bishop,
1983). The hypothe sis that HSV may act as a mutagen was first 
proposed when chromasomal aberrations were observed in HSV 
infected cells (Stich et al., 1964; Hampar and Ellison, 1961). 
Inactivated HSV-1 (UV irradiated or neutral-red inactivated) or 
infection of non-premissive cell lines with wt HSV-2 has been 
shown to induce mutations in the cellular hypoxanthine guanine 
phosphoribosyl transferase (HGPRT) gene (Schelhofer and Zur 
Hausen, 1982; Pilon et al., 1985). A cloned fragment of  DNA 
corresponding to mtr I of HSV-1 has in addition been shown to 
produce an increase in the frequency of histidine reversion 
mutants in E. coli (Shillitoe et al., 1986).
Analysis of the mutagenic properties of HSV has been 
facili tated by the use of  the shuttle vector system of Seidman 
(Seidman et al., 1985), which had previously been used to 
examine the mutagenic effects of UV-irradiation and chemical 
carcinogens on mammalian cells (Hauser et al., 1986; Munson et 
al., 1987; Dixon et al., 1989; Seidman et al., 1987; Moraes et al., 
1989). It was shown that HSV-1 infection induced a significant 
increase in the mutation frequency of the target plasmid above the 
level o f  mutations arising spontaneously in uninfected cells and 
that this increase was evident from 2h pi, peaking between 4h-8h 
pi (Hwang and Shillitoe, 1990; Clarke and Clements., 1991). 
Analysis of a series of  HSV-1 ts, insertion and deletion mutants 
and UV irradiated virus, demonstrated that neither viral 
replication or gene expression were required for the mutagenic 
effect o f  the virus. The mutagenic activity of the virus was 
therefore likely to be a component of the incoming virion or the
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viral DNA itself  (Clarke and Clements., 1991). It was also shown 
that lytic infection was not required for mutagenesis, lytic 
infection with vaccinia virus did not increase the mutation 
frequency and non-lytic infection with adenovirus did (Hwang and 
Shillitoe, 1990). Analysis of the types of  mutations induced 
showed that mutations arising spontaneously were different from 
those arising from HSV infection. A greater proportion of 
spontaneous mutations were point mutations (64% vs 40%) the 
majority of  virus induced mutations arising from deletion of 
plasmid DNA or insertion of  regions of  cellular or plasmid DNA, 
with the proportion of more complex mutations increasing as 
infection proceeded (Hwang and Shillitoe, 1990). There was good 
correlation reported between the types of mutations induced by 
HSV infection (Hwang and Shillitoe, 1991) and those seen in 
chromasomal DNA resulting from exposure to UV light (Hauser et 
al., 1987; 1988) and also those occurring in patients with a DNA 
repair deficiency (Seidman et al., 1987; Bredberg et al., 1986).
Recent studies have ruled out the involvement of  a number 
of HSV-1 genes, namely IE175, UL41 (VHS), UL23 (TK), 
UL30/UL42 (DNA polymerase) (Shillitoe et al., 1993) and 
UL39/UL40 (ribonucleotide reductase) (Clarke et al., 1991). In 
addition Shillitoe et al., (1993) propose that a small viral peptide, 
encoded within the HSV-1 mtr I, which was previously shown to 
increase the mutation frequency of bacteria (Shillitoe et al., 
1986), is responsible for the mutagenic effects of HSV-1.
The original aim of this part of  my thesis was to confirm and 
extend the work carried out in this Institute by P. Clarke (Clarke 
et al., 1991). To identify the exact component of HSV 
responsible for the observed mutagenic properties of  the virus,
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with the short-term aim of increasing the efficiency of the shuttle 
vector assay system used in the initial studies of Clarke and 
Clements, (1991).
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5.2 Materials and Methods
In this section the additional methods and materials required 
for this part of the work are described. The majority of materials 
and methods used are as described in Chapter 2.
5.2.1 M aterials
(a) Cells
CV-l cells, derived from African Green monkey kidney 
fibroblasts, were used for transfection studies.
FG-293 cells, derived from human embryonal kidney, 
transformed by adenovirus type 5, were used for transfection 
studies and the pZ189 mutagenesis assay.
(b) B acter ia l  cells
E. coli strain MBM7070 (F-, lacZamCA7020, lacY l .  hsdR-. 
hsdM+, ara-D 139. (araABC-leu)7679, galU, galK, rpsL. thj_), was 
used for propagation of the pZ189 plasmid in the mutagenesis 
assay. Bacteria were propagated in either L-broth or LM broth 
(L-broth supplemented with lOmM MgSC>4 and lOmM Mg CI2 ).
(c) V iruses
HSV-1 strain 17G41, a recombinant virus generated from 
HSV-1 strain 17+ containing the UL41 (VHS) gene from HSV-2 
strain G (Fenwick and Everett, 1990) was supplied by Dr. J. 
McLauchlan. HSV-1 strain 14-012 was a gift from Prof; E. 
Shillitoe, Houston, Texas.
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(d) P lasm id
The pZ189 plasmid designed by Seidman et al., (1985) was 
used for the mutagenesis assay.
(e) T issue culture media
FG-293 cells were grown in Eagle's A+B (with phenol red), 
supplemented with 4mM glutamine, lOOunits/ml pencillin, 
lOOunits/ml streptomycin and 10% foetal calf  serum. Cells were 
grown and harvested as described in Chapter 2.
5.2.2 Methods
(a) Virus growth curve
35mm tissue culture plates were seeded with either BHK or 
FG-293 cells to give a confluent monolayer after overnight 
incubation at 37°C in 5% CO2 . The cells were then infected with 
virus at 5pfu/cell in 200pl of  PBS supplemented with 10% NBCS. 
Virus was left to adsorb for lh  at 37°C, the cells were then 
washed twice in serum free medium and overlayed with growth 
medium. Plates were harvested at appropriate times by scraping 
the cells into the medium and sonicating the suspension to 
disperse any cell clumps. Each sample was then titrated on BHK 
monolayers.
(b) Preparat ion  of  com petent  M B M 7070  cells
Method A: a 10ml overnight culture o f  MBM7070 bacteria 
was grown in LM broth, 1ml of this culture was transferred to 
lOOmls of LM and incubated at 37°C in a shaking incubator until 
an OD600 of  0.45 was reached. The cells were pelleted by 
centrifugation (4000rpm, 5min, 4°C) and the pellet resuspended in
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40ml ice cold buffer (lOOmM CaCl2, lOmM DTT and lOmM MES) 
and held on ice for 20min. The cells were pelleted as before and 
resuspended in a 4ml final volume of buffer. Cells were stored at 
4°C for up to 5 days.
Method B: 2ml of an overnight culture of bacteria was 
transferred to lOOmls of L-broth and incubated in a shaking 
incubator at 37°C until an OD600 of 0.2 was reached. The cells 
were pelleted and resuspended in 40 ml of ice cold 0 . 1M CaCl2 
and held on ice for 40min pelleted once more and resuspended in 
2ml of  0 . 1M CaCl2. Cells were stored at 4°C for up to 5 days.
Method C: 1ml of an overnight culture of bacteria was
transferred to 100ml of L broth and incubated at 37°C in a 
shaking incubator until an OD600 of 0.45 was reached. The cells 
were pelleted at 2500rpm for lOmin at 4°C and resuspended in 
10ml ice cold L broth containing 10% PEG, 5% DMSO, lOmM 
MgCl2 and lOmM M g S 0 4 and held on ice for lOmin. Cells were 
aliquoted in lOOpl volumes and either used immediately or stored 
at -70°C.
Method D: The preparation of competent cells for
electroporation has been described in Materials and Methods 
Section 2.2.10 (a).
(c) T ransform ation  of bacter ia l  cells
Competent cells prepared by methods A, B and C were 
transformed in essentially the same manner. lOOpg of DNA was 
mixed with 1 0 0 jlxI of  competent cells and incubated on ice for 
45min. The cells were then heat shocked at 42°C for 2min after 
which 900pl of L broth was added and the mixture incubated in a 
shaking incubator for lh at 37°C. The cells were plated onto
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solid medium (1.5% Bacto agar in L broth) containing ampicillin 
( lpg /m l)  and incubated at 37°C overnight to allow the formation 
of bacterial colonies. Heat shock was omitted when the 
competent cells were prepared by method C. Transformation by 
electroporation has been described in Materials and Methods 
Section 2.2.10 (b).
(d) T ransfect ion  of  DNA into t issue culture cells
Three transfection methods were used two of which, calcium 
phosphate precipitation with a DMSO boost and Lipofection, were 
described in Materials and Methods Section 2 .2 . 6  (a) and (b). The 
third method a simple calcium phosphate precipitation is 
essentially as described by Graham and Van der EB, (1973). lOpg 
of plasmid DNA was mixed with 420pl of TE and 60pl of  2M 
CaCl2 was added dropwise whilst vortexing. The DNA/CaCl2 
solution was then added dropwise, whilst vortexing, to 480pl of 
2xHBS (280mM NaCl, 1.5mM Na2H P 0 4, 50mM hepes pH 7.1). 
The mixture was left at RT for 20min to allow the precipitate to 
form, and was then added dropwise to the 70-80% confluent cell 
monolayer (50mm tissue culture plates) by swirl mixing into the 
GM. After overnight incubation at 37°C the GM was removed and 
the cell monolayer washed twice in serum free medium, the cells 
were then overlayed with fresh GM before further incubation.
(e) Hirt  extraction  of  plasmid DNA from eukaryotic  ce l ls
As described by Hirt (1967), GM was removed from the cells 
and replaced with 0.5ml Hirt extraction buffer (0.5% w:v SDS, 
lOmM EDTA, pH 7.5) followed by incubation at RT for 15-20min. 
The viscous lysate was scraped from the plates and poured into a
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vial, 5M NaCl was then added giving a final concentration of 1M 
NaCl and the solution mixed gently by inversion. The mixture 
was stored for at least 8 h at 4°C, then centrifuged (17,000rpm, 
30min, 4°C) to pellet the genomic DNA. The supernatant, 
containing the plasmid DNA, was treated with RNaseA (lOOpg/ml) 
for 3h at 37°C, phenol/chloroform extracted 3 times, chloroform 
extracted once and the DNA ethanol precipitated. After 
lyophil isation the DNA was resuspended in 30pl H2 0 .
(f) pZ189 m utagenesis  assay
The method is essentially as described by Shillitoe et al., 
(1990). Using the simple calcium phosphate precipitation method 
subconfluent 50mm plates of  FG-293 cells were transfected with 
10pg of the plasmid pZ189. Transfection medium was 
subsequently replaced with fresh GM at 18h. Mock infected cells 
were incubated for a further 24h to allow replication of the 
plasmid. Cells to be infected with virus were left for 8 h, 18h or 
2 0 h after replacing the transfection medium before being infected 
with virus at a moi of lOpfu/cell (approximately 4x106 cells/plate) 
for 18h, 6 h or 4h respectively. Mock infected and infected plates 
were therefore harvested after a total incubation period of 42h. 
Progeny plasmids were extracted from the cell lysate using the 
extraction method of Hirt (1967), followed by treatment with the 
Dpnl restric tion endonuclease to remove any unreplicated forms. 
The enzyme Dpnl cuts only DNA that has been methylated by the 
E.coli dam methylase, all plasmids which have undergone 
replication in a eukaryotic system escape digestion, whereas 
incoming plasmid DNA of bacterial origin is digested. Progeny 
plasmids were then used to transform MBM7070 bacteria and the
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resultant colonies grown on LB agar plates supplemented with 
50jng/ml 5-bromo-4-chloro-3-indolyl-P-D-galactopyranoside (X- 
gal) and 45jag/ml isopropylthio-p-D galactoside (IPTG). This 
strain of  E. coli contains a suppressible (amber) mutation in the 
P-galactosidase gene, when transformed with pZ189 encoding a 
suppressor tRNA, blue colonies are produced when grown in the 
presence of X-gal and IPTG and white colonies are produced when 
the suppressor tRNA is mutated. Any white colonies isolated 
were replated twice to confirm their mutant phenotype. The 
percentage frequency of mutagenesis was calculated using the 
following formula.
Mutation = No. of white colonies xlOO 
frequency total No. of colonies
(h) H ydroxylam ine  mutation o f  plasmid DNA
24pg of plasmid DNA was added to 1ml of  400mM 
hydroxylamine solution (400mM hydroxylamine, ImM EDTA, 
50mM Na pyrophosphate). The mixture was incubated on ice for 
45min then incubated at 75°C for lh. The action of 
hydroxylamine was quenched by the addition of Tris buffer and 
the mutated DNA was recovered by ethanol precipitation.
(i) C hloram phenico l  acetyl  transferase  assay
Thin layer chromatography method : Cells extracts were 
produced by several cycles of freeze thawing in Tris buffer as 
described previously. 25pl of cell extract was added to the 35pl 
reaction mix (0.5pCi 14C chloramphenicol, ImM acetyl co-enzyme 
A, 200mM Tris pH 7.8) and incubated at 37°C for lh ,  200pl of 
ethyl acetate was then added and mixed thoroughly. The mixture
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was centrifuged (13,000rpm for 2 h) and the ethyl acetate fraction, 
containing the chloramphenicol and its acetyl derivatives removed 
to a fresh tube and evaporated to dryness. The residue was 
redissolved in 3 0 jlxI  of ethyl acetate and applied to a thin layer 
chromatography plate (tic). Ascending chromatography was 
performed using a 95% chloroform and 5% methanol (v:v) solvent. 
Finally the tic plate was air dried and the bands visualised by 
autoradiography.
(i) A ssay  o f  v ir ion host shut o ff  (VHS)
Virus particle counts were performed in this Institute by J. 
Aiken on HSV-1 strain 17+, HSV-1 strain 17G41 virions and L- 
particles. Virion particle and L-particle dilutions were prepared 
in Glasgow's modified Eagle's medium containing 2.5pg/ml 
actinomycin D. Confluent 35mm tissue culture plates containing 
BHK or FG-293 cell monolayers were inoculated with either 
virion or L-particle dilutions at 5 x l0 9particles/cell;  
l x l 0 9particles/cell ; 2 x l 0 8particles/cell  4 x l 0 7particles/cell and 
4 x l0 6particles/cell . After lh  the inoculum was replaced with 
GMEM containing l /5 th  the normal concentration of methionine, 
supplemented with 2% NBCS and 2.5jng/ml actinomycin D. At 
2 .5 h after inoculation with the virus particles the cells were 
labelled for lh  with 180pCi/ml [3 5S]-L-methionine in GMEM 
containing 5% NBCS and actinomycin D. After incubation the 
medium was discarded and the cells harvested by scraping into 
200pl protein gel boiling mix and heated to 100°C for 5min.. 
1/1  Oth of each sample was precipitated with trichloroacetic acid 
and the amount of radiolabelled protein present determined by 
measurement of  the radioactive counts present using a
160
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scintil lation counter. The efficiency of protein synthesis in the 
infected samples was expressed as a percentage of the protein 
synthesis found in the mock infected control.
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5.3 R e s u l t s
5.3.1 The pZ189 mutagenesis assay
Developed by Seidman et a l ., (1985), the pZ189 mutagenesis 
assay has been used extensively to study the effects of mutagens 
on mammalian cells. The plasmid, pZ189 (Figure 5.2), contains 
both the origin of replication and early gene region from the SV40 
virus and the pBR327 plasmid origin and as such can replicate in 
both SV40 permissive cell lines and bacterial cells, replicating as 
efficiently as wt SV40 viral DNA (Seidman et at., 1985). Several 
features of the plasmid make it particularly useful for the study of 
mutagenesis. The mutagenesis marker, the tRNA supF  gene, is 
located between two essential functions of the plasmid, the 
ampicillin resistance gene and the pBR327 origin of replication, 
producing a vector with a greatly reduced frequency of 
deletion/insertion mutations following passage through 
mammalian cells and a spontaneous mutation frequency which is 
1 0 - to 2 0 -fold lower than other similar shuttle vector plasmids 
(Seidman et a l ., 1985). The tRNA suppresses an amber mutation 
in the lacZ gene of the E. coli strain MBM7070. Transformation 
with intact sup F  allows the lacZ gene to function normally and 
form blue colonies on medium supplemented with X-gal and IPTG. 
Mutation of the tRNA results in inactivation of  the lacZ gene with 
the production of white colonies. The mutagenic frequency of any 
mutagen can therefore be measured simply and expressed 
quantitatively as the percentage of white colonies formed in the 
total population of transformants. In addition the marker gene is 
only 150bp in size, the entire length o f  the gene can be readily 
sequenced and determination of the types of mutations which have 
been induced is therefore simple.
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EcoRI
Ori pBR327Ampr
SupF
PZ189
5504 bps
Ori
T A g SV40
FIGURE 5.2 :
The pZ189 shuttle vector. The 5504bp vector contains 
the ampicillin resistance gene (Ampr), the pBR327 
origin of replication (Ori pBR327), the E.Coli supF 
suppressor tRNA and the origin of  replication and TAg 
coding region from SV40. Arrows indicate direction of 
transcription.
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This system was adopted to examine the mutagenic 
properties of HSV (Hwang and Shillitoe, 1990; 1991; Shillitoe et 
al., 1993; Clarke and Clements., 1991). Cells transfected with the 
pZ189 plasmid were subsequently infected with wt and mutant 
HSV, the mutation frequencies determined and the mutations 
produced analysed. The results of these experiments have already 
been discussed in Section 5.1.3 (d). However a marked difference 
was observed in the number of  transformants recovered from the 
transfection experiments, carried out by these two research 
groups, Hwang and Shillitoe recovered an average
of 9000 transformants/lOpg transfected DNA from the mock 
infected control and approximately 8000 transformants from the 
HSV infected test: approximately three times the number of mock 
infected transformants and five times the number of HSV infected 
transformants obtained by Clarke and Clements, (1991). The level 
of  recovery attained by Hwang and Shillitoe was in keeping with 
that attained by other research groups, using the assay to study 
the effect of chemical mutagens on mammalian cells. It was 
essential therefore that the efficiency of transformant recovery 
was increased to allow confirmation and expansion of the initial 
data of  Clarke and Clements, (1991). Each aspect of  the assay - 
plasmid preparation, transfection, infection and transformation 
has therefore been studied in turn and optimised.
5.3.2 Plasmid preparation
Different batches of  pZ189 plasmid DNA were tested for the 
frequency of occurrence of spontaneous mutations (Table 5.1). 
Large scale preparation of plasmid DNA was carried out as 
described in Materials and Methods Section 2.2.2 (b). Three of
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the five batches received an additional boost of chloramphenicol 
(lOOpg/ml). Chloramphenicol is known to enhance replication of 
plasmid DNA by preventing bacterial protein synthesis, however 
there is also a concomitant increase in misincorporation of 
r ibonucleotides,  instead of  deoxyribonucleotides. This is thought 
to stimulate the DNA repair mechanism and due to the poor proof  
reading ability of  this mechanism can result in point mutations 
within the DNA. DNA from each plasmid batch was used to 
transform E. coli strain MBM7070 (prepared by method A Section
5.2.2 (b)). The total number of transformants recovered and the 
number of  white (mutant) colonies were counted and the mutation 
frequencies determined (Table 5.1). Two of the plasmid batches 
had unacceptably high levels of  spontaneous mutations and were 
therefore not used in this study. Addition of chloramphenicol did 
not appear to influence the occurrence of these spontaneous 
mutations, two out of  three batches which received the 
chloramphenicol boost produced no mutants, while one of the two 
untreated batches had a mutation frequency of 0.099 which is 
higher than the average recorded spontaneous mutation frequency 
(0.05%) of the mutagenesis assay (Seidman et al., 1985).
5 .3.3 T ransfect ion  o f  mammalian cells
A comparison of three transfection methods was carried out 
using three cell lines FG-293, CV-1 and HeLa. The transfection 
methods used were : A - lipofection described in Materials and 
Methods Section 2.2.6 (b), B - the simple calcium phosphate 
precipitation method described in Section 5.2.2 (d) with and 
without the addition of ljig of  calf-thymus carrier DNA/pg of 
plasmid DNA and C - calcium phosphate precipitation with a
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boost of  20% DMSO or 20% glycerol. The plasmid pLW2, which 
contains a CAT reporter gene, was transfected into the three cell 
lines and CAT activity, determined by the tic method, was used as 
a measure of transfection efficency. Figure 5.3 shows the 
autoradiographs obtained from these transfection studies. Of the 
three cell lines tested the FG-293 cells, which were recommended 
by Seidman because they have a low spontaneous mutation 
frequency, gave the best results with all transfection methods. 
FG-293 cell extracts, from cells transfected using method B 
(without carrier DNA), when diluted 1:300 in CAT buffer, were 
capable of completely converting chloramphenicol to its acetyl 
derivatives. While the CV-1 and HeLa cell extracts were positive 
for CAT activity when undiluted, no activity was detected at the 
1:300 dilution of extract (Figure 5.3 panels A and B). Using 
method C the FG-293 cell line was similarly the most readily 
transfected (Figure 5.3 panel C) with neither the glycerol or 
DMSO boost confering any advantage. All transfections were 
therefore carried out by the simple calcium phosphate 
precipitation method using the FG-293 cell line.
5.3.4 Infection with HSV-1
Several aspects of  this part of the mutagenesis assay were 
studied. Firstly to ensure that sufficient time was allowed for the 
tranfected plasmid to replicate in the FG-293 cell line before 
infecting with HSV-1, a time course of  plasmid replication was 
carried out. Secondly the ability of HSV-1 to infect the human 
derived cell line FG-293 compared to the hamster cell line (BHK), 
which was used for characterisation and propagation of the virus, 
was examined. Thirdly the effect of different infection times on
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recovery of plasmid and the percentage mutation frequency 
obtained was studied.
(a) Time course of  plasmid replication
pZ189 plasmid DNA was extracted from FG-293 cell 
monolayers at 6 , 12, 18, 24, 36, 48 and 60h post transfection. 
The extracts were digested with Dpnl to remove input plasmid and 
the replicated plasmid was linearised by single cut digestion with 
EcoRI. Aliquots were electrophoresed on a 1% agarose gel 
containing ethidium bromide, and the plasmid DNA visualised by 
UV-light (Figure 5.4). Replicated plasmid DNA was visible by 
18h post transfection and replication continued steadily 
throughout the time period of the replication assay. Therefore by 
the time the cells were subsequently infected at 26, 36 and 38h 
post- transfection plasmid replication would definitely be ongoing.
(b) HSV infect ion  o f  the FG-293 ceil  line
One step growth curves were carried out on HSV-1 infected 
FG-293 cells and BHK cells (Figure 5.5). The kinetics of virus 
growth, lag time and onset of replication, were similar in both 
cell lines. The overall virus yield was one Log lower in the FG- 
293 cells which was as expected in this human cell line (Dr. D. 
Dargan personal communication).
In addition the ability of the virus to shut off host 
macromolecular synthesis, taken as an indication of the efficiency 
of virus infection, was measured. Both the BHK and FG-293 cells 
were infected with a range of HSV-1 17G41 virus particle and L- 
particle dilutions and the level of protein synthesis was quantified 
relative to an uninfected control (Table 5.2). HSV-1 17G41
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FIGURE 5.4:
Time course for replication of the pZ189 plasmid in FG-293 cells. 
Aliquots of linearised pZ189 DNA extracted from FG-293 cells at 
6 , 12, 18, 24, 36, 48 and 60h post-transfection were
electrophoresed on an agarose gel containing ethidium bromide 
and the DNA bands visualised by UV light. Linearised pZ189 is 
indicated by an arrow. * - cellular contaminant, C - 500ng, 200ng
and lOOng of linearised pZ189, X - Lambda DNA size marker, the 
sizes o f  DNA fragments (bp) generated by Hindlll  digestion are 
indicated on the left of the gel. Transfections were performed in 
triplicate. Small bands of <2,000bp are fragments of pZ189 input 
DNA generated by Dpnl digestion.
E
«*-a
0
0
j
10
Hours Pos t  Infection
FIGURE 5.5 :
Single step growth curve of HSV-1 in FG-293 cells I  
and BHK cells □  infected at 5pfu/cell. Virus yield is 
given as LOG pfu/ml.
VIRUS PARTICLES 
PER CELL
EFFICIENCY OF HOST 
PROTEIN SYNTHESIS
BHK-C13 FG-293
5xl09 23.3% 18.7%
lxlO9 26.3% 17.6%
17G41 2xl08 24.9% 44.3%
4xl07 63.8% 85.4%
8xl06 89.6% 100%
5xl09 17.0% 8.4%
17G41 lxlO9 16.5% 14.8%
L-PARTICLES 2xl08 24.5% 47.6%
4xl07 76.0% 56.6%
8xl06 90.5% 105.7%
TABLE 5.2:
Shows the level of host protein synthesis occurring in FG-293 
and BHK cells following infection with either HSV-1 virus 
particles or L-particles, expressed as a % of the protein synthesis 
occurring in an uninfected control.
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contains both the HSV-1 strain 17+ and HSV-2 strain G UL41 
(VHS) genes and is extrem ely efficient in shut o ff of host 
m acrom olecular synthesis. Both cell lines showed sim ilar levels 
o f host protein synthesis shut off. When the cells were infected 
with either virus partic les or L -particles at 5 x l0 9partic les/cell, 
protein synthesis in both cell lines was reduced to approxim ately 
20% of the uninfected control and suppression reduced steadily as 
the number of virus partic les used to infect the cells was 
decreased.
(c) Infect ion  times
The effect o f different infection times on the recovery of 
plasm id DNA and the level of m utagenesis produced was 
determ ined. pZ189 transfected  FG-293 cells were infected for 4h, 
6h and 16h before the subsequent extraction  of plasm id and 
m easurem ent of the % m utation frequency. Recovery of the 
plasm id was unaffected by the the length of the infection period, 
averaging approxim ately 9000 transform ants/transfection . The 
virus induced m utation frequency (0.05% ) was also unaffected by 
the length o f the infection period and was 2 .5-fold higher that the 
mock infected level (Table 5.3). It was noted however that the 
virus induced increase in m utation frequency was not as great as 
expected, producing an average 2 .5-fold  increase instead of the 
5-fold increase observed in the previous studies (C larke and 
Clem ents, 1991; Hwang and Shillitoe, 1990).
Thus the FG-293 cell line proved suitable for use in the 
m utagenesis assay and the tim ing of transfection  and infection 
appeared to have little  effect on the overall efficiency of 
transform ant recovery and the % m utagenesis frequency.
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5.3.5 T ransform ation  of  E. coli strain M BM 7070
Two methods of transform ation were compared, heat shock 
described in Section 5.2.2 (d), using com petent cells prepared by 
three calcium  chloride derived methods A, B and C described in 
Section 5.2.2 (c) and electroporation described in M aterials and 
M ethods 2.2.10 (a) and (b). lOOpg of either pZ189 or pUC18 
DNA was used to transform  MBM7070 cells by the m ethods 
detailed above, the results are shown in Table 5.4. 
E lectroporation proved to be the method of choice producing 
1 .8 x l0 8 transform ants/pg  of pZ189 DNA. The other methods 
producing 106 transform ants/pg of pZ189 DNA.
5.3.6 HSV induced mutagenesis
The pZ189 m utagenesis assay was used to determ ine the 
m utation frequency induced by infection with a range o f HSV-1 
virus stocks. Cells were infected at a moi of 10 pfu/cell for 6h, 
the resu lts of these experim ents are shown in Table 5.5. Two of 
the experim ents were carried out in Prof. E. S h illitoe’s laboratory 
under the supervision o f his research assistan t S. Zhang. The 
virus induced m utation frequency was determ ined on average to be 
0.043% , 2 .5-fold  above the spontaneous m utation frequency of 
0.02%. These results are in agreem ent with those presented in 
Table 5.3. No difference in the ability  to increase the m utagenic 
frequency was observed between the three HSV-1 strains or the 
four HSV-1 (17+) stocks used. Included as a positive control for 
the assay are the results of transfection  studies using 
hydroxylam ine m utated pZ189 DNA. The resulting m utation 
frequency was extrem ely high 0.62% dem onstrating that there is 
no deficiency in the detection o f m utations which could account
1 6 8
Transformation
method p Z l 89
Plasmid
pU C18
A 1.2x106 (7 ) 5.36x106 (5)
B 1.41x106 (6) 5.9x106 (6)
C 2.62x105 (3) 4.49x106 (3)
D 1.8x108 (6) 4.4x108 (2)
TABLE 5.4:
Comparison o f  four transformation methods. Values represent  
the mean number o f  transformants produced from lp g  o f  
plasmid DNA. The number o f  experiments from which the 
mean was derived is given in parenthesis. Transformation was  
carried by heat shock using competent cells prepared by 
A - calcium chloride precipitation with DTT and MES,
B - calcium chloride precipitation
C - calcium chloride precipitation with a DMSO boost.
Method D - transformation by electroporation.
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for the reduced levels of HSV induced m utation frequency 
observed.
s.4 Discussion
The short term aim of increasing the efficiency of the 
m utagenesis assay has been achieved. Recovery o f transform ants 
from the mock infected control and virus infected test averaging 
8448 and 7427 transform ants/lO pg transfected DNA respectively. 
This com pares favourably with the data o f Hwang and Shillitoe
(1990). The virus induced m utation frequency was shown 
consistently  to be around 2.5-fold higher than the spontaneous 
m utation frequency, which dem onstrates that HSV-1 infection can 
increase the level of m utations occurring in target DNA and by 
inference cellu lar DNA. However this observed increase in the 
m utation frequency induced by HSV infection was lower than that 
obtained by Clarke and Clements, (1991) and Hwang and Shillitoe
(1990). S tatistical analysis of this data using F isher's exact test 
showed that the virus induced m utation frequency was not 
sign ifican tly  different from the spontaneous m utation frequency 
(p>0.5).
Fulfilm ent o f the original aim of this study, iden tification  of 
the m utagenic property o f the virus, requires that individual 
properties of viral proteins and/or viral DNA be exam ined 
separately  from the virus as a whole. Any m utation frequency 
produced would be likely under these circum stances to be lower 
than that produced by the whole virus. Using this assay at its 
current level o f sensitiv ity  it would seem unlikely that any 
changes in m utation frequency could be unequivocally  linked to a 
particu lar property of the virus. Considerable tim e had already
1 6 9
M u ta g en esis
been spent on optim isation of transform ant recovery in the 
m utagenesis assay and further optim isation was deemed 
im practical. In view of this and the fact that Prof. E. Shillitoe 
had intim ated that he was ready to publish a detailed analysis o f 
the m utagenic properties o f HSV (Shillitoe et a l ., 1993), it was 
decided that further work on the project would not be carried out.
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